Universitätspublikationen
Refine
Year of publication
Document Type
- Article (4771)
- Preprint (174)
- Doctoral Thesis (101)
- Conference Proceeding (75)
- Part of Periodical (12)
- Part of a Book (8)
- Book (7)
- Review (4)
- Report (1)
- Working Paper (1)
Language
- English (5154) (remove)
Has Fulltext
- yes (5154)
Keywords
- inflammation (80)
- COVID-19 (57)
- SARS-CoV-2 (48)
- glioblastoma (38)
- apoptosis (37)
- cancer (37)
- Inflammation (34)
- autophagy (29)
- prostate cancer (29)
- breast cancer (27)
- Cancer (26)
- biomarker (24)
- immunotherapy (23)
- ADHD (22)
- macrophage (22)
- Apoptosis (21)
- Depression (21)
- Video (19)
- chemotherapy (19)
- epilepsy (19)
- hypoxia (19)
- mitochondria (19)
- Breast cancer (18)
- Epilepsy (18)
- data science (18)
- microRNA (18)
- pain (18)
- reactive oxygen species (18)
- aging (17)
- angiogenesis (17)
- Biomarker (16)
- Quality of life (16)
- children (16)
- glioma (16)
- Cirrhosis (15)
- Germany (15)
- Neuroscience (15)
- Stroke (15)
- Surgery (15)
- Treatment (15)
- depression (15)
- endothelial cells (15)
- fMRI (15)
- proliferation (15)
- radical prostatectomy (15)
- tumor microenvironment (15)
- Genetics (14)
- MRI (14)
- Magnetic resonance imaging (14)
- cirrhosis (14)
- cytokines (14)
- obesity (14)
- quality of life (14)
- schizophrenia (14)
- stroke (14)
- Biomarkers (13)
- HIV (13)
- Human behaviour (13)
- Mortality (13)
- NADPH oxidase (13)
- Oncology (13)
- Outcome (13)
- Radiotherapy (13)
- attention (13)
- bladder cancer (13)
- macrophages (13)
- multiple sclerosis (13)
- Angiogenesis (12)
- Capsule endoscopy (12)
- EEG (12)
- Gene expression (12)
- Immunotherapy (12)
- Machine learning (12)
- Mitochondria (12)
- ROS (12)
- lung cancer (12)
- mTOR (12)
- prevention (12)
- psoriasis (12)
- survival (12)
- targeted therapy (12)
- Endoscopy (11)
- Heart failure (11)
- Immunology (11)
- cell death (11)
- child (11)
- diagnosis (11)
- epidemiology (11)
- hepatitis C virus (11)
- integrins (11)
- invasion (11)
- macrophage polarization (11)
- miRNA (11)
- mortality (11)
- outcome (11)
- radiotherapy (11)
- Atrial fibrillation (10)
- COPD (10)
- Chemotherapy (10)
- Diagnostic markers (10)
- Epidemiology (10)
- Hepatocellular carcinoma (10)
- Parkinson’s disease (10)
- Primary care (10)
- Research article (10)
- Survival (10)
- cognition (10)
- colorectal cancer (10)
- epigenetics (10)
- extracellular matrix (10)
- gene therapy (10)
- infection (10)
- leukemia (10)
- metastasis (10)
- migration (10)
- neuroblastoma (10)
- oxidative stress (10)
- prevalence (10)
- proteomics (10)
- risk factors (10)
- surgery (10)
- treatment (10)
- Autophagy (9)
- Bipolar disorder (9)
- Blood (9)
- General practice (9)
- Hemorrhage (9)
- Macrophages (9)
- PCR (9)
- Pain (9)
- Prostate cancer (9)
- Proteomics (9)
- Schizophrenia (9)
- Small bowel (9)
- Suicide (9)
- VEGF (9)
- artificial intelligence (9)
- brain metastases (9)
- complications (9)
- coronavirus (9)
- development (9)
- elderly (9)
- fibrosis (9)
- innate immunity (9)
- liver (9)
- machine learning (9)
- metabolism (9)
- neurodegeneration (9)
- osteoarthritis (9)
- portal hypertension (9)
- ACLF (8)
- Acute myeloid leukemia (8)
- Cardiovascular magnetic resonance (8)
- Children (8)
- Diagnosis (8)
- Drug therapy (8)
- Europe (8)
- Hepatitis C virus (8)
- Liver diseases (8)
- Multimorbidity (8)
- NASH (8)
- Osteoporosis (8)
- Seizure (8)
- TAVI (8)
- Trauma (8)
- adhesion (8)
- aortic stenosis (8)
- biomarkers (8)
- curcumin (8)
- differentiation (8)
- drug resistance (8)
- hepatocellular carcinoma (8)
- human (8)
- magnetic resonance imaging (8)
- monocytes (8)
- p53 (8)
- periodontitis (8)
- physical activity (8)
- polypharmacy (8)
- polytrauma (8)
- sphingosine-1-phosphate (8)
- trauma (8)
- ubiquitin (8)
- vaccination (8)
- Autism spectrum disorder (7)
- Borrelia (7)
- Cell biology (7)
- DNA methylation (7)
- EGFR (7)
- Endothelial cells (7)
- Forensic entomology (7)
- HCV (7)
- Herb induced liver injury (7)
- Hypoxia (7)
- Medical research (7)
- Mental health and psychiatry (7)
- Molecular biology (7)
- NK cells (7)
- Obesity (7)
- PD-L1 (7)
- Patients (7)
- Postural control (7)
- Prognosis (7)
- Rheumatoid arthritis (7)
- TRAIL (7)
- antiviral therapy (7)
- atherosclerosis (7)
- bipolar disorder (7)
- chronic kidney disease (7)
- efficacy (7)
- gender (7)
- gene expression (7)
- heart failure (7)
- hematopoietic stem cell transplantation (7)
- hereditary angioedema (7)
- hippocampus (7)
- iron (7)
- liver cirrhosis (7)
- liver transplantation (7)
- machine-learning (7)
- microbiome (7)
- mouse (7)
- multimorbidity (7)
- natural killer cells (7)
- neuropathic pain (7)
- pregnancy (7)
- primary care (7)
- prognosis (7)
- qualitative research (7)
- renal cell carcinoma (7)
- seizure (7)
- sepsis (7)
- sphingolipids (7)
- therapy (7)
- thrombosis (7)
- toxicity (7)
- working memory (7)
- ATM (6)
- Antiviral therapy (6)
- Calliphoridae (6)
- Cancer treatment (6)
- Clinical trial (6)
- Colorectal cancer (6)
- Comorbidity (6)
- Complications (6)
- Crohn’s disease (6)
- Data science (6)
- Death rates (6)
- Diabetes mellitus (6)
- Elderly (6)
- Glioblastoma (6)
- HBV (6)
- HDAC (6)
- Histology (6)
- Hypertension (6)
- Immunohistochemistry (6)
- Incidence (6)
- Liver transplantation (6)
- Malaria (6)
- Mammakarzinom (6)
- Morbidity (6)
- Multiple sclerosis (6)
- Multivariate analysis (6)
- Neurology (6)
- Oral anticoagulation (6)
- Outcomes (6)
- PI3K (6)
- Patient blood management (6)
- Pneumonia (6)
- Portal hypertension (6)
- Pregnancy (6)
- Prevalence (6)
- Rare diseases (6)
- Reactive oxygen species (6)
- Rectal cancer (6)
- Risk factors (6)
- Surgical and invasive medical procedures (6)
- T cell (6)
- T cells (6)
- Transfusion (6)
- Translational research (6)
- Viral load (6)
- acute myeloid leukemia (6)
- acute-on-chronic liver failure (6)
- asthma (6)
- atrial fibrillation (6)
- bevacizumab (6)
- cochlear implant (6)
- cytotoxicity (6)
- dentate gyrus (6)
- diabetes (6)
- environmental tobacco smoke (6)
- exercise (6)
- exosomes (6)
- fibroblasts (6)
- flow cytometry (6)
- growth (6)
- immunity (6)
- information theory (6)
- integrin (6)
- iron deficiency (6)
- melanoma (6)
- mesenchymal stromal/stem cells (6)
- microglia (6)
- ovarian cancer (6)
- particulate matter (6)
- platelets (6)
- radiation (6)
- resistance (6)
- signal transduction (6)
- sphingosine 1-phosphate (6)
- stress (6)
- tumor-associated macrophages (6)
- vitamin D (6)
- AML (5)
- Adenocarcinoma (5)
- Aging (5)
- Anemia (5)
- Anticoagulation (5)
- Aortic stenosis (5)
- Artificial intelligence (5)
- Aspergillus (5)
- Atherosclerosis (5)
- Attention (5)
- Attitude (5)
- Autopsy (5)
- B cells (5)
- Balloon enteroscopy (5)
- Biochemistry (5)
- C-reactive protein (5)
- Cardiovascular diseases (5)
- Cell signalling (5)
- Clinical trials (5)
- Cognition (5)
- Consensus (5)
- Critical care (5)
- Cytokines (5)
- DMEK (5)
- Dopamine (5)
- Drug induced liver injury (5)
- Enteroscopy (5)
- Epigenetics (5)
- Ewing sarcoma (5)
- Experimental models of disease (5)
- Gender (5)
- Gene regulation (5)
- Glioma (5)
- HIV-1 (5)
- HNSCC (5)
- Heart (5)
- Hepatotoxicity (5)
- Herbal hepatotoxicity (5)
- Hippocampus (5)
- Hodgkin lymphoma (5)
- IL-6 (5)
- MEG (5)
- Machine-learning (5)
- Melanoma (5)
- MicroRNAs (5)
- Molecular neuroscience (5)
- Mouse models (5)
- Musculoskeletal system (5)
- NF-κB (5)
- NK cell (5)
- NK-92 (5)
- NKG2D (5)
- Non-small cell lung cancer (5)
- Omicron (5)
- Parkinson's disease (5)
- Physical activity (5)
- Physiology (5)
- Platelet-rich fibrin (5)
- Polypharmacy (5)
- Predictive markers (5)
- Prevention (5)
- Prävention (5)
- Psychiatric disorders (5)
- RUCAM (5)
- Radiomics (5)
- Randomized controlled trial (5)
- Rhabdomyosarcoma (5)
- Safety (5)
- Sepsis (5)
- Signaling (5)
- Smac (5)
- Surgical oncology (5)
- Targeted therapy (5)
- Training (5)
- Tumor microenvironment (5)
- Ubiquitination (5)
- Ultrasound (5)
- Vaccination (5)
- Validation (5)
- XIAP (5)
- acute coronary syndrome (5)
- acute lymphoblastic leukemia (5)
- adaptation (5)
- adolescents (5)
- ataxia telangiectasia (5)
- cardiac surgery (5)
- cell therapy (5)
- ceramides (5)
- chimeric antigen receptor (5)
- clinical trial (5)
- colon cancer (5)
- complement (5)
- conduct disorder (5)
- dental implant (5)
- dental implants (5)
- diabetes mellitus (5)
- diffusion tensor imaging (5)
- digital medicine (5)
- everolimus (5)
- forensic entomology (5)
- graph theory (5)
- guideline (5)
- histology (5)
- hyperglycemia (5)
- immunohistochemistry (5)
- influenza (5)
- lipocalin-2 (5)
- liver fibrosis (5)
- lncRNA (5)
- long non-coding RNA (5)
- mTORC1 (5)
- medical students (5)
- meningioma (5)
- metabolomics (5)
- metastases (5)
- mice (5)
- mutual information (5)
- natural killer cell (5)
- outcomes (5)
- overall survival (5)
- patient blood management (5)
- patients (5)
- phosphorylation (5)
- plasticity (5)
- precision medicine (5)
- predictive coding (5)
- preeclampsia (5)
- prophylaxis (5)
- prostaglandins (5)
- public health (5)
- quantitative MRI (5)
- regeneration (5)
- rhabdomyosarcoma (5)
- safety (5)
- sulforaphane (5)
- synaptic plasticity (5)
- systematic review (5)
- transcranial magnetic stimulation (5)
- ubiquitination (5)
- valproic acid (5)
- vector (5)
- 177Lu-PSMA-617 (4)
- 3D printing (4)
- ABCB1 (4)
- ARDS (4)
- Acute inflammation (4)
- Acute lymphoblastic leukemia (4)
- Adhesion (4)
- Age groups (4)
- Alcohol (4)
- Alzheimer’s disease (4)
- Angiography (4)
- Animal models (4)
- Aortic valve (4)
- Ascites (4)
- Aspergillus fumigatus (4)
- Ataxia telangiectasia (4)
- Autism (4)
- Bacterial infection (4)
- Behandlung (4)
- Biopsy (4)
- Bladder cancer (4)
- Blood pressure (4)
- Bone density (4)
- Bone marrow (4)
- Brain (4)
- Brain metastasis (4)
- Burden of illness (4)
- CIK cells (4)
- CRISPR/Cas9 (4)
- CT (4)
- CXCR4 (4)
- Cardiology (4)
- Cardiovascular disease (4)
- Cell staining (4)
- Cell therapy (4)
- Cesarean section (4)
- Chronic kidney disease (4)
- Classification (4)
- Clinical genetics (4)
- Cochlear implant (4)
- Cohort studies (4)
- Computed tomography (4)
- Conduct disorder (4)
- DILI (4)
- DNA damage (4)
- Data processing (4)
- Decision making (4)
- Decorin (4)
- Denosumab (4)
- Density equalizing mapping (4)
- Developmental biology (4)
- Diagnostic medicine (4)
- Dravet syndrome (4)
- ER stress (4)
- Education (4)
- Emotion regulation (4)
- Emotions (4)
- Endoscopic retrograde cholangiopancreatography (4)
- Evaluation (4)
- Everolimus (4)
- Evidence-based medicine (4)
- Exercise (4)
- Extracellular matrix (4)
- Extracellular vesicles (4)
- Fibrosis (4)
- Flow cytometry (4)
- Gastric cancer (4)
- Genetics research (4)
- Guidelines (4)
- HCC (4)
- Health care (4)
- Healthcare worker (4)
- Heart transplantation (4)
- Hematology (4)
- Hereditary angioedema (4)
- Homeostasis (4)
- IAP proteins (4)
- In vitro (4)
- Infection (4)
- Innate immunity (4)
- IntelliCage (4)
- Intensive care (4)
- Intensive care units (4)
- Interleukin-6 (4)
- Kinematic analysis (4)
- Knees (4)
- Labor and delivery (4)
- Legs (4)
- Liver cirrhosis (4)
- Liver fibrosis (4)
- Long non-coding RNAs (4)
- Lung failure (4)
- MRSA (4)
- MSD (4)
- Mechanisms of disease (4)
- Medical education (4)
- Medical risk factors (4)
- Metastasen (4)
- Molecular medicine (4)
- Mouse (4)
- Multidetector computed tomography (4)
- Myocardial infarction (4)
- NAFLD (4)
- Neonates (4)
- Neutropenia (4)
- Next-generation sequencing (4)
- Nox4 (4)
- NoxO1 (4)
- Nrf2 (4)
- OSCE (4)
- PSMA (4)
- Patient safety (4)
- Pediatric (4)
- Personalized medicine (4)
- Physicians (4)
- Prediction (4)
- Proliferation (4)
- Prophylaxis (4)
- Psychology (4)
- Pulmonary embolism (4)
- Quantitative MRI (4)
- Registry (4)
- Roussel Uclaf Causality Assessment Method (4)
- STAT3 (4)
- Sex (4)
- Sex differences (4)
- Status epilepticus (4)
- Stem cell (4)
- Stem cells (4)
- Systematic review (4)
- Thrombosis (4)
- Tissue engineering (4)
- acetaminophen (4)
- acute kidney injury (4)
- adverse events (4)
- age (4)
- alirocumab (4)
- anaemia (4)
- anemia (4)
- animal model (4)
- antibodies (4)
- antioxidants (4)
- augmentation (4)
- bibliometrics (4)
- bibliometry (4)
- bioinformatics (4)
- brachytherapy (4)
- cGMP (4)
- cancer stem cells (4)
- cardiovascular disease (4)
- cell biology (4)
- cell migration (4)
- cerebrospinal fluid (4)
- cervical cancer (4)
- chemoradiotherapy (4)
- chemoresistance (4)
- cholesterol (4)
- climate change (4)
- clinical study (4)
- combination therapy (4)
- computed tomography (4)
- connectivity (4)
- critical care (4)
- cystic fibrosis (4)
- cytomegalovirus (4)
- dendritic cells (4)
- dentist (4)
- direct-acting antivirals (4)
- doxorubicin (4)
- electrolytic cleaning (4)
- entropy (4)
- ergonomics (4)
- external beam radiotherapy (4)
- extracellular vesicles (4)
- fatigue (4)
- functional magnetic resonance imaging (4)
- general practice (4)
- haemophilia treatment (4)
- health-related quality of life (4)
- heart (4)
- hemorrhage (4)
- hepatitis C (4)
- imaging (4)
- immune evasion (4)
- immune response (4)
- impulsivity (4)
- in vitro (4)
- inflammasome (4)
- inflammatory bowel disease (4)
- kidney (4)
- leukocytes (4)
- levetiracetam (4)
- lipoxygenase (4)
- mass spectrometry (4)
- mesenchymal stromal cells (4)
- metabolic syndrome (4)
- metastatic prostate cancer (4)
- motility (4)
- musculoskeletal disorders (4)
- neural oscillations (4)
- nitric oxide (4)
- nociception (4)
- p21 (4)
- pancreatic cancer (4)
- pandemic (4)
- pediatric (4)
- perception (4)
- periimplantitis (4)
- peripheral artery disease (4)
- phagocytosis (4)
- primary cilium (4)
- primary immunodeficiency (4)
- proteome (4)
- psoriatic arthritis (4)
- questionnaire (4)
- rapamycin (4)
- registry (4)
- rheumatoid arthritis (4)
- sex differences (4)
- simulation training (4)
- smoking (4)
- spirochetes (4)
- status epilepticus (4)
- temozolomide (4)
- temporal lobe epilepsy (4)
- thrombolysis (4)
- thymus (4)
- tissue engineering (4)
- tooth loss (4)
- transfusion (4)
- transplantation (4)
- traumatic brain injury (4)
- treatment centres (4)
- tumor growth (4)
- tumor progression (4)
- vaccine (4)
- wound healing (4)
- (surface) partial differential equations (3)
- 3D rapid prototyping (3)
- ADAM15 (3)
- Acute kidney injury (3)
- Adults (3)
- Adverse events (3)
- Amblyopia (3)
- Antibiotics (3)
- Antiretroviral therapy (3)
- Anxiety (3)
- Aortic valve replacement (3)
- Ataxia-telangiectasia (3)
- B-cell lymphoma (3)
- BAG3 (3)
- BCR/ABL (3)
- BMC (3)
- BMI (3)
- BRAF (3)
- BRD4 (3)
- Behavior (3)
- Bibliometrics (3)
- Blood-brain barrier (3)
- Bone defect (3)
- Bone regeneration (3)
- Bone tissue engineering (3)
- C. elegans (3)
- C1 inhibitor (3)
- CAD/CAM (3)
- CAR (3)
- CD36 (3)
- CDK4/6 (3)
- COMP (3)
- CRM (3)
- CRP (3)
- CTGF (3)
- CXCL12 (3)
- Calcium (3)
- Cancer chemotherapy (3)
- Cancer detection and diagnosis (3)
- Cancer genetics (3)
- Cancer genomics (3)
- Candida (3)
- Cannabis (3)
- Cardiac surgery (3)
- Case report (3)
- Catheter ablation (3)
- Cell proliferation (3)
- Cerebellum (3)
- Cerebrospinal fluid (3)
- Chaperone (3)
- Chemoradiotherapy (3)
- Child (3)
- Chromatin accessibility (3)
- Chronic hepatitis C (3)
- Citation analysis (3)
- Clinical Trials and Observations (3)
- Clinical decision support systems (3)
- Cognitive impairment (3)
- Cognitive neuroscience (3)
- Collagen (3)
- Complex I (3)
- Computer software (3)
- Computer-assisted diagnosis (3)
- Connective tissue (3)
- Coronary heart disease (3)
- Costs (3)
- Cytoskeleton (3)
- DAA (3)
- DNA mismatch repair (3)
- DNase1-seq (3)
- DTI (3)
- Deep brain stimulation (3)
- Dental implant (3)
- Dental students (3)
- Dose response (3)
- Drug hepatotoxicity (3)
- Drug resistance (3)
- ECMO (3)
- EEG microstates (3)
- Eccentric fixation (3)
- Edema (3)
- Efficiency (3)
- Ejection fraction (3)
- Endocrinology (3)
- Endothelium (3)
- Exosomes (3)
- Eyes (3)
- FFLU (3)
- FTY720 (3)
- Fasting (3)
- Feedback (3)
- Fibronectin (3)
- Fingolimod (3)
- Finite Volumes (3)
- Fistula (3)
- Functional clustering (3)
- G-CSF (3)
- GPCR (3)
- Gene Regulation (3)
- Gene fusion (3)
- Gene therapy (3)
- Genome-wide association studies (3)
- Global health (3)
- HAE (3)
- HER2/neu (3)
- HPV (3)
- HSCT (3)
- Head and neck cancer (3)
- Healthcare costs (3)
- Healthy adults (3)
- Hepatitis C (3)
- HoLEP (3)
- Hospitals (3)
- Human genetics (3)
- IAPs (3)
- IBD (3)
- IL-1β (3)
- Immune cells (3)
- Induction chemotherapy (3)
- Infections (3)
- Inflammatory bowel disease (3)
- Inflammatory diseases (3)
- Interleukin (3)
- Interleukin-22 (3)
- Ischemia (3)
- Kidney transplantation (3)
- Knowledge (3)
- LPS (3)
- Langerhans cell histiocytosis (3)
- Language (3)
- Lesions (3)
- Liver Transplantation (3)
- LncRNA (3)
- Lumbar spine (3)
- Lyme disease (3)
- MCAK (3)
- MLL (3)
- MYC (3)
- Macrophage polarization (3)
- Major depressive disorder (3)
- Masquelet technique (3)
- Mass spectrometry (3)
- Memory (3)
- Mental health (3)
- Mesenchymal stem cells (3)
- Messenger RNA (3)
- Metabolic diseases (3)
- Metabolomics (3)
- Microbiology (3)
- Microbiome (3)
- Microwave ablation (3)
- Migration (3)
- Mitochondrial dysfunction (3)
- Mitosis (3)
- Morphogenesis (3)
- Motor control (3)
- Multianalyte detection (3)
- Musculoskeletal disorder (3)
- NSCLC (3)
- Neurodegeneration (3)
- Neuroinflammation (3)
- Neurotransmitter (3)
- Nitric oxide (3)
- Nivolumab (3)
- Non-coding RNA (3)
- Nox (3)
- OXA-48 (3)
- Observational study (3)
- Occlusion treatment (3)
- PARK2 (3)
- PD1/PDL1 (3)
- PDGFRβ (3)
- Pandemic (3)
- Pathogenesis (3)
- Pediatric patients (3)
- Penile carcinomas (3)
- Peri-implantitis (3)
- Phagocytosis (3)
- Pharmacology (3)
- Phosphorylation (3)
- Platelets (3)
- Podospora anserina (3)
- Portal veins (3)
- Pre-analytics (3)
- Preclinical research (3)
- Preterm birth (3)
- Primary health care (3)
- Prognostic markers (3)
- Progranulin (3)
- Protease inhibitor therapy (3)
- Public health (3)
- Pulmonary hypertension (3)
- Questionnaire (3)
- RCT (3)
- RITA (3)
- RNA (3)
- RNA therapeutics (3)
- Reaction time (3)
- Registries (3)
- Regression analysis (3)
- Reliability (3)
- Renal cell carcinoma (3)
- Research Article (3)
- Respiration (3)
- S1P (3)
- SUMO (3)
- Sarcoma (3)
- Screening (3)
- Senescence (3)
- Sensitivity (3)
- Simulated patients (3)
- Sleep (3)
- Spine (3)
- Sport (3)
- Sports and exercise medicine (3)
- Squamous cell carcinoma (3)
- Statistical data (3)
- Stereotactic body radiation therapy (3)
- Studien (3)
- Sudden cardiac death (3)
- Surgeons (3)
- Surveillance (3)
- TGF-β (3)
- TIPS (3)
- TKI (3)
- Tacrolimus (3)
- Telemedicine (3)
- Temozolomide (3)
- Therapy (3)
- Thoracic trauma (3)
- Torque (3)
- Toxicity (3)
- Transarterial chemoembolization (3)
- Transcription factors (3)
- Treatment outcome (3)
- Type 2 diabetes (3)
- Undergraduate medical education (3)
- Upper body posture (3)
- Variant histology (3)
- Wound healing (3)
- Zika virus (3)
- Zoonosis (3)
- acute coronary syndromes (3)
- acute decompensation (3)
- adenosine (3)
- adjuvant chemotherapy (3)
- aged (3)
- ageing (3)
- aggression (3)
- albumin (3)
- alcohol (3)
- alcohol use disorder (3)
- allogeneic stem cell transplantation (3)
- alveolar ridge augmentation (3)
- anal cancer (3)
- animal (3)
- animal models (3)
- anti-angiogenic therapy (3)
- antiviral (3)
- arteriogenesis (3)
- ascites (3)
- astrocytes (3)
- autism spectrum disorder (3)
- bacteria (3)
- behavior (3)
- bioenergetics (3)
- bleeding (3)
- blood (3)
- blood transfusion (3)
- body mass index (3)
- bone (3)
- bone regeneration (3)
- bortezomib (3)
- brain metastasis (3)
- burden of illness (3)
- cAMP (3)
- callous-unemotional traits (3)
- calretinin (3)
- cancer immunotherapy (3)
- carbapenemases (3)
- cardiac (3)
- caregivers (3)
- cartilage (3)
- caspase-2 (3)
- caspase-8 (3)
- catheter ablation (3)
- cell cycle (3)
- cerebellum (3)
- chemokines (3)
- chronic myeloid leukemia (3)
- cisplatin (3)
- classical Hodgkin lymphoma (3)
- clinical research (3)
- clinical trials (3)
- clock genes (3)
- co-infection (3)
- collagen (3)
- comorbidity (3)
- complexome profiling (3)
- computational virology (3)
- confinement (3)
- continuous performance test (3)
- cortex (3)
- cortisol (3)
- cytokine-induced killer cells (3)
- dementia (3)
- dental education (3)
- dental profession (3)
- dexamethasone (3)
- diabetic nephropathy (3)
- diagnostic algorithm (3)
- dopamine (3)
- drug discovery (3)
- drug induced liver injury (3)
- echocardiography (3)
- electroencephalography (3)
- electrophysiology (3)
- endocannabinoids (3)
- endoplasmic reticulum (3)
- epidermal growth factor receptor (3)
- event-related potentials (3)
- executive function (3)
- fenfluramine (3)
- focal adhesion (3)
- follow-up (3)
- functional connectivity (3)
- functional outcome (3)
- gamma (3)
- gastric cancer (3)
- gene regulation (3)
- glycolysis (3)
- growth inhibition (3)
- haemophilia care (3)
- head and neck cancer (3)
- healthcare worker (3)
- heart rate (3)
- hematopoietic stem and progenitor cells (3)
- hemodialysis (3)
- hepatitis B (3)
- hepatitis C virus (HCV) (3)
- herb induced liver injury (3)
- histone acetylation (3)
- hyperactivity (3)
- immune cells (3)
- immune checkpoint inhibitors (3)
- immune escape (3)
- immune reconstitution (3)
- immunology (3)
- inertial motion capture (3)
- insulin resistance (3)
- interleukin-22 (3)
- invasive fungal disease (3)
- invasive fungal infection (3)
- iron metabolism (3)
- irradiation (3)
- kidney transplantation (3)
- leptin (3)
- lipids (3)
- liver injury (3)
- lockdown (3)
- long-term prophylaxis (3)
- lung function (3)
- lyme disease (3)
- lymphoma (3)
- mRNA (3)
- magnetoencephalography (3)
- management (3)
- massively parallel multigrid solvers (3)
- mathematical modeling (3)
- memory (3)
- metformin (3)
- miRNAs (3)
- microwave ablation (3)
- mild cognitive impairment (3)
- mitochondrial disease (3)
- mitophagy (3)
- mitosis (3)
- modeling (3)
- monitoring (3)
- mouse model (3)
- multidrug resistance (3)
- multiple myeloma (3)
- mycophenolic acid (3)
- necroptosis (3)
- neoadjuvant therapy (3)
- neonate (3)
- neoplasms (3)
- neurocritical care (3)
- neuroimaging (3)
- neutralization (3)
- neutralizing antibodies (3)
- next-generation sequencing (3)
- non-coding RNA (3)
- observational study (3)
- oncology (3)
- osteoporosis (3)
- overweight (3)
- oxidative phosphorylation (3)
- p47phox (3)
- patient safety (3)
- pediatric patients (3)
- pentose phosphate pathway (3)
- perforant path transection (3)
- perfusion (3)
- peri-implantitis (3)
- plasmid (3)
- pneumonia (3)
- postoperative complications (3)
- postoperative pain (3)
- prefrontal cortex (3)
- primary health care (3)
- primary prostate cancer (3)
- prostaglandin (3)
- proteoglycan (3)
- pulmonary hypertension (3)
- radical prostatecomy (3)
- rat (3)
- realistic geometries (3)
- remodelling (3)
- renal cell cancer (3)
- reproducibility (3)
- resting state (3)
- review (3)
- rituximab (3)
- salvage therapy (3)
- screening (3)
- seizures (3)
- senescence (3)
- serum (3)
- severe acute respiratory syndrome coronavirus 2 (3)
- sex (3)
- signaling (3)
- skeletal muscle (3)
- sleep (3)
- soft tissue sarcoma (3)
- sphingolipid (3)
- spinal cord (3)
- stem cell transplantation (3)
- strength training (3)
- stress response (3)
- supportive periodontal therapy (3)
- surgical procedures (3)
- systematic biopsy (3)
- systemic antibiotics (3)
- therapeutics (3)
- tobacco prevention (3)
- toll-like receptor (3)
- transcription factor (3)
- transcriptome (3)
- transient elastography (3)
- tyrosine kinase inhibitor (3)
- tyrosine kinase inhibitors (3)
- ultrasound (3)
- vemurafenib (3)
- viral dynamics (3)
- working conditions (3)
- yeast (3)
- 3D spatio-temporal resolved mathematical models (2)
- 5-lipoxygenase (2)
- A/D transition (2)
- ABCC1 (2)
- ABCG2 (2)
- AIDS (2)
- AKI (2)
- ALK (2)
- ALL (2)
- AMPK (2)
- ATP (2)
- ATP-citrate lyase (2)
- Abort (2)
- Academic medicine (2)
- Access (2)
- Accidental reaction (2)
- Acinetobacter baumannii (2)
- Acoustics (2)
- Activities of daily living (2)
- Acuris (2)
- Acute Myeloid Leukemia (AML) (2)
- Acute decompensation (2)
- Acute lymphocytic leukaemia (2)
- Acute myeloid leukaemia (2)
- Acute-on-chronic liver failure (2)
- Addiction (2)
- Addison’s disease (2)
- Adherence (2)
- Adipose tissue (2)
- Adipose-derived mesenchymal stem cells (2)
- Adolescents (2)
- Adult neurogenesis (2)
- Aedes aegypti (2)
- Aedes albopictus (2)
- Age estimation (2)
- Akaike information criterion (AIC) (2)
- Alcohol consumption (2)
- Alcoholic liver disease (2)
- Algorithms (2)
- Alleles (2)
- Allergen avoidance (2)
- Allergic asthma (2)
- Allergy (2)
- Allosteric inhibition (2)
- Alzheimer (2)
- Alzheimer's disease (2)
- Anaemia (2)
- Anandamide (2)
- Anatomy (2)
- Animal model (2)
- Anti-IgE (2)
- Antibodies (2)
- Anticoagulant therapy (2)
- Antimicrobial treatment (2)
- Antiretrovirals (2)
- Aortic dissection (2)
- Apheresis (2)
- Apixaban (2)
- Arrhythmia (2)
- Asphyxia (2)
- Assessment (2)
- Ataxia (2)
- Attention-deficit/hyperactivity disorder (2)
- Auditory system (2)
- Aurora A (2)
- Austria (2)
- Autoimmunity (2)
- Autologous biomaterial (2)
- BA.1 (2)
- BCL2 (2)
- BCL6 (2)
- BCOR (2)
- BCX7353 (2)
- BDNF (2)
- BMNC (2)
- BNT162b2 (2)
- BPH (2)
- BRCA1 (2)
- BRCA2 (2)
- Babesia divergens (2)
- Babesia microti (2)
- Benefit (2)
- Bevacizumab (2)
- Big Five (2)
- Biglycan (2)
- Bile duct stone (2)
- Biofilm (2)
- Bioinformatics (2)
- Biomedical informatics (2)
- Biophysical models (2)
- Biorecognition strategies (2)
- Biosynthetic mesh (2)
- Birth weight (2)
- Bleeding (2)
- Blood groups (2)
- Blood loss (2)
- Blood loss estimation (2)
- Blood plasma (2)
- Bloodstream infections (2)
- Blow flies (2)
- Body mass index (2)
- Body modification (2)
- Bone marrow aspiration (2)
- Bone marrow-derived mesenchymal stem cells (2)
- Borrelia burgdorferi (2)
- Brain tumor (2)
- Breast neoplasms (2)
- Breast tumors (2)
- Burden of disease (2)
- CAM (2)
- CBA (2)
- CC16 (2)
- CCL2 (2)
- CD14 (2)
- CD16 (2)
- CD19 (2)
- CD44 (2)
- CDK9 (2)
- CDKN1A (2)
- CIOMS (2)
- CLP (2)
- CMR (2)
- COVID 19 (2)
- COVID-19 surveillance (2)
- CPE (2)
- CRISPR/Cas (2)
- CSM (2)
- CTLA-4 (2)
- CUELA (2)
- CV9202 (2)
- CXCR3 (2)
- Callous-unemotional traits (2)
- Calpain (2)
- Cancer epidemiology (2)
- Cancer models (2)
- Cancer therapy (2)
- Cancer-specific mortality (2)
- Cannabidiol (2)
- Capecitabine (2)
- Cardiac arrest (2)
- Cardiac hypertrophy (2)
- Cardiac magnetic resonance (2)
- Cardioprotection (2)
- Cardiovascular biology (2)
- Case management (2)
- Causality assessment (2)
- Celiac disease (2)
- Cell binding (2)
- Cell culture (2)
- Cell death (2)
- Cell death and immune response (2)
- Cell differentiation (2)
- Cell division (2)
- Cell salvage (2)
- Checkpoint inhibitor (2)
- Chemical biology (2)
- Chemokines (2)
- Cholangiography (2)
- Cholangiopancreatography (2)
- Chondrocytes (2)
- Chronic disease (2)
- Chronic hepatitis (2)
- Chronic inflammation (2)
- Chronic obstructive pulmonary disease (2)
- Clinical Global Impression of Change (2)
- Clinical presentation (2)
- Clinical studies (2)
- Clinical study (2)
- Cocaine (2)
- Cochlear implantation (2)
- Cognitive behavioral therapy (2)
- Colloids (2)
- Colonoscopy (2)
- Communication (2)
- Community based intervention (2)
- Community health services (2)
- Comorbidities (2)
- Comparative analysis (2)
- Compliance (2)
- Complication management (2)
- Computational models (2)
- Computed Tomography (2)
- Computer hardware (2)
- Computer science (2)
- Connectivity (2)
- Corona (2)
- Coronary artery disease (2)
- Cortex (2)
- Cost-effectiveness (2)
- Covid-19 (2)
- Cre-recombinase (2)
- Croatia (2)
- Crohn's disease (2)
- Cryoelectron microscopy (2)
- Crystal structure (2)
- CspZ (2)
- Cuela (2)
- CyberKnife robotic radiosurgery (2)
- CysLTR1 (2)
- Cystic fibrosis (2)
- Cytogenetics (2)
- Cytoskeletal proteins (2)
- DMARDs (biologic) (2)
- DNA damage response (2)
- DSM (2)
- Daptomycin (2)
- Data visualization (2)
- Decision (2)
- Decision trees (2)
- Degradation (2)
- Dengue (2)
- Density-equalizing mapping (2)
- Dental implants (2)
- Dentist (2)
- Dentistry (2)
- Development (2)
- Diabetes (2)
- Diagnose (2)
- Diagnostic algorithm (2)
- Diagnostic imaging (2)
- Diagnostic test (2)
- Differential diagnosis (2)
- Differentiation (2)
- Digestive system procedures (2)
- Direct current electrical stimulation (2)
- Directly acting antiviral agent (2)
- Disease Activity (2)
- Diseases (2)
- Disintegration (2)
- Distance to water (2)
- Docetaxel (2)
- Double-balloon enteroscopy (2)
- Drug development (2)
- Drugs (2)
- Dynamic MRI (2)
- E3 ligase (2)
- EEG-fMRI (2)
- EET (2)
- ELISA (2)
- EMT (2)
- ENCODE-DREAM in vivo Transcription Factor binding site prediction challenge (2)
- EQ-5D (2)
- ERP (2)
- ESBL (2)
- EWSR1 (2)
- Ears (2)
- Edoxaban (2)
- Efficacy (2)
- Electrical stimulation (2)
- Electroencephalography (2)
- Electrophysiology (2)
- Elevation (2)
- Empathy (2)
- Encephalopathy (2)
- EndMT (2)
- Endocannabinoid (2)
- Endocannabinoids (2)
- Endoscopic retrograde (2)
- Endoscopic ultrasound (2)
- Endothelial permeability (2)
- Ensemble learning (2)
- Enterobacteriaceae (2)
- Enterscopy (2)
- Entscheidungsassistenz (2)
- Entzündung (2)
- Environmental support (2)
- EphB4 (2)
- Epicutaneous immunotherapy (2)
- Epidemiology and End Results (2)
- Epidermal growth factor receptor (2)
- Epileptic seizures (2)
- Epileptische Anfälle (2)
- Epstein-Barr virus (2)
- Equity (2)
- Ergonomics (2)
- Etiology (2)
- European Union (2)
- Evidence-based dentistry (2)
- Extended donor criteria (2)
- Extracellular matrix proteins (2)
- Eye movements (2)
- FEV1 (2)
- FFPE (2)
- FGFR (2)
- FHIR (2)
- Face (2)
- Family practice (2)
- Fatty liver (2)
- Feasibility (2)
- Fibroblasts (2)
- Flaps (2)
- Forensic medicine (2)
- Frailty (2)
- Frühgeburt (2)
- Fuchs endothelial dystrophy (2)
- Functional characterization (2)
- Functional connectivity (2)
- Functional electrical stimulation (2)
- Functional magnetic resonance imaging (2)
- G2A (2)
- GEMs (2)
- GFAP (2)
- GWAS (2)
- Gadobutrol (2)
- Gait analysis (2)
- Gastritis (2)
- Gastrointestinal bleeding (2)
- Gene ontology (2)
- General practitioners (2)
- Genetic testing (2)
- Geographic variation (2)
- Geographically weighted regression (GWR) (2)
- Geriatric patients (2)
- German people (2)
- Glaucoma (2)
- Gleason score (2)
- Glucose (2)
- Glucose metabolism (2)
- Glycolysis (2)
- Grafts (2)
- Growth factors (2)
- Guideline (2)
- H1N1 (2)
- HCMV (2)
- HDACi (2)
- HER2 (2)
- HIF (2)
- HIV protease inhibitors (2)
- HL7 FHIR (2)
- HOD (2)
- HSV (2)
- HSV-1 (2)
- Health care workers (2)
- Health economics (2)
- Health policy (2)
- Health services (2)
- Health services research (2)
- Healthcare resource utilization (2)
- Hematologic malignancies (2)
- Hemodynamics (2)
- HepG2 (2)
- Hepatitis (2)
- Hepatocytes (2)
- Heterogeneity (2)
- High oblique sagittal osteotomy (2)
- High-density lipoprotein (2)
- Holmes tremor (2)
- Hospital (2)
- ICD (2)
- ICU (2)
- IDH mutation (2)
- IHC (2)
- IL-10 (2)
- IL-33 (2)
- IR-A (2)
- ISR (2)
- Identification (2)
- Image analysis (2)
- Image processing (2)
- Immune suppression (2)
- Immune system (2)
- Immunity (2)
- Immunogenicity (2)
- Immunosuppression (2)
- Implementation (2)
- In vivo (2)
- Incidence rate (2)
- Incisional hernia (2)
- Indirect-binding (2)
- Indonesia (2)
- Infection control (2)
- Infectious diseases (2)
- Influenza (2)
- Information theory (2)
- Injuries (2)
- Injury (2)
- Innate Immunity (2)
- Insulin (2)
- Insulin signalling (2)
- Integration (2)
- Integrin (2)
- Intensive care treatment (2)
- Interferon (2)
- Interleukin-1 (2)
- Internet (2)
- Iron (2)
- Iron deficiency (2)
- Iron deficiency anemia (2)
- Ischemia/reperfusion injury (2)
- Ixodes ricinus (2)
- Jaw (2)
- Joint loading (2)
- KGF (2)
- Ketogenic diet (2)
- Ki-67 (2)
- Klebsiella pneumoniae (2)
- Knee joint (2)
- L-DOPA (2)
- LCMV (2)
- LSCC (2)
- LVAD (2)
- Learning and memory (2)
- Left hemisphere (2)
- Leptin (2)
- Leukemia (2)
- Leukemias (2)
- Linear regression analysis (2)
- Lipid signalling (2)
- Lipidomics (2)
- Liver (2)
- Liver cancer (2)
- Liver injury (2)
- Livestock (2)
- Local climate (2)
- Local therapy (2)
- Long-term potentiation (2)
- Longitudinal (2)
- Low back pain (2)
- Low-molecular-weight heparin (2)
- Low-virulent infection (2)
- Luciferase (2)
- Lucilia sericata (2)
- Lung cancer (2)
- Lyme borreliosis (2)
- Lymph nodes (2)
- Lymphectasia (2)
- Lymphocytes (2)
- Lymphoma (2)
- Lysophosphatidic acids (2)
- Lysosome (2)
- MALAT1 (2)
- MCAO (2)
- MCI (2)
- MICA (2)
- MLH1 (2)
- MLKL (2)
- MMP9 (2)
- MR spectroscopy (2)
- MTT assay (2)
- Macroautophagy (2)
- Magnetic resonance (2)
- Malaria prevalence (2)
- Marburg virus (2)
- Markovianity (2)
- Maxillary sinus (2)
- Medical consultation (2)
- Medical diagnostics (2)
- Medication Appropriateness Index (2)
- Medicine (2)
- Medizinstudenten (2)
- Meldepflicht (2)
- Membrane potential (2)
- Membrane proteins (2)
- Mesh (2)
- Meta-analysis (2)
- Metabolic syndrome (2)
- Metabolism (2)
- Metastasis (2)
- Metastatic (2)
- Metastatic breast cancer (2)
- Metastatic castration-resistant prostate cancer (2)
- Methicillin-resistant Staphylococcus aureus (2)
- Microsurgery (2)
- Migrants (2)
- Minimal residual disease (2)
- Mitochondrial ROS (2)
- Mitochondrial complex I (2)
- MitraClip (2)
- Mixed methods (2)
- Mobilization (2)
- Model (2)
- Molecular autopsy (2)
- Molecular profiling (2)
- Molecular subtypes (2)
- Monitoring (2)
- Monocytes (2)
- Morphology (2)
- Morphometry (2)
- Mountain (2)
- Multidrug resistance (2)
- Multiple chronic conditions (2)
- Multivariable analysis (2)
- Mutation (2)
- Mutations (2)
- Myalgia (2)
- Myeloid Neoplasia (2)
- Myocardial perfusion (2)
- Myocarditis (2)
- NADH dehydrogenase (2)
- NADH:ubiquinone oxidoreductase (2)
- NCCN (2)
- NCoR1 (2)
- NF-κB pathway (2)
- NFκB (2)
- NIRS (2)
- NK cells (2)
- NO (2)
- NOTCH1 (2)
- NS5A (2)
- Necrotizing enterocolitis (2)
- Neoplasms (2)
- Nepal (2)
- Nephrectomy (2)
- Nerve fibers (2)
- Nerve regeneration (2)
- Neural circuits (2)
- Neural stem cells (2)
- Neuroimaging (2)
- Neuron (2)
- Neuronal morphology (2)
- Neurons (2)
- Neurotoxicity (2)
- Nicotine (2)
- Non-REM sleep (2)
- Non-interventional study (2)
- Normal distribution (2)
- Nox1 (2)
- Nucleic acid biomarkers (2)
- Nutrition (2)
- OCT (2)
- Observational (2)
- Obstetrics and gynecology (2)
- Occupational health (2)
- Olfactory system (2)
- Ophthalmology (2)
- Opioids (2)
- Opportunistic infections (2)
- Optical phenomena (2)
- Optogenetics (2)
- Oral immunotherapy (2)
- Oral surgery (2)
- Ordinary least squares (OLS) (2)
- Organ dysfunction (2)
- Organ dysfunctions (2)
- Organ preservation (2)
- Oroantral (2)
- Orthognathic surgery (2)
- Osteoarthritis (2)
- Osteogenic differentiation (2)
- Osteoporotic fractures (2)
- Outcome assessment (2)
- Outcomes research (2)
- Outpatients (2)
- Ovarian cancer (2)
- Oxidative stress (2)
- OxyELITE Pro (2)
- P2X7 receptor (2)
- PD-1 (2)
- PINK1 (2)
- PML (2)
- PRNT (2)
- PROTAC (2)
- PSA (2)
- PTEN (2)
- Pacemaker (2)
- Pain management (2)
- Palliative care (2)
- Palliative care [MeSH] (2)
- Parenteral nutrition (2)
- Parkin (2)
- Parkinson disease (2)
- Particulate matter (2)
- Pathologic complete response (2)
- Pathology (2)
- Patient manikins (2)
- Patient needs (2)
- Patient preference (2)
- Patientenbedürfnisse (2)
- Pediatric infections (2)
- Pelargonium sidoides (2)
- Penile cancer (2)
- Percutaneous coronary intervention (2)
- Periodontal treatment (2)
- Periodontitis (2)
- Peritonitis (2)
- Persistence (2)
- Person-Umwelt-Passung (2)
- Person-environment fit (2)
- Petri net (2)
- Philadelphia chromosome (2)
- Phylogenetic analysis (2)
- Physical environment (2)
- Plasma (2)
- Plasmodium (2)
- Plasticity (2)
- Plerixafor (2)
- Plk1 inhibitors (2)
- Pneumocystis jirovecii (2)
- Point-of-care testing (2)
- Polytrauma (2)
- Positron emission tomography (2)
- Post-mortem interval (2)
- Post-translational modifications (2)
- Postoperative radiochemotherapy (2)
- Posttraumatic stress disorder (2)
- Posture analysis (2)
- Poverty (2)
- Practical skills (2)
- Predictive coding (2)
- Predominant polarity (2)
- Preeclampsia (2)
- Preventive medicine (2)
- Primary cilium (2)
- Prisoners (2)
- Prisons (2)
- Probability density (2)
- Probability distribution (2)
- Prognostic (2)
- Prognostic tool (2)
- Prostatic neoplasms (2)
- Proteasome (2)
- Protein Translocation (2)
- Protein biomarkers (2)
- Protein translation (2)
- Protein-Protein Interactions (2)
- Pseudomonas aeruginosa (2)
- Psoriasis (2)
- Psychedelics (2)
- Pulmonary veins (2)
- Qualitative research (2)
- Quality of care (2)
- Questionnaires (2)
- RDoC (2)
- RIPK3 (2)
- RNA binding proteins (2)
- RNA interference (2)
- RNA interference (RNAi) (2)
- RNA isolation (2)
- RNA therapy (2)
- RNA-sequencing (2)
- RNAseq (2)
- RNF4 (2)
- Rab7 (2)
- Radiation (2)
- Radical prostatectomy (2)
- Radiochemotherapy (2)
- Rainfall (2)
- Random forest (2)
- Randomized controlled trials (2)
- Recurrence (2)
- Red blood cell transfusion (2)
- Redoxin (2)
- Refractory ALL (2)
- Regeneration (2)
- Rehabilitation (2)
- Relaxometry (2)
- Remission (2)
- Renal system (2)
- Reproducibility (2)
- Rescue medication (2)
- Research architecture (2)
- Respiratory chain (2)
- Respiratory distress syndrome (2)
- Restenosis (2)
- Resting-state (2)
- Reward (2)
- Rheumatoid Arthritis (2)
- Ribavirin (2)
- Risiko (2)
- Risk assessment (2)
- Risk factor (2)
- Risk stratification (2)
- Rivaroxaban (2)
- Roussel Uclaf Causality Assessment Method (RUCAM) (2)
- Rural area (2)
- S1P lyase (2)
- S1P receptors (2)
- SAMHD1 (2)
- SARS-CoV-2 monitoring (2)
- SARS-CoV-2 testing (2)
- SARS‐CoV‐2 (2)
- SCC (2)
- SCCHN (2)
- SD-OCT (2)
- SENP (2)
- SF-36 (2)
- SIRT1 (2)
- SKAP1 (2)
- SOD (2)
- SPM (2)
- SPTAN1 (2)
- STAT1 (2)
- STING (2)
- SV2A (2)
- SVR (2)
- Scheimpflug imaging (2)
- Scientists (2)
- Seizures (2)
- Self-renewal (2)
- Sensory processing (2)
- Serum (2)
- Sestrin 2 (2)
- Short bowel syndrome (2)
- Simulation training (2)
- Skills (2)
- Smoking habits (2)
- Social epidemiology (2)
- Social health determinants (2)
- Social participation (2)
- Socio-economic analysis (2)
- Socioeconomic status (2)
- Sonication (2)
- Sorafenib (2)
- Specificity (2)
- Speech (2)
- Sphingolipids (2)
- Spinal cord (2)
- Spirochetes (2)
- Standard endoscopy (2)
- Standard value (2)
- Standardization (2)
- Stem-cell therapies (2)
- Strength training (2)
- Streptococcus pneumoniae (2)
- Stress (2)
- Striatum (2)
- Structural plasticity (2)
- Study protocol (2)
- Subarachnoid hemorrhage (2)
- Sudden death (2)
- Sumatra (2)
- Sunitinib (2)
- Superficial vein thrombosis (2)
- Superoxide (2)
- Supported decision making (2)
- Survival analysis (2)
- Survivin (2)
- Sweden (2)
- Synaptic plasticity (2)
- Synaptic transmission (2)
- Synovial sarcoma (2)
- Systematic reviews (2)
- Systemic inflammation (2)
- Systemic therapy (2)
- T-cell (2)
- T-cell receptor (2)
- T-cells (2)
- TACE (2)
- TBK1 (2)
- TBSS (2)
- TF-complexes (2)
- TGF-β1 (2)
- TGFβ (2)
- TMT (2)
- TRPA1 (2)
- TSC (2)
- Target identification (2)
- Targeted therapies (2)
- Teaching (2)
- Teeth (2)
- Thailand (2)
- Theft (2)
- Thermoregulation (2)
- Thromboembolism (2)
- Thrombolysis (2)
- Thrombotic thrombocytopenic purpura (2)
- Thyroid (2)
- Tick (2)
- Tight junctions (2)
- Toll-like receptor (2)
- Tomography (2)
- Tomography (x-ray computed) (2)
- Tooth loss (2)
- Transcription (2)
- Transcription Factors (2)
- Transmission (2)
- Traumatic brain injury (2)
- Traumatic injury (2)
- Treg cell (2)
- Troponin (2)
- Tumour immunology (2)
- UGCG (2)
- Ubiquitin Ligase (2)
- Ubiquitylation (2)
- Ulcerative colitis (2)
- Ultrasonography (2)
- Unterstützung der Umwelt (2)
- Urethral cancer (2)
- Urology (2)
- Usability (2)
- Uteroglobin (2)
- V4 (2)
- VDR (2)
- VEGF receptors (2)
- VIGALL (2)
- VRE (2)
- Vaccine (2)
- Vaccine uptake rate (2)
- Vascular endothelial growth factor (VEGF) (2)
- Vascularization (2)
- Vasculitis (2)
- Veins (2)
- Viral infection (2)
- Vision (2)
- Visual acuity (2)
- Visual estimation (2)
- Visual quality (2)
- Vitamin D (2)
- Vitamin D deficiency (2)
- Vmem (2)
- Volume therapy (2)
- Warburg effect (2)
- Wearable cardioverter-defibrillator (2)
- White blood cells (2)
- Wnt (2)
- Women (2)
- Working memory (2)
- Wounds (2)
- X-ray crystallography (2)
- Zebrafish (2)
- Zika fever (2)
- Zoopotentation (2)
- Zooprophylaxis (2)
- ablation (2)
- abuse (2)
- accident (2)
- acetyl-CoA (2)
- acute lung injury (2)
- acute myeloid leukaemia (2)
- acute respiratory distress syndrome (2)
- adalimumab (2)
- additives (2)
- adenovirus (2)
- adherence (2)
- adipocytes (2)
- adipose-derived mesenchymal stem cells (2)
- adipose-derived stromal/stem cells (2)
- adjuvant therapy (2)
- adjuvante Therapie (2)
- adolescence (2)
- adoptive cancer immunotherapy (2)
- adult (2)
- adult neurogenesis (2)
- advanced care planning (2)
- adverse reaction (2)
- age-related macular degeneration (2)
- air flow (2)
- alcoholic liver disease (2)
- algorithm (2)
- allogeneic hematopoietic stem cell transplantation (2)
- alpha band (2)
- alpha power (2)
- alpha-synuclein (2)
- amino acids (2)
- amphiregulin (2)
- amyotrophic lateral sclerosis (ALS) (2)
- analgesics (2)
- anaplastic large cell lymphoma (2)
- angiography (2)
- animal experiment (2)
- animal experiments (2)
- anorexia nervosa (2)
- antibacterial activity (2)
- antibiotic resistance (2)
- antibiotic therapy (2)
- anticoagulation (2)
- anticonvulsants (2)
- antiepileptic drug (2)
- antiepileptic drugs (2)
- antifungal therapy (2)
- antioxidant (2)
- antiseizure medication (2)
- antisocial behavior (2)
- antiviral drugs (2)
- anxiety (2)
- aortic valve stenosis (2)
- aptamer (2)
- arachidonic acid (2)
- arousal (2)
- arthritis (2)
- aspirin (2)
- astrocytoma (2)
- atezolizumab (2)
- attachment loss (2)
- audiovisual (2)
- auditory cortex (2)
- autism (2)
- autoantibodies (2)
- autoimmune diabetes (2)
- autoimmunity (2)
- autologous stem cell transplantation (2)
- automation (2)
- betulinic acid (2)
- bibliometric analysis (2)
- biliary stricture (2)
- bio imaging (2)
- biocompatibility (2)
- biofilm (2)
- biologics (2)
- bioluminescence (2)
- biopsy (2)
- biopsy cores (2)
- blood flow restriction (2)
- blood pressure (2)
- blood-brain barrier (2)
- body plethysmography (2)
- bone healing (2)
- bone marrow microenvironment (2)
- bone metabolism (2)
- bone metastasis (2)
- borrelia (2)
- brain cancer (2)
- brain function (2)
- brain imaging (2)
- brain networks (2)
- brain states (2)
- brain tumor (2)
- brain-derived neurotrophic factor (2)
- brainstem (2)
- bulimia nervosa (2)
- cART (2)
- cabozantinib (2)
- calcitriol (2)
- calprotectin (2)
- campesterol (2)
- cancer cell metabolism (2)
- cancer specific survival (2)
- cancer therapy (2)
- cancer treatment (2)
- cancer-associated fibroblasts (2)
- cancer-specific mortality (2)
- cancer-specific survival (2)
- capsaicin (2)
- carbapenem resistance (2)
- carbapenemase (2)
- cardiolipin (2)
- cardiovascular (2)
- case-referent study (2)
- caspase-1 (2)
- cataract surgery (2)
- cell motility (2)
- cell proliferation (2)
- cells (2)
- central nervous system (2)
- ceramide (2)
- cerebral hemorrhage (2)
- cerebral venous thrombosis (2)
- cerebrovascular disease (2)
- cesarean section (2)
- chemotaxis (2)
- chemotherapy resistance (2)
- chest trauma (2)
- childhood acute myeloid leukemia (2)
- childhood cancer (2)
- children and adolescents (2)
- cholangiocarcinoma (2)
- cholestanol (2)
- cholesterol absorption (2)
- cholesterol synthesis (2)
- chronic granulomatous disease (2)
- chronic hepatitis C (2)
- chronic inflammation (2)
- chronic thromboembolic pulmonary hypertension (2)
- cigarette (2)
- circadian (2)
- circadian rhythm (2)
- circadian rhythms (2)
- circular RNA (2)
- cisplatin resistance (2)
- citation (2)
- cleaning (2)
- clinical benefit (2)
- clinical immunology (2)
- clinical isolates (2)
- clinical studies (2)
- clinically important restrictions and symptoms (2)
- coagulopathy (2)
- colon (2)
- colon carcinoma cells (2)
- colorectal cancer (CRC) (2)
- colorectal carcinoma (2)
- comorbidities (2)
- complementary and alternative medicine (2)
- complementary medicine (2)
- complex I (2)
- complex systems (2)
- compliance (2)
- complication (2)
- computer-assisted (2)
- concordance (2)
- congenital diaphragmatic hernia (2)
- connective tissue (2)
- consensus (2)
- constipation (2)
- contemporary (2)
- convulsive seizures (2)
- coping (2)
- corneal edema (2)
- corneal transplantation (2)
- corona virus (2)
- coronary artery bypass graft surgery (2)
- coronary artery disease (2)
- corpus callosum (2)
- cost-effective (2)
- critical size defect (2)
- criticality (2)
- critically ill patients (2)
- cryoballoon (2)
- cryopreservation (2)
- cyclooxygenase (2)
- cyclosporin A (2)
- cytochrome P450 2E1 (2)
- cytokine (2)
- cytotoxic T cells (2)
- dabrafenib (2)
- dance (2)
- deafness (2)
- decision making (2)
- decompensated liver cirrhosis (2)
- delay (2)
- delirium (2)
- dental assistant (2)
- dental assistants (2)
- dentists (2)
- dentoalveolar surgery (2)
- desensitization (2)
- detoxification (2)
- deubiquitinase (DUB) (2)
- diagnostics (2)
- diet (2)
- dietary supplements (2)
- dihydroceramide (2)
- disease burden (2)
- disease models (2)
- disease progression (2)
- disintegration (2)
- dislocation (2)
- distress (2)
- docetaxel (2)
- doxycycline (2)
- drug release (2)
- drug-induced liver injury (2)
- dual task (2)
- dysphagia (2)
- early breast cancer (2)
- eating disorders (2)
- economic burden (2)
- education (2)
- eicosanoids (2)
- elderly patients (2)
- electrocardiography (2)
- electron transport chain (2)
- emergency care (2)
- encoding (2)
- endoscopic retrograde cholangiopancreatography (2)
- endothelial (2)
- endothelial cell (2)
- endovascular treatment (2)
- entorhinal cortex lesion (2)
- ephrinB2 (2)
- epidemics (2)
- epidermal growth factor (2)
- epigenetic (2)
- epileptic encephalopathy (2)
- epileptogenesis (2)
- epithelial to mesenchymal transition (2)
- erastin (2)
- erectile dysfunction (2)
- esophageal cancer (2)
- euthymic (2)
- evaluation (2)
- evolution (2)
- expertise (2)
- extraversion (2)
- factor H (2)
- faculty development (2)
- fall (2)
- fasting (2)
- female subjects (2)
- femoral artery ligation (2)
- ferric carboxymaltose (2)
- ferroptosis (2)
- fibrinolysis (2)
- focal therapy (2)
- fracture (2)
- frühes Mammakarzinom (2)
- functional genetics (2)
- functional genomics (2)
- furcation involvement class III (2)
- fusion (2)
- fusion biopsy (2)
- gait analysis (2)
- gene signature (2)
- genetic diversity (2)
- genetics (2)
- genome (2)
- glecaprevir (2)
- glucose metabolism (2)
- growth factor (2)
- guided bone regeneration (2)
- haemophilia (2)
- haemophilia A (2)
- head and neck neoplasms (2)
- head and neck squamous cell carcinoma (2)
- health (2)
- health care (2)
- health information exchange (2)
- healthcare personnel (2)
- healthcare workers (2)
- hearing loss (2)
- hedgehog signaling (2)
- hematopoiesis (2)
- hematopoietic stem cells (2)
- hemolysis (2)
- hemorrhagic transformation (2)
- hepatic encephalopathy (2)
- hepatitis B virus (2)
- hepatotoxicity (2)
- herbal hepatotoxicity (2)
- hippocampal sclerosis (2)
- histamine (2)
- histological validation (2)
- histone deacetylase (2)
- histone deacetylase inhibitor (2)
- homeostatic plasticity (2)
- human biology and medicine (2)
- human cytomegalovirus (2)
- human genomics (2)
- human immunodeficiency virus (2)
- humans (2)
- hyperalgesia (2)
- hyperhomocysteinemia (2)
- iCBT (2)
- iDILI (2)
- iPS (2)
- idiopathic pulmonary fibrosis (2)
- immune system (2)
- immune therapy (2)
- immunocytochemistry (2)
- immunosuppression (2)
- induced membrane (2)
- induction chemotherapy (2)
- infections (2)
- infectious disease (2)
- infectivity (2)
- infiltration (2)
- inhibitors (2)
- injury (2)
- inner ear (2)
- insulin (2)
- integrated stress response (2)
- integration (2)
- integrative medicine (2)
- interferon (2)
- interferon gamma (2)
- interleukin-4 (2)
- interleukins (2)
- intermediate risk (2)
- internet (2)
- intracranial hemorrhage (2)
- irritable bowel syndrome (2)
- job-exposure matrix (2)
- joint contact forces (2)
- keratinized mucosa (2)
- kidney cancer (2)
- kidney function (2)
- kinase inhibitor (2)
- kinase regulation (2)
- kinematic analysis (2)
- kinematics (2)
- knowledge discovery (2)
- lapatinib (2)
- lathosterol (2)
- layer-specificity (2)
- lenalidomide (2)
- leukodystrophy (2)
- leukopenia (2)
- leukotriene (2)
- lifestyle intervention (2)
- lipidomics (2)
- liver damage (2)
- liver disease (2)
- liver metastases (2)
- local control (2)
- local information dynamics (2)
- local recurrence (2)
- localized prostate cancer (2)
- long-term outcome (2)
- long-term potentiation (2)
- long-term success (2)
- long-term survival (2)
- long-term tooth survival (2)
- longevity (2)
- low molecular weight heparin (2)
- low-glycaemic meal replacement (2)
- lung development (2)
- lymph node dissection (2)
- lymphocytes (2)
- mRNA stability (2)
- mTOR inhibitor (2)
- maintenance (2)
- malignancy (2)
- mammary carcinoma (2)
- mandatory reporting (2)
- marginal bone loss (2)
- mast cells (2)
- mathematical models of viral RNA cycle (2)
- matrix (2)
- medical education (2)
- medication management (2)
- medication review (2)
- medulloblastoma (2)
- melatonin (2)
- membrane protein complex (2)
- mental health (2)
- mesenchymal stromal cell (2)
- meta-analysis (2)
- metastatic (2)
- metastatic castration-resistant prostate cancer (2)
- methylprednisolone (2)
- miR (2)
- miR-181 (2)
- miR-21 (2)
- microdosing (2)
- microenvironment (2)
- microsurgery (2)
- modularity (2)
- molecular dynamics (2)
- molecular marker (2)
- molecular mechanisms (2)
- molecular typing (2)
- monoclonal antibody (2)
- morbidity (2)
- morphogenesis (2)
- morphometry (2)
- mouse models (2)
- mucormycetes (2)
- multicentre study (2)
- multidetector computed tomography (2)
- multinucleated giant cells (2)
- multisensory integration (2)
- musculoskeletal (2)
- musculoskeletal modeling (2)
- music (2)
- myelodysplastic syndrome (2)
- nanoparticles (2)
- natural product (2)
- ncRNA (2)
- neoadjuvant chemotherapy (2)
- network analysis (2)
- neural network (2)
- neurocognition (2)
- neurocognitive (2)
- neurodegenerative diseases (2)
- neuroendocrine (2)
- neurogenesis (2)
- neuromodulation (2)
- neurooncology (2)
- neuropathy (2)
- neurophysiology (2)
- neuroprotection (2)
- neuroticism (2)
- neutropenia (2)
- neutrophils (2)
- newborn (2)
- next generation sequencing (2)
- next generation sequencing (NGS) (2)
- niche (2)
- nivolumab (2)
- non-small cell lung cancer (2)
- non-small-cell lung cancer (2)
- nursery schools (2)
- nutlin-3 (2)
- occupational exposure (2)
- occupational health (2)
- occupational infections (2)
- olfaction (2)
- oligomerisation (2)
- omega-3 fatty acids (2)
- oncogene (2)
- oncomodulation (2)
- online survey (2)
- oral and maxillofacial surgery (2)
- oscillations (2)
- osteogenesis (2)
- other-cause mortality (2)
- out-patient paediatrics (2)
- p16 (2)
- paclitaxel (2)
- pain management (2)
- paired associative stimulation (2)
- palatal tremor (2)
- partial information decomposition (2)
- passive smoke (2)
- pathology (2)
- patient (2)
- patient centered care (2)
- patient preferences (2)
- patient triage (2)
- patient-reported outcomes (2)
- pediatric surgery (2)
- pelvic packing (2)
- penile cancer (2)
- peptide aptamer (PA) (2)
- peri-implant diseases (2)
- pericytes (2)
- periodontal diseases (2)
- periodontitis stage III and IV (2)
- peri‐implantitis (2)
- pertussis (2)
- phagocytes (2)
- pharmacodynamics (2)
- pharmacogenetics (2)
- pharmacokinetics (2)
- pharmacoresistance (2)
- pharmacovigilance (2)
- phosphate (2)
- photodynamic therapy (2)
- physiotherapy (2)
- pibrentasvir (2)
- platelet-rich fibrin (2)
- polo-like kinase 1 (2)
- poly(lactic-co-glycolic acid) (PLGA) (2)
- polygenic risk score (2)
- polymerase chain reaction (2)
- polymorphism (2)
- population dynamics (2)
- post-translational modifications (2)
- posttraumatic stress disorder (2)
- preclinical (2)
- prediction (2)
- predictive (2)
- predictor (2)
- preterm birth (2)
- primary sclerosing cholangitis (2)
- process evaluation (2)
- prognostic (2)
- prognostic factors (2)
- prognostic value (2)
- progranulin (2)
- prostaglandin E (2)
- prostate carcinoma cells (2)
- proteasome (2)
- proteasome inhibitor (2)
- protein kinase (2)
- protein phosphorylation (2)
- protein quality control (2)
- protein-protein interaction (2)
- protein-rich (2)
- proteostasis (2)
- proximal tubule (2)
- psychiatric comorbidity (2)
- psychiatric disorders (2)
- psychosis (2)
- pulmonary embolism (2)
- pulmonary vein isolation (2)
- qRT-PCR (2)
- quality (2)
- quality assurance (2)
- radical cystectomy (2)
- radioimmunotherapy (2)
- randomized (2)
- randomized controlled trial (2)
- rare disease (2)
- rare diseases (2)
- rat model (2)
- re-osseointegration (2)
- real-world (2)
- real-world data (2)
- receptor (2)
- recommendations (2)
- reference values (2)
- refractory (2)
- regenerative medicine (2)
- regulatory T cell (2)
- relapse (2)
- relaxometry (2)
- reliability (2)
- renal failure (2)
- renal function (2)
- renal tubular epithelial cells (2)
- research (2)
- residual myometrial thickness (2)
- resistance mutation (2)
- resistant cell lines (2)
- resolution (2)
- resolution of inflammation (2)
- respiratory chain (2)
- respiratory failure (2)
- respiratory tract infection (2)
- resting-state (2)
- resveratrol (2)
- revision surgery (2)
- ribavirin (2)
- risk (2)
- risk assessment (2)
- risk group (2)
- risk prediction (2)
- saliva (2)
- sarcoma (2)
- scaffold (2)
- school-based prevention (2)
- scientometrics (2)
- scientometry (2)
- second-hand smoke (2)
- second-line (2)
- secondary data analysis (2)
- secretion (2)
- secretome (2)
- secukinumab (2)
- selection (2)
- sensory neuropathy (2)
- serine protease (NS3-4A) (2)
- shunt (2)
- siRNA (2)
- signal transducer and activator of transcription 5 (Stat5) (2)
- signature (2)
- simulation (2)
- single-sided deafness (2)
- sitosterol (2)
- skin (2)
- smoking cessation (2)
- smooth muscle cells (2)
- soft tissue (2)
- soluble MICA (2)
- sound-induced flash illusion (2)
- speech perception (2)
- sphingosine 1-phosphate receptor (2)
- sphingosine kinase (2)
- spiking neural networks (2)
- spinal dural leaks (2)
- spine head (2)
- sport (2)
- spreadsheet (2)
- squamous cell carcinoma (2)
- stability (2)
- stage (2)
- stakeholder analysis (2)
- standard value (2)
- starvation (2)
- stationarity (2)
- steatosis (2)
- stem cells (2)
- stereotactic radiosurgery (2)
- stress granules (2)
- sub-lineage (2)
- subchondral bone (2)
- superficial siderosis (2)
- survival rate (2)
- survivin (2)
- sympathetic nervous system (2)
- symptoms (2)
- synaptopodin (2)
- synchronization (2)
- synchrony (2)
- synergy (2)
- synovium (2)
- tDCS (2)
- telemedicine (2)
- temperature (2)
- temsirolimus (2)
- testosterone (2)
- tetracycline (2)
- tetrahydrobiopterin (2)
- tetrahydrocannabinol (2)
- therapy monitoring (2)
- therapy resistance (2)
- tissue Doppler imaging (2)
- tobacco (2)
- tobacco smoke (2)
- tolerability (2)
- tooth transplantation (2)
- total hip replacement (2)
- tracking (2)
- trafficking (2)
- training (2)
- transcription factors (2)
- transcriptomics (2)
- transforming growth factor-β (2)
- translation (2)
- trastuzumab (2)
- trials (2)
- triple-negative breast cancer (2)
- trophoblast (2)
- trophoblasts (2)
- tuberous sclerosis complex (2)
- tumor (2)
- tumor angiogenesis (2)
- tumor infiltrating lymphocytes (2)
- tumor necrosis factor (2)
- tumor stroma (2)
- tumor suppressor (2)
- tumor-infiltrating lymphocytes (2)
- type 1 diabetes (2)
- unilateral hip osteoarthritis (2)
- upgrading (2)
- urethral stricture (2)
- urethroplasty (2)
- urinary incontinence (2)
- urological cancer (2)
- ursodeoxycholic acid (2)
- ustekinumab (2)
- uteroglobin (2)
- vaccination rates (2)
- vascular biology (2)
- vascular disease (2)
- vasodilation (2)
- ventral striatum (2)
- very high risk (2)
- virus (2)
- viruses (2)
- visual cortex (2)
- vitamin B deficiency (2)
- von Willebrand disease (2)
- von Willebrand factor (2)
- waiting time (2)
- walking (2)
- weight loss (2)
- weight reduction (2)
- white matter hyperintensity (2)
- within-host viral modelling (2)
- women (2)
- workflow (2)
- zebrafish (2)
- zinc (2)
- Ärztliche Aufklärung (2)
- (cardiac) surgery (1)
- (lyso)phospholipids (1)
- (novel) brominated flame retardants ((N)BFR) (1)
- (sub-) luxation (1)
- 1,2-dichloroethane (1)
- 1,25-Dihydroxyvitamin D (1)
- 1-propanol (1)
- 14-3-3 gene family (1)
- 15-PGDH (1)
- 16 segment AHA model (1)
- 16S rRNA sequencing (1)
- 16p11.2 (1)
- 17-AAG (1)
- 17‐OH itraconazole (1)
- 19F MR spectroscopy (1)
- 1H MR spectroscopy (1)
- 1H NMR; Conformational Properties (1)
- 1α,25(OH)2D3 (1)
- 2-AG (1)
- 2-Arachidonoyl glycerol (1)
- 2-deoxy-d-glucose (1)
- 2-deoxyglucose (2-DG) (1)
- 2-hydroxyglutarate (1)
- 2019-nCoV (1)
- 223Radium-dichloride (1)
- 26 LncRNA (1)
- 2‑methoxyestradiol (1)
- 2′,3′-cGAMP (1)
- 3 mm RAS instruments (1)
- 3 mm instruments (1)
- 3-hydroxyanthranilic acid (1)
- 3-hydroxyisovaleryl carnitine (1)
- 3-year survival (1)
- 32D progenitor cells (1)
- 3Cs technology (1)
- 3D culture (1)
- 3D gait analysis (1)
- 3D laparoscopy (1)
- 3D printed cell-free scaffold (1)
- 3D printing using composite resin (1)
- 3D printing using zirconia (1)
- 3D spatiotemporal resolved mathematical models (1)
- 3D tissue models (1)
- 3D-models (1)
- 3D-printing (1)
- 3T3-L1 mouse fibroblasts (1)
- 3years (1)
- 4-1BB (1)
- 4-FA (1)
- 4-fluoroamphetamine (1)
- 5 lipoxygenase (1)
- 5' UTR (1)
- 6-Schritt-Methode (1)
- 8 weeks (1)
- 9-aminoacridine (1)
- 90% or more improvement in baseline Psoriasis Area and Severity Index (1)
- 99mTc-MIBI (1)
- 99mTc-pertechnetate (1)
- A-FFIP (1)
- A-PRF+ (1)
- A2BP1 (1)
- A375 human melanoma cell line (1)
- A375 human melanoma cells (1)
- A498 cells (1)
- A549 (1)
- AA-amylodosis (1)
- AAA (1)
- AAA+ disaggregase (1)
- AB-serum (1)
- ABC transporter (1)
- ABCB5 (1)
- ABS (1)
- ABT-737 (1)
- ACE inhibitor (1)
- ACE-inhibitor (1)
- ACKR (1)
- ACL (1)
- ACT-777991 (1)
- ACTH (1)
- ACURATE neo (1)
- ADAM-17 (1)
- ADAM10 (1)
- ADAMTS-13 (1)
- ADAMTS13 (1)
- ADCC (1)
- ADGRE1 (1)
- ADHD differential diagnosis (1)
- ADHS (1)
- AGC kinase (1)
- AGMO (1)
- AICAR (1)
- AIH immunopathogenesis (1)
- AIS (1)
- AJAP1 (1)
- AKT (1)
- AKT signaling (1)
- AKT-mTOR pathway (1)
- ALD (1)
- ALDH2 (1)
- ALF (1)
- ALK gene (1)
- ALK-rearranged NSCLC (1)
- AMD3100 (1)
- AML – acute myeloid leukemia (1)
- AMP-activated kinase (1)
- AMP-activated kinase (AMPK) (1)
- AO-PCCF (1)
- AOSpine (1)
- AOSpine injury score (1)
- APMPPE - acute posterior multifocal placoid pigment epitheliopathy (1)
- APP (1)
- APP processing (1)
- APRI (1)
- APT-CEST (1)
- ARA (1)
- ARID5B (1)
- ASA404 (1)
- ASAP (1)
- ASCT (1)
- ASD-specific (1)
- ASO (1)
- ASPECTS (1)
- AT-101 (1)
- AT1 receptor antagonist (1)
- ATG3 (1)
- ATG4 (1)
- ATG8 (1)
- ATO (1)
- ATXN2 (1)
- AU-rich element (1)
- AVM hemorrhage (1)
- AZD7762 (1)
- Abatacept (1)
- Abdominal infections (1)
- Abdominal surgery (1)
- Abdominal trauma (1)
- Abductor pollicis longus (1)
- Abiraterone acetate (1)
- Abl kinase inhibitors (1)
- Ablation (1)
- Ablation Techniques (1)
- Abrasion (1)
- Abronia graminea (1)
- Abronia lythrochila (1)
- Absenteeism (1)
- Absolute quantification (1)
- Abusive head trauma (AHT) (1)
- Academic health centres (1)
- Academics (1)
- Accelerometry (1)
- Accessibility (1)
- Accidents (1)
- Accumulated degree days (1)
- Acellular dermis (1)
- Acer platanoides (1)
- Acid ceramiase (1)
- Acidic Amino Acids (1)
- Acquired drug resistance (1)
- Acquired resistance (1)
- Actaea cimicifuga (1)
- Actin (1)
- Actinomycin D (1)
- Action potential (1)
- Activated partial thromboplastin time (1)
- Active middle ear implants (1)
- Activity control (1)
- Acute (1)
- Acute HIV infection (1)
- Acute Hemiparesis (1)
- Acute Myeloid Leukemia (1)
- Acute appendicitis (1)
- Acute bronchitis (1)
- Acute calcolous cholecystitis (1)
- Acute coronary syndrome (1)
- Acute cough (1)
- Acute elbow dislocation (1)
- Acute heart failure (1)
- Acute hospital (1)
- Acute kidney failure (1)
- Acute leukemia (1)
- Acute respiratory distress syndrom (1)
- Acute-on-chronic subdural hematoma (1)
- Adeno associated virus (1)
- Adenylyl cyclase (1)
- Adherence junctions (1)
- Adhesins (1)
- Adipose tissue-derived mesenchymal stem cells (1)
- Adiposity (1)
- Adjustment of dosage at steady state (1)
- Adjuvant therapies (1)
- Administrative claims data (1)
- Adolescence (1)
- Adult (1)
- Adult T-cell acute lymphoblastic leukemia (1)
- Adult-onset ADHD (1)
- Advanced biliary tract cancer (1)
- Advanced breast cancer (1)
- Advanced glycation endproducts (1)
- Advanced stage (1)
- Adverse drug reaction (1)
- Adverse effects (1)
- Aeroplysinin-1 (1)
- Affect (1)
- Affective Misattribution Procedure (1)
- Affective disorders (1)
- Affinity Chromatography (1)
- Affinity Labeling (1)
- Africa (1)
- Ag-RDT (1)
- Aganglionosis (1)
- Age (1)
- Age determination (1)
- Age determination by skeleton (1)
- Ageing (1)
- Aggression (1)
- Aggressive periodontitis (1)
- Agoraphobia (1)
- Agreement (1)
- Air traffic (1)
- Airport-related emissions (1)
- Airways (1)
- Akt-mTOR pathway (1)
- Akt-mTOR signaling (1)
- Aktivierte partielle Thromboplastinzeit (1)
- Akutes Koronarsyndrom (1)
- Albumin (1)
- Albumin ratio (1)
- Aliphatic halogenated hydrocarbons (1)
- Alisertib (1)
- All oral (1)
- All-oral therapy (1)
- All-trans retinoic acid (1)
- Allergen immunotherapy (1)
- Allergic rhinitis (1)
- Allergoid (1)
- Allgemeinmedizin (1)
- Allochromatium vinosum (1)
- Allogeneic (1)
- Allogeneic Stem Cell Transplantation (SCT) (1)
- Allogeneic hematopoietic stem (1)
- Allogeneic stem cell transplantation (1)
- Allograft bone block (1)
- Alpelisib (1)
- Alpha oscillations (1)
- Alpha power (1)
- Alpha-fetoprotein (AFP) (1)
- Alpha-synuclein (1)
- Alpha-synuclein deficiency (1)
- Alternative oxidase (1)
- Alveolar ridge augmentation (1)
- Alzheimer’s dementia (1)
- Ambient air (1)
- Ambroxol (1)
- Ambulatory Assessment (1)
- Ameloblastoma (1)
- Amino acid analysis (1)
- Amino acids (1)
- Aminosäuremetabolismus (1)
- Aminosäuren (1)
- Aminotransferases (1)
- Amisulpride (1)
- Amitriptyline (1)
- Amizon (1)
- Amniotic fluid (1)
- Amphetamine (1)
- Amygdala (1)
- Amyloid precursor protein (1)
- Amyloid-beta 42 (1)
- Amyotrophic lateral sclerosis (1)
- Anaesthesia (1)
- Anahuasca (1)
- Anakinra (1)
- Anal cancer (1)
- Analgesia (1)
- Analogue modelling (1)
- Analysis tool (1)
- Anaplastic astrocytoma (1)
- Anatomic competence (1)
- Andersen-Tawil syndrome (1)
- Anderson–Fabry (1)
- Andexanet alpha (1)
- Andropogon virginicus (1)
- Anemia management (1)
- Anesthesia, Intravenous (1)
- Aneurysm (1)
- Aneurysmal subarachnoid hemorrhage (1)
- Aneurysms (1)
- Angiectasia (1)
- Angiodysplasia (1)
- Angioedema (1)
- Angiogenèse (1)
- Angiomyolipoma (1)
- Angioplasty (1)
- Angststörungen (1)
- Animal disease models (1)
- Animal experiment (1)
- Animal wings (1)
- Anion and Zwitterion Transport (1)
- Aniridia (1)
- Ankle arthrometer (1)
- Anomalous venous atrial connections (1)
- Anopheles (1)
- Anorexia Nervosa (1)
- Anosmia (1)
- Anschlussheilbehandlung (1)
- Antarctic marine sponges (1)
- Anterior cingulate cortex (1)
- Anterior cruciate ligament (1)
- Anterior cruciate ligament reconstruction (1)
- Anti platelet therapy (1)
- Anti-CMV IgG (1)
- Anti-TNF (1)
- Anti-inflammatory (1)
- Anti-rheumatic agents (1)
- Anti-seizure medication (1)
- Anti-tumor immunity (1)
- Antiangiogenesis (1)
- Antibiotic (1)
- Antibiotic generic drugs (1)
- Antibiotic steward-ship (1)
- Antibiotic stewardship (1)
- Antibiotic therapy (1)
- Antibody avidity (1)
- Antibody isotypes (1)
- Antibody therapy (1)
- Antibody-mediated rejection (1)
- Anticholinergic (1)
- Anticoagulant (1)
- Anticoagulants (1)
- Anticoagulants [MeSH] (1)
- Anticonvulsant (1)
- Anticonvulsants (1)
- Antidepressant (1)
- Antifungal agents (1)
- Antigen test (1)
- Antigen-presenting cells (1)
- Antigennachweis (1)
- Antigens (1)
- Antihormone therapy (1)
- Antimicrobial resistance (1)
- Antineoplastic agents (1)
- Antioxidant (1)
- Antioxidants (1)
- Antiplatelet therapy (1)
- Antiproliferative (1)
- Antireflux surgery (1)
- Antirheumatic agents (1)
- Antithrombotic therapy (1)
- Antivenom (1)
- Antiviral agents (1)
- Antiviral immune response (1)
- Antiviral response (1)
- Anura (1)
- Anwendbarkeit (1)
- Anxiolytic pharmacological therapy (1)
- Aortic Valve Replacement (1)
- Aortic aneurysm (1)
- Aortic arch replacement (1)
- Aortic debranching (1)
- Aortic input function (1)
- Aortic stiffness (1)
- Aortic valve sparing (1)
- Aperiodic (1)
- Apes (1)
- Aphakia (1)
- Aphantasia (1)
- Appendectomy (1)
- Aquaporins (1)
- Ara h2-specific IgE (1)
- Arabin pessary (1)
- Arabin-Pessar (1)
- Arbeitsgedächtnis (1)
- ArchT (1)
- Archaebacterial Lipids (1)
- Area deprivation (1)
- Arms (1)
- Aromatase Inhibitors (1)
- Aromatase inhibitors (1)
- Arrhythmia syndromes (1)
- Arrhythmia/all (1)
- Artemether-lumefantrine (1)
- Artemisinin-combination-therapy (1)
- Arteria ophthalmica (1)
- Arteriogenesis (1)
- Arteriovenous malformation (1)
- Artesunate (1)
- Arthroplasty (1)
- Arthroscopy (1)
- Artificial Intelligence (1)
- Artificial feeding bioassays (1)
- Artificial iris (1)
- Asian bush mosquito (1)
- Asparaginase (1)
- Aspergillosis (1)
- Aspergillus species (1)
- Aspirin (1)
- Assay variation (1)
- Assessment of care (1)
- Asthma (1)
- Asthma and allergic disorders (1)
- Astrocytoma (1)
- Astrocytoma grades (1)
- Ataxia score (1)
- Atazanavir (1)
- Atelopus carbonerensis (1)
- Atelopus mucubajiensis (1)
- Atelopus tamaense (1)
- Atezolizumab (1)
- Athlete (1)
- Atm (1)
- Atomoxetine (1)
- Atrial Fibrillation (1)
- Atrial appendage occlusion (1)
- Atrial fibrillation classification (1)
- Atrial function (1)
- Attack (1)
- Attention Deficit Hyperactivity Disorder (1)
- Attention Deficit Hyperactivity Disorder (ADHD) (1)
- Attention deficit (1)
- Attention-Deficit/Hyperactivity Disorder (ADHD) (1)
- Attention-deficit / hyperactivity disorder (1)
- Attentional bias (1)
- Atxn2 (1)
- Audio equipment (1)
- Audio signal processing (1)
- Audiology (1)
- Audition (1)
- Auditory (1)
- Auditory cortex (1)
- Auditory rehabilitation (1)
- Auric nanoparticles (1)
- Aurora (1)
- Aurora Ax (1)
- Aurora kinase (1)
- Aurora kinase inhibitor (1)
- Australia (1)
- Autism Spectrum disorder (1)
- Autism spectrum disorders (1)
- Autistic Behavior (1)
- Autistic disorder (1)
- Auto transfusion (1)
- Auto-ML (1)
- Autogenous bone block (1)
- Autoimmune encephalomyelitis (1)
- Autoimmune response (1)
- Autoimmune vasculopathy (1)
- Autologous stem cell transplantation (1)
- Automated Tube Potential Selection (1)
- Automated sRNA analysis (1)
- Automatic Environmental Tobacco Smoke Emitter (1)
- Automation (1)
- Autonomic nervous system (1)
- Autosomal recessive cutis laxa type 1C (1)
- Awareness (1)
- Axiography (1)
- Axon (1)
- Axons (1)
- Ayahuasca (1)
- Ayurveda (1)
- Ayurvedic herbal products (1)
- Azacitidine (1)
- Azan (1)
- Azan trichrome stain (1)
- Azathioprine (1)
- Azidothymidine (1)
- B cell cancer (1)
- B cell differentiation (1)
- B cell malignancies (1)
- B cell precursor acute lymphoblastic leukemia (1)
- B cell receptor (1)
- B cell subpopulations (1)
- B-cell (1)
- B-cell antigen receptor (1)
- B-cell immunology (1)
- B-cell non-Hodgkin lymphoma (1)
- B-cell receptor (1)
- B-cell transcription factors (1)
- B.1.1.529 (1)
- B.1.1.7 (1)
- B.1.617.1 (1)
- B.1.617.2 (1)
- B16 cells (1)
- B3GNT2 (1)
- BA.4 (1)
- BA.5 (1)
- BATF3 (1)
- BBB (1)
- BCL-2 (1)
- BCL11b (1)
- BCORL1 (1)
- BCR signaling (1)
- BCR-ABL (1)
- BEACOPP (1)
- BET proteins (1)
- BEZ235 (1)
- BFIS (1)
- BG-index (1)
- BH3 mimetics (1)
- BI1361849 (1)
- BIAM switch assay (1)
- BIAM-switch (1)
- BIRC5 (1)
- BK channel (1)
- BMAC (1)
- BMP4 (1)
- BMSC (1)
- BNC2 (1)
- BNT2b2 (1)
- BPD (1)
- BPDCN (1)
- BPO (1)
- BPTF (1)
- BRAF V600E (1)
- BRAF inhibitors (1)
- BRAF mutation (1)
- BRD4-NUT (1)
- BRUCE (1)
- BRVO (1)
- BTC (1)
- BTK (1)
- BV6 (1)
- Babesia venatorum (1)
- Bacillus subtilis (1)
- Back pain (1)
- Back scan (1)
- Backpropagating action potential (1)
- Bacteraemia (1)
- Bacteria (1)
- Bacteria-host interaction (1)
- Bacterial abundance (1)
- Bacterial adhesion (1)
- Bacterial leakage (1)
- Bacterial meningitis (1)
- Bacterial pathogenesis (1)
- Bacterial pathogens (1)
- BadA, (1)
- Bag6 (1)
- Balance (1)
- Ballet (1)
- Ballon-assisted enteroscopy (1)
- Balloon-expandable TAVI (1)
- Bamlanivimab (1)
- Bariatric surgery (1)
- Barlow disease (1)
- Barrier (1)
- Bartonella (1)
- Bartonella adhesin A (1)
- Bartonella grahamii (1)
- Bartonella henselae (1)
- Bartonella schoenbuchensis (1)
- Basal Ganglia (1)
- Basal ganglia (1)
- Bathyergidae (1)
- Batten disease (1)
- Bayesian (1)
- Bayesian inference (1)
- Bayesian model (1)
- Bcl-2 (1)
- Bcr-Abl (1)
- Beck Depression Inventory (1)
- Beckwith–Wiedemann syndrome (1)
- Becton Dickinson (1)
- Bee venom allergy (1)
- Beginners (1)
- Behandlungspfad (1)
- Behavioral analysis (1)
- Behavioral tests (1)
- Behavioural ecology (1)
- Benchmarks (1)
- Benign disorder (1)
- Benign enlargement of the subarachnoid spaces (BESS) (1)
- Benign prostatic hyperplasia (1)
- Bentall operation (1)
- Berci needle (1)
- Berotralstat (1)
- Best practice (1)
- Best-practice model (1)
- Bias (1)
- Bibliometric analysis (1)
- Biceps brachii (1)
- Bidirectional genes (1)
- Big Data (1)
- Big five (1)
- Bilateral cochlear implant (1)
- Bilateral sagittal split osteotomy (1)
- Biliary physiology (1)
- Biliary tree (1)
- Biliary tree stones (1)
- Bilirubin (1)
- Billroth II gastroenterostomy (1)
- Billroth papillotome (1)
- Billroth’s operation-II (1)
- Bio safety (1)
- Bioactivity-guided fractionation (1)
- Bioavailability prediction (1)
- Bioenergetics (1)
- Biofluids (1)
- Biological (1)
- Biological Activity (1)
- Biological heart valves (1)
- Biological invasion (1)
- Biological markers (1)
- Biological profile (1)
- Biological sciences (1)
- Biomarker Discovery Study (1)
- Biomarkers & Diagnostic Imaging (1)
- Biomechanical analysis (1)
- Biophysics (1)
- Bioprosthesis (1)
- Biotechnology (1)
- Bipolar (1)
- Birth (1)
- Bis-azido-NAD+ Analog (1)
- Bisphosphonates (1)
- Black cohosh (1)
- Black cohosh induced liver injury (1)
- Bleeding Risk (1)
- Blindness (1)
- Blocked occlusion (1)
- Blog (1)
- Blood cells (1)
- Blood coagulation disorder (1)
- Blood loss calculator (1)
- Blood loss formula (1)
- Blood management (1)
- Blood sample handling (1)
- Blood sampling (1)
- Blood transfusion (1)
- Bloodstream infection (1)
- Blow fly (1)
- Blowflies (1)
- BluePrint (1)
- Blurred vision (1)
- Blutspenderscreening (1)
- Blutung (1)
- Blutungskontrolle (1)
- Blutübertragbare Virusinfektionen (1)
- Body Composition (1)
- Body limbs (1)
- Body sway (1)
- Body-contouring surgery (1)
- Bone and joint mechanics (1)
- Bone cancer (1)
- Bone cement implantation syndrome (1)
- Bone conduction devices (1)
- Bone disease (1)
- Bone diseases (1)
- Bone diseases, Metabolic (1)
- Bone dust (1)
- Bone marrow aspirate concentrate (1)
- Bone marrow cells (1)
- Bone marrow fibrosis (1)
- Bone marrow mononuclear cells (1)
- Bone metastases (1)
- Bone metastasis (1)
- Bone remodelling (1)
- Bone strength assessment (1)
- Bone substitute (1)
- Bone tumor (1)
- Borrelia miyamotoi (1)
- Bortezomib (1)
- Bottom-up (1)
- Bowel obstruction (1)
- Brachial artery (1)
- Brachytherapy (1)
- Bradycardia (1)
- Bradykinin (1)
- Brain DNA methylation (1)
- Brain anatomy (1)
- Brain asymmetry (1)
- Brain damage (1)
- Brain development (1)
- Brain injuries (1)
- Brain injury (1)
- Brain ischemia (1)
- Brain repair (1)
- Brain tumor surgery (1)
- Brain tumors (1)
- Breast cancer survivers (1)
- Breast conserving surgery (1)
- Breast neoplasm (1)
- Breast reconstruction (1)
- Breathing (1)
- Breech delivery (1)
- Bright light therapy (1)
- Brij 35 (1)
- BrijL23 (1)
- Brms (1)
- Brodalumab (1)
- Bronchial inflammation (1)
- Bronchitis severity scale (1)
- Bronchodilator agents (1)
- Bronchopulmonary dysplasia (1)
- Browsertool (1)
- Brustkrebs (1)
- Bufonidae (1)
- Bungarus niger (1)
- Burkholderia arboris (1)
- Burkitt’s lymphoma (1)
- Burns (1)
- Burst (1)
- Bypass liner (1)
- C-clamp (1)
- C-reactive proteins (1)
- C1 esterase inhibitor (human) (1)
- C1-INH (C1 inhibitor, C1-esterase inhibitor) (1)
- C1-esterase inhibitor protein (1)
- C1-inhibitor (1)
- C1-inhibitor deficiency (1)
- C2 domain (1)
- C3M (1)
- C4M (1)
- C5 acylcarnitine (1)
- C57BL/6J mice (1)
- C57BL/6N mice (1)
- C6 ceramide (1)
- CA (1)
- CA1 (1)
- CAC-DRS Score (1)
- CAD-CAM (1)
- CAD/ CAM crown (1)
- CAD/CAM crown (1)
- CAKUT (1)
- CAPON (1)
- CAR-NK cell (1)
- CAR-T cell (1)
- CAT (1)
- CBC (1)
- CCC-2 (1)
- CCN2 (1)
- CD137 (1)
- CD23 (1)
- CD271 (1)
- CD3 (1)
- CD3/19 depletion (1)
- CD3/CD19 depletion (1)
- CD34 (1)
- CD34 selection (1)
- CD34+ cell enumeration (1)
- CD34 + cells (1)
- CD4 binding site (1)
- CD4+ T cells (1)
- CD40 (1)
- CD41 (1)
- CD45RA Depletion (1)
- CD45RA naïve lymphocytes (1)
- CD47 (1)
- CD49d (1)
- CD56 (1)
- CD62L (1)
- CD62P (1)
- CD62p+Exosomes (1)
- CD74 (1)
- CD8 (1)
- CD8+ T cell (1)
- CD8+ T cells (1)
- CD8+ T lymphocytes (1)
- CD8+ T-cell mediated tumor suppression (1)
- CD8+ tumor infiltrating lymphocytes (1)
- CD95/Fas receptor (1)
- CDH13 (1)
- CDI (1)
- CDK inhibitor (1)
- CDK-cyclin axis (1)
- CDK2 (1)
- CDK4/6 inhibitor (1)
- CDK4/6 inhibitors (1)
- CDK4/CDK6 (1)
- CDKN2A (1)
- CEBPD (1)
- CEBPE (1)
- CEST EPI (1)
- CGD (1)
- CHA2DS2-VASc-score (1)
- CHEPs (1)
- CHIP (1)
- CHRDL1 (1)
- CHRNA10 (1)
- CHRNA7 (1)
- CHRNA9 (1)
- CIK cell (1)
- CIM (1)
- CIRS (1)
- CK2α (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- CLOCC (1)
- CMS (1)
- CMVepidemiology (1)
- CNDAC (1)
- CNS (1)
- CNS cancer (1)
- CNS toxicity (1)
- CNS tumor (1)
- CNVs (1)
- CO2-induced forced ventilation (1)
- COBAS Taqman (1)
- COI (1)
- COII (1)
- COMT (1)
- COPD course and therapy (1)
- COVID (1)
- COVID 19 pandemic (1)
- COVID-19 epitope signatures (1)
- COVID-19 pandemic (1)
- COVID-19 vaccination (1)
- COVID-19, Primary care (1)
- COVID‐19 (1)
- CPT1A (1)
- CQL (1)
- CRBN (1)
- CRE-dependent transcription (1)
- CRE-luciferase (1)
- CREB inhibitor (1)
- CRISPR screen (1)
- CRISPR/dCas9 (1)
- CRM1 (1)
- CRPC (1)
- CRT (1)
- CRT-D (1)
- CRVO (1)
- CSC marker (1)
- CT dual-energy computed tomography (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- CT-guidance (1)
- CT-guided interventions (1)
- CTX (1)
- CUELA system (1)
- CUP (1)
- CVD biomarker (1)
- CVID (1)
- CWS Studiengruppe (1)
- CXCL10 (1)
- CXCL13 (1)
- CXCL16 (1)
- CXCR3 antagonism (1)
- CY-503 (1)
- CYBA/p22phox (1)
- CYP1A1 (1)
- CYP450 (1)
- Ca2+ imaging (1)
- CaMPARI (1)
- Cabozantinib (1)
- Caco 2 cells/metabolism (1)
- Caco-2 cells (1)
- Caco‐2 cells (1)
- Caenorhabditis elegans (1)
- Caffeine (1)
- Calcium calmodulin kinase (1)
- Calcium gluconate (1)
- Calcium signalling (1)
- Calnexin (1)
- Calprotectin (1)
- Canada (1)
- Cancer Staging (1)
- Cancer detection (1)
- Cancer development (1)
- Cancer epigenetics (1)
- Cancer of unknown primary (1)
- Cancer progression (1)
- Cancer risk factors (1)
- Cancer staging (1)
- Cancer stem cells (1)
- Cancer survivors (1)
- Cancer therapeutic resistance (1)
- Cancer-specific survival (1)
- Candida spp (1)
- Capnography (1)
- Capsaicin (1)
- Capsule endoscopy, video (1)
- Carbapenem-resistente Gram-negative Bakterien (CRGN) (1)
- Carbapenemase (1)
- Carbapenemasen (1)
- Carbohydrates (1)
- Carbon tetrachloride (1)
- Carcinoma, Ductal, Breast (1)
- Cardiac (1)
- Cardiac Fibrosis (1)
- Cardiac acoustic biomarkers (1)
- Cardiac biomarkers (1)
- Cardiac device therapy (1)
- Cardiac fibroblast (1)
- Cardiac function (1)
- Cardiac implantable electronic devices (1)
- Cardiac infarction (1)
- Cardiac masses (1)
- Cardiac monitoring (1)
- Cardiac necroenzymes (1)
- Cardiac output (1)
- Cardiac rehabilitation (1)
- Cardiac remodeling (1)
- Cardiac remodelling (1)
- Cardiac resynchronization therapy (1)
- Cardiac surgery patients (1)
- Cardiac troponin (1)
- Cardio-oncology (1)
- CardioMEMS™ HF system (1)
- Cardiogenic shock (1)
- Cardiomyocyte signaling pathways (1)
- Cardiomyopathy (1)
- Cardiopulmonary bypass (1)
- Cardiotoxicity (1)
- Cardiovascular Magnetic Resonance (CMR) (1)
- Cardiovascular disease risk (1)
- Cardiovascular epidemiology (1)
- Cardiovascular genetics (1)
- Cardiovascular mortality (1)
- Cardiovaskuläre Erkrankungen (1)
- Care home (1)
- Career promotion (1)
- Careers (1)
- Caregiver burden (1)
- Carotid injury (1)
- Carrier-bound fibrin sealant (1)
- Cartilage (1)
- Cartilage Biology (1)
- Cas9 inhibitor (1)
- Case management [MeSH] (1)
- Casirivimab (1)
- Caspase-8 (1)
- Castleman’s disease (1)
- Catch-up validation study (1)
- Catheters (1)
- Cats (1)
- Catumaxomab (1)
- Causality (1)
- Causality assessment. (1)
- Cause of death (1)
- Cdk1/cyclin B1 (1)
- Cell Adhesion (1)
- Cell Biology (1)
- Cell Death (1)
- Cell Metabolism (1)
- Cell Migration (1)
- Cell Signaling (1)
- Cell Surface Receptor (1)
- Cell adhesion (1)
- Cell cortex (1)
- Cell cultures (1)
- Cell cycle (1)
- Cell distribution (1)
- Cell membranes (1)
- Cell metabolism (1)
- Cell motility (1)
- Cell plasticity (1)
- Cell processing (1)
- Cell surface proteoglycans (1)
- Cell-assisted lipotransfer (1)
- Cell-based Assays (1)
- Cell-based therapies (1)
- Cell-to-Cell Spread (1)
- Cellular (1)
- Cellular Immune Response (1)
- Cellular energy metabolism (1)
- Cellular imaging (1)
- Cellular inflammatory response (1)
- Cellular network formation (1)
- Cellular neuroscience (1)
- Cellular stress (1)
- Cellular stress responses (1)
- Cement gap (1)
- Cementation (1)
- Center-specific time in therapeutic range (cTTR) (1)
- Centers for Disease Control and Prevention (1)
- Central Europe (1)
- Central nervous system (1)
- Central nervous system metastases (1)
- Centrifugation (1)
- Ceramic (1)
- Ceramides (1)
- Cerasorb (1)
- Cerclage (1)
- Cerebellar ataxia (1)
- Cerebral Vasospasm (1)
- Cerebral cortex (1)
- Cerebral hypoperfusion (1)
- Cerebral ischemia (1)
- Cerebral oxygen saturation (1)
- Cerebral toxoplasmosis HIV (1)
- Cerebral vasospasm (1)
- Cerebrospinal Fluid (1)
- Cerebrovascular (1)
- Cerebrovascular disorders (1)
- Certification (1)
- Cervical (1)
- Cesarean delivery (1)
- Cezanne (1)
- ChAdOx1-S (1)
- Checkpoint Inhibitor (1)
- Checkpoint kinase (1)
- Checkpoints (1)
- Chemical company (1)
- Chemical ecology (1)
- Chemical labeling (1)
- Chemical modification (1)
- Chemiluminescence (1)
- Chemobrain (1)
- Chemoembolization (1)
- Chemokine CCL2 (1)
- Chemoprevention (1)
- Chemoradiation (1)
- Chemorefractory advanced gastric cancer (1)
- Chemosensitivity (1)
- Chest pain unit (1)
- Chikungunya (1)
- Chikungunya virus (1)
- Child abuse (1)
- Child adiposity (1)
- Child and adolescent psychotherapy (1)
- Children and adolescents (1)
- Chimeric Antigen Receptor (CAR) (1)
- Chimerism (1)
- Chinese crocodile lizard (1)
- Chlorides (1)
- Chloroform (1)
- Cholecystectomy (1)
- Cholesterin (1)
- Cholesterol (1)
- Cholinergic (1)
- Chondral Lesion (1)
- Chondrocyte (1)
- Chondrocyte signalling (1)
- Chorion (1)
- Chrna7 knockout (1)
- Chromatin and Epigenetics (1)
- Chromatin conformation (1)
- Chromodomains (1)
- Chromoendoscopy (1)
- Chromosomal deletion (1)
- Chronic Hepatitis C (1)
- Chronic ankle instability (1)
- Chronic care model (1)
- Chronic conditions (1)
- Chronic depression (1)
- Chronic disease [MeSH] (1)
- Chronic diseases (1)
- Chronic health condition (1)
- Chronic heart failure (1)
- Chronic hepatitis C virus (1)
- Chronic illness (1)
- Chronic infection (1)
- Chronic intestinal failure (1)
- Chronic lymphocytic leukemia (1)
- Chronic medical conditions (1)
- Chronic obstructive airway disease (1)
- Chronic pancreatitis (1)
- Chronic periodontiti (1)
- Chronification (1)
- Chronology of disease (1)
- Cigarettes (1)
- Cine (1)
- Cinnarizine (1)
- Cinryze® (1)
- Circadian (1)
- Circadian rhythms and sleep (1)
- Circulating MiRNA (1)
- Circulation (1)
- Cirugía (1)
- Citation (1)
- Citationrate (1)
- Cities (1)
- Claudin 5 (1)
- Clavien–Dindo classification (1)
- Cleanliness level (1)
- Cleft palate (1)
- Click chemistry (1)
- Climate inequity (1)
- Clincial pharmacology (1)
- CliniMACS (1)
- Clinical (1)
- Clinical Skills (1)
- Clinical competence (1)
- Clinical effectiveness (1)
- Clinical efficacy (1)
- Clinical frailty scale (1)
- Clinical management (1)
- Clinical outcome (1)
- Clinical pathway (1)
- Clinical pathways (1)
- Clinical pharmacology (1)
- Clinical phenotype (1)
- Clinical practice guidelines (1)
- Clinical psychometry (1)
- Clinical skills (1)
- Clinical variation (1)
- Clip (1)
- Cln3 (1)
- Clonidine (1)
- Clostridioides difficile (1)
- Clostridium (1)
- Closure (1)
- ClpB (1)
- Cluster (1)
- Cluster randomization (1)
- Clustering (1)
- Co-culture (1)
- Co-morbidity (1)
- Coagulation (1)
- Coagulopathy management (1)
- Cochleaimplantation (1)
- Cochlear Implant (1)
- Coenzyme Analogue (1)
- Coenzyme Binding (1)
- Coeval folding and boudinage (1)
- Coexistence (1)
- Cofilin (1)
- Cognitive (1)
- Cognitive behavioural therapy (1)
- Cognitive dysfunction (1)
- Cognitive enhancers of exposure therapy (1)
- Cognitive neurology (1)
- Cognitive psychology (1)
- Coherent infomax (1)
- Cohort study (1)
- Colchicum (1)
- Cold hardiness (1)
- Cold pain (1)
- Cold tolerance (1)
- Collagen Maps (1)
- Collagen antibody-induced arthritis (1)
- Collagen hemostat (1)
- Collagen type I (1)
- Collagen type III (1)
- Collagen-based biomaterial (1)
- Collagens (1)
- Colon cancer (1)
- Colon capsule endoscopy (1)
- Colonic neoplasms (1)
- Colonisation (1)
- Colony stimulating factor 1 receptor (1)
- Colorimetric blood loss estimation (1)
- Combined immune checkpoint blockade (1)
- Combined surgical therapy (1)
- Combo® DTS (1)
- Combustion (1)
- Communicable diseases (1)
- Comparative effectiveness research (1)
- Comparative study (1)
- Comparators (1)
- Compartmental modeling (1)
- Competencies (1)
- Complement cascade (1)
- Complement system (1)
- Complementary medicine (1)
- Complementation rate (1)
- Complete heart block (1)
- Complete response (1)
- Completed suicide (1)
- Complex Formation (1)
- Complex II (1)
- Complex decongestive therapy (1)
- Complex elbow fractures (1)
- Complex hernia (1)
- Complex networks (1)
- Complexin 1 (1)
- Complexin-1 (1)
- Complexome profiling (1)
- Complicated stage (1)
- Complication (1)
- Comprehensive cancer centers (1)
- Comprehensive complication index (1)
- Compression stocking (1)
- Computational biology and bioinformatics (1)
- Computational biophysics (1)
- Computational model (1)
- Computational neuroscience (1)
- Computational sRNA analysis (1)
- Computational science (1)
- Computed axial tomography (1)
- Computed tomography imaging (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computed tomography, X-ray (1)
- Computer simulation (1)
- Computer-Assisted (1)
- Computer-aided drug design (1)
- Computer-unterstützte (1)
- Computers (1)
- Concurrent CNS diseases (1)
- Concurrent chemoradiotherapy (1)
- Conditional gene trap (1)
- Conduct problems (1)
- Conduit function (1)
- Cone-beam computed tomography (1)
- Confinement (1)
- Confocal endomicroscopy (1)
- Conformational change (1)
- Congenital (1)
- Congenital CMVinfection (1)
- Congenital anomalies (1)
- Congenital diaphragmatic hernia (1)
- Congenital duodenal obstruction (1)
- Congenital ocular motor apraxia (1)
- Coniosporium corticale (1)
- Connectomics (1)
- Conometric connection (1)
- Consciousness (1)
- Consensus document (1)
- Consensus methods (1)
- Consensus statement (1)
- Conservative (1)
- Conservative treatment (1)
- Consortia (1)
- Constipation (1)
- Constitution (1)
- Constrained posture (1)
- Constriction (1)
- Contact precautions (1)
- Contingent Negative Variation, CNV (1)
- Continuous Performance Test, CPT (1)
- Continuous renal replacement therapy (1)
- Contractile function (1)
- Contrast agent (1)
- Contrast-Enhancing Lesions (1)
- Contrast-enhanced (1)
- Contrast-medium, injection rate, iodine concentration, hepatic malignancy, multiphasic CT (1)
- Control (1)
- Conventional Chemotherapeutic (1)
- Conventional and unconventional ubiquitination (1)
- Conventional dendritic cells (1)
- Conventional synthetic disease-modifying antirheumatic drug (1)
- Convolutional Neural Networks (1)
- Cooperation (1)
- Coping (1)
- Copy number (1)
- Copy number variation (1)
- Cord blood transplantation (1)
- Core needle biopsy (1)
- Cornea (1)
- Corneal tomography (1)
- Corona pandemic (1)
- Corona virus (1)
- Coronary CT (1)
- Coronary Heart Disease (1)
- Coronary Plaque Burden (1)
- Coronary artery disease (CAD) (1)
- Coronary calcification (1)
- Coronary intervention (1)
- Coronavirus (1)
- Coronaviruses (1)
- Cortical degeneration (1)
- Cortical thickness (1)
- Corucia zebrata (1)
- Cost-effectiveness analysis (1)
- Couch tracking (1)
- Council for International Organizations of Medical Sciences (1)
- Course (1)
- CoxVa (1)
- Craniomaxillofacial injuries (1)
- Credentialing (1)
- Crisis (1)
- Crispr/Cas (1)
- Critical Online Reasoning Assessment (1)
- Critical bleeding (1)
- Critical care and emergency medicine (1)
- Critical haematocrit (1)
- Critical pathway (1)
- Critical size (1)
- Cross-contamination (1)
- Cross-frequency coupling (1)
- Cross-sectional (1)
- Cross-sectional study (1)
- Crosscorrelation (1)
- Crossmodal (1)
- Cryo-electron microscopy (1)
- Cryoablation (1)
- Cryoballoon (1)
- Cryptococcus (1)
- Cryptostroma corticale (1)
- CspA (1)
- Cue-P3 (1)
- Culex pipiens (1)
- Culex pipiens biotypes pipiens/molestus (1)
- Culicidae (1)
- Culture positive (1)
- Cumulative dose (1)
- Curcumis sativus (1)
- Cure (1)
- Curvilinear dose response (1)
- Custom-made mouthguard (1)
- Cuticular hydrocarbons (1)
- Cyanoacrylate (1)
- CyberKnife (1)
- Cyclin T1 (1)
- Cyclosporin A (1)
- Cyp46a1 (1)
- Cystatin C (1)
- Cysteine‐Rich Domain (CRD) (1)
- Cytochrome P450 (1)
- Cytochrome P450 enzymes (1)
- Cytokine (1)
- Cytokines Induction (1)
- Cytologie (1)
- Cytology (1)
- Cytomegalovirus (CMV) (1)
- Cytoplasm (1)
- Cytoplasmic staining (1)
- Cytoreductive nephrectomy (1)
- Cytotoxic CD8+ T cell (1)
- Cytotoxicity (1)
- C‐reactive protein (1)
- D-amino acid oxidase (1)
- D-dimer (1)
- D2-autoreceptor (1)
- DAMP (1)
- DAMPs (1)
- DBH genotype (1)
- DBS (1)
- DC-NK cell interaction (1)
- DCK (1)
- DCM (1)
- DDA (1)
- DDIT4 (1)
- DECT (1)
- DEE (1)
- DFNB9 (1)
- DHA (1)
- DILI database case quality (1)
- DKK1 (1)
- DKTK-ROG (1)
- DLBCL (1)
- DMARDs (synthetic) (1)
- DME (1)
- DMXAA (1)
- DNA (1)
- DNA Adducts (1)
- DNA Damage (1)
- DNA double-strand break repair (1)
- DNA integrity (1)
- DNA repair (1)
- DNA replication (1)
- DNA sequence analysis (1)
- DNA sequencing (1)
- DNA-PK (1)
- DNA-based identification (1)
- DNA-binding proteins (1)
- DNA-protein crosslinks (1)
- DOK1 (1)
- DOMS (1)
- DPPIV (1)
- DR5 (1)
- DSAEK (1)
- DSS /AOM (1)
- DST (1)
- DTHR (1)
- DUBs (1)
- DVI (1)
- DWI (1)
- DYRK1A (1)
- DYT1 (1)
- Dabigatran (1)
- Dancer (1)
- Dark triad (1)
- Darunavir (1)
- Data Analysis (1)
- Data acquisition (1)
- Data mining (1)
- Data monitoring (1)
- Data preprocessing (1)
- Data reduction (1)
- Data structure detection (1)
- Data validation (1)
- Database (1)
- Database searching (1)
- Databases (1)
- Dataset bias (1)
- Daubert criteria (1)
- David technique (1)
- De-isolation (1)
- Dead space (1)
- Decision Confidence (1)
- Decision impact (1)
- Decision support (1)
- Decision-making (1)
- Decolonization (1)
- Decontamination (1)
- Deep learning (1)
- Deep neural network (1)
- Deep vein thrombosis (1)
- Defibrillation (1)
- Deficient Inhibition (1)
- Deformation (1)
- Deformation oblique layer (1)
- Degrader design (1)
- Dehydrogenase (1)
- Dehydrogenases (1)
- Delayed Cerebral Ischemia (1)
- Delayed union (1)
- Deletion mutation (1)
- Delivery mode (1)
- Delivery quality assurance (1)
- Delphi Survey (1)
- Delphi consensus (1)
- Dementia (1)
- Dendritic Cells (1)
- Dendritic cells (1)
- Dendritic spines (1)
- Denervation (1)
- Dengue fever (1)
- Dengue virus (1)
- Density equalizing (1)
- Dental Tissues (1)
- Dental air (1)
- Dental casts (1)
- Dental education (1)
- Dental phobia (1)
- Dental practice (1)
- Dental training (1)
- Dentists (1)
- Dentition (1)
- Depolarization (1)
- Depression stigma (1)
- Dermal fat (1)
- Dermatitis (1)
- Dermatomyositis (1)
- Desinfektion von Flugzeugen (1)
- Desmin (1)
- Detection (1)
- Detection workflow (1)
- Deutschland (1)
- Developmental Biology (1)
- Developmental and epileptic encephalopathy (1)
- Developmental disorders (1)
- Developmental programming (1)
- Developmental trajectory (1)
- Developmentally adapted cognitive processing therapy (1)
- Devic disease (1)
- Devic syndrome (1)
- Device (1)
- Dexamethasone (1)
- Dexterity (1)
- Diabetic nephropathy (1)
- Diagnostic accuracy (1)
- Diagnostic differentiation (1)
- Diagnostic dye (1)
- Diagnostic error (1)
- Diagnostic techniques and procedures (1)
- Diagnostic tests (1)
- Diagnostics (1)
- Diagnostik (1)
- Dicer (1)
- Dichloromethane (1)
- Diesel (1)
- Diet (1)
- Dietary HDAC inhibitor (1)
- Dietary intake (1)
- Dietary supplements (1)
- Dieulafoy’s lesion (1)
- Differential Thermoanalysis (1)
- Differential expression (1)
- Difficult Airway Management (1)
- Diffuse astrocytoma (1)
- Diffuse large B cell lymphoma (1)
- Diffusion MRI (1)
- Diffusion magnetic resonance imaging (1)
- Digenic model (1)
- Digestive system (1)
- Digital (1)
- Digital breast tomosynthesis (DBT) (1)
- Digital hybrid visualization (1)
- Digital mammography (1)
- Digital pathology (1)
- Digital rectal examination (1)
- Digital subtraction angiography (1)
- Digital workshops (1)
- Dilated cardiomyopathy (1)
- Dimer (1)
- Dimers (Chemical physics) (1)
- Dimethyltryptamine (1)
- Dipeptide (1)
- Diphosphonates (1)
- Diphtheria (1)
- Diptera (1)
- Direct Acting Antivirals (DAA) (1)
- Direct acting antiviral therapies (1)
- Direct costs (1)
- Direct measurement (1)
- Direct oral anticoagulation (1)
- Direct-acting antiviral agents (DAAs) (1)
- Direct-acting antivirals (1)
- Disabilities (1)
- Disabling back pain (1)
- Disaster victim identification (1)
- Disc herniation (1)
- Discitis (1)
- Discovery (1)
- Discs large (1)
- Disease burden (1)
- Disease management (1)
- Disease progression (1)
- Disinfection of aircraft (1)
- Dislocations of the knee (1)
- Dissemination (1)
- Dissociative seizures (1)
- Distress (1)
- Distress screening (1)
- Distribution (1)
- Distribution limits (1)
- Dizygotic ectopic (1)
- Dog (1)
- Dogs (1)
- Dome-and-basin structure (1)
- Domestic (1)
- Donor Selection (1)
- Donor screening (1)
- Dorsal root ganglia (1)
- Dorsolateral prefrontal cortex (1)
- Dose optimization (1)
- Dot-probe task (1)
- Double balloon enteroscopy (1)
- Double-blind placebo-controlled trial (1)
- Doubling time (1)
- Downgrading (1)
- Doxorubicin (1)
- Dravet (1)
- Droplets (1)
- Drospirenon (1)
- Drug (1)
- Drug Discovery (1)
- Drug Therapy (1)
- Drug addiction (1)
- Drug discovery (1)
- Drug interactions (1)
- Drug permeability (1)
- Drug resistance/synergy (1)
- Drug screens (1)
- Drug susceptibility testing (1)
- Drug targeting (1)
- Drug targets (1)
- Dual energy CT (1)
- Dual therapy (1)
- Dual-Source CT (1)
- Dual-energy computed tomography (1)
- Duchenne’s muscular dystrophy (1)
- Dumon stents (1)
- Duodenal atresia (1)
- Duodenal stenosis (1)
- Duodenum (1)
- Dural onlays (1)
- Dvc1 (1)
- Dysfibrinogenämia (1)
- Dysfunctional social assumptions (1)
- Dysphagia (1)
- D’Amico classification (1)
- E protein structure (1)
- E-Learning (1)
- E-cadherin (1)
- E-cadhérine (1)
- E-health (1)
- E-learning (1)
- E. coli (1)
- E/I-Balance (1)
- E3-Ligases (1)
- EBM (1)
- EBRT (1)
- ECLS (1)
- ECM (1)
- EDB (1)
- EDOF (1)
- EDTA-plasma (1)
- EEG reference choices (1)
- EFP1 (1)
- EGF (1)
- EGFL7 (1)
- EGFP (1)
- EGFR inhibitor (1)
- EGFR pathway (1)
- EGFRvIII mutation (1)
- EGR1-dependent transcription (1)
- EHL concentrates (1)
- EIIIB (1)
- EMD 55900 (1)
- EMD 72000 (1)
- EMR1 (1)
- ENIGMA (1)
- EP300 (1)
- EPA (1)
- EQ (1)
- EQ5D5L (1)
- EQA scheme (1)
- EQIP (1)
- ER-phagy (1)
- ERAL1 (1)
- ERBB2 (1)
- ERBB2 (HER2/neu) (1)
- ERK inhibitor (1)
- ERK3/MAPK6 (1)
- ERM (1)
- ERMS (1)
- ERSCongress (1)
- ES (1)
- ES cells (1)
- ESMO-MCBS (1)
- ESR Spectroscopy (1)
- ESR and Infrared Studies (1)
- ET (1)
- ETP-ALL (1)
- ETS (1)
- EVAR (1)
- EWS/Fli1 (1)
- EZ-IO® needle driver (1)
- Early (prenatal and postnatal) life experiences (1)
- Early Rheumatoid Arthritis (1)
- Early diagnosis (1)
- Early goal-directed therapy (1)
- Early intervention (1)
- Early recurrence (1)
- Early setting (1)
- Ebola (1)
- Ebola virus (1)
- Echocardiography (1)
- Echovirus-30 (1)
- Eclampsia (1)
- Ecological Momentary Assessment (EMA) (1)
- Ecological momentary assessment (1)
- Economic analysis (1)
- Economic benchmarks (1)
- Economic evaluation (1)
- Economic impact (1)
- Economics (1)
- Ectopic bone formation (1)
- Ectopic pregnancy (1)
- Ectopic varices (1)
- Edentulous jaw (1)
- Educación médica (1)
- Effective connectivity (1)
- Effective half-life (1)
- Effectivity (1)
- Ego dissolution (1)
- Eicosanoids (1)
- Einreibetechnik (1)
- Elastogenesis (1)
- Elderly patients (1)
- Elderly trauma patient (1)
- Elective caesarean section (1)
- Electric stimulation (1)
- Electrical accident (1)
- Electrical instability (1)
- Electroconvulsive Therapy (1)
- Electroencephalography – EEG (1)
- Electrolytes (1)
- Electron transport chain (1)
- Electronic cigarettes (1)
- Electrotonic analysis (1)
- Elektroencephalographie (1)
- Elimination (1)
- Ellipsoids (1)
- Ellipticine (1)
- Elternurteil (1)
- Embolization (1)
- Embryos (1)
- Emergency (1)
- Emergency medicine (1)
- Emergency room (1)
- Emergency treatment (1)
- Emotion (1)
- Emotion processing (1)
- Emotional intelligence (1)
- Emotional recognition (1)
- Empfehlungen (1)
- Emphysema (1)
- Employment (1)
- Employment effect (1)
- Empty puparia (1)
- Ena/VASP proteins (1)
- Encephalitis Viruses (1)
- End-of-life decisions (1)
- Endocrine cancer (1)
- Endocrine system and metabolic diseases (1)
- Endocrine therapy (1)
- Endogenous retroviruses (ERV) (1)
- Endoluminal (1)
- Endometrial cancer (1)
- Endometrial carcinoma (1)
- Endometriosis (1)
- Endomicroscopy (1)
- Endoplasmic reticulum (1)
- Endorectal (1)
- Endoscopic papillotomy (1)
- Endoscopic retrograde Cholangiopancreatography (ERCP) (1)
- Endoscopic retrograde cholangiography (1)
- Endoscopic sphincterotomy (1)
- Endoscopic treatment (1)
- Endosomes (1)
- Endothelial (1)
- Endothelial cell (EC) (1)
- Endothelial nitric oxide synthase (1)
- Endothelial progenitor cells (1)
- Endothelial protein C receptor (1)
- Endothelial-to-mesenchymal transition (1)
- Endotoxins (1)
- Endovascular aortic repair (1)
- Endpoints (1)
- Energy (1)
- Energy metabolism (1)
- Energy-efficiency (1)
- England (1)
- Engraftment (1)
- Enteral nutrition (1)
- Enteric nervous system (1)
- Enterobacterales (1)
- Enterostomy (1)
- Enterostomy closure (1)
- Enterostomy formation (1)
- Entfernung (1)
- Entorhinal cortex lesion (1)
- Entrenamiento práctico (1)
- EnvZ signalling (1)
- Envenomation (1)
- Environmental biotechnology (1)
- Environmental chemistry (1)
- Environmental enrichment (1)
- Environmental impacts (1)
- Environmental sciences (1)
- Enzyme kinetics (1)
- Enzyme mechanisms (1)
- Enzyme regulation (1)
- Enzyme-linked immunoassays (1)
- Eosinophils (1)
- EpCAM positive tumor (1)
- Ephrin-B2–EphB4 (1)
- Epidemiological data (1)
- Epidermolysis bullosa simplex with muscular dystrophy (1)
- Epidural abscess (1)
- Epidural block (1)
- Epilepsiezentren (1)
- Epilepsy center (1)
- Epilepsy centers (1)
- Epileptischer Anfall (1)
- Epithelial cells (1)
- Epithelialization (1)
- Epithelioma Cells (1)
- Epsilon (1)
- Epstein–Barr virus (1)
- Equipment (1)
- Eradication (1)
- ErbB-signaling (1)
- Erythema migrans (1)
- Erythrocytes (1)
- Erythrophagocytosis (1)
- Erythropoiesis (1)
- Esophageal adenocarcinoma (1)
- Esophageal adenocarcinoma (EAC) (1)
- Esophagectomy (1)
- Esophagogastric (1)
- Estimated glomerular filtration rate (1)
- Estradiol (1)
- Estrogen Receptor Modulators (1)
- Etanercept (1)
- Ethnicity (1)
- Eukaryotic sRNA (1)
- European Society for Immunodeficiencies (ESID) (1)
- European babesiosis (1)
- European registry for idiopathic pulmonary fibrosis (eurIPFreg) (1)
- Euthanasie (1)
- Euthymic phase (1)
- Evaluation in microsurgery (1)
- Event related potentials (1)
- Event-related potential (1)
- Everolimus resistance (1)
- Evidence based medicine (1)
- Evidence-based (1)
- Evidence-based drug discovery (1)
- Evidenz (1)
- Evidenzbasiert (1)
- Evolutionary biology (1)
- Ewing-like (1)
- Exacerbations (1)
- Examination questions (1)
- Excitability (1)
- Exemestane (1)
- Exercise challenge (1)
- Exercise challenge at an ambient temperature (1)
- Exercise challenge in a cold chamber (1)
- Exercise testing (1)
- Exercise therapy (1)
- Exercise training (1)
- Exercise-induced asthma (1)
- Exercise-induced bronchoconstriction (1)
- Exertional angina and myocardial perfusion (1)
- Exhaled nitric oxide (1)
- Exoscope (1)
- Exosomal cytokines (1)
- Expansion (1)
- Expectation violation (1)
- Experimental autoimmune encephalomyelitis (1)
- Expert Systems (1)
- Expertensysteme (1)
- Experts (1)
- Explicit (1)
- Expression (1)
- Extended Glasgow outcome scale (eGOS) (1)
- Extension study (1)
- External beam radiotherapy (1)
- External-/self-assessment (1)
- Extinction (1)
- Extracellular RNA (1)
- Extracellular RNA (eRNA) (1)
- Extracellular signal-regulated kinase 1/2 (1)
- Extracorporeal circulation (1)
- Extracorporeal devices (1)
- Extracorporeal life support (1)
- Extracorporeal membrane oxygenation (1)
- Extracorporeal purification (1)
- Extraprostatic (1)
- Extreme hypo-fractionation (1)
- Exudates and transudates (1)
- F4/80 (1)
- F508del homozygous (1)
- FAAM (1)
- FABP (1)
- FAIR (1)
- FAK (1)
- FAM134 (1)
- FAM134B (1)
- FAPI PET (1)
- FAV00A (1)
- FBK-R23 (1)
- FDG-PET/CT (1)
- FF-ATP synthase dimer (1)
- FFP3 respirator (1)
- FHIR Search (1)
- FIB-4 (1)
- FIH1 (1)
- FLT3 (1)
- FOLFIRI (1)
- FOXO1 (1)
- FOXO3 (1)
- FOXO3a (1)
- FPR (1)
- FREEDOM (1)
- FSME-Virus (1)
- FSS (1)
- FTMT (1)
- FX06 (1)
- FXR (1)
- Face masks (1)
- Facet joint osteoarthritis (1)
- Facial nerve (1)
- Factor H (1)
- Factor analysis (1)
- FactorXIII Val34Leu polymorphism (1)
- Faktor V Leiden Mutation (1)
- Faktor XIII Val34Leu Polymorphismus (1)
- Falciparum (1)
- Fall (1)
- Falls (1)
- Family Physician (1)
- Famines (1)
- Fascia (1)
- Fast Healthcare Interoperability Resources (1)
- Fast-track (1)
- Fat layer (1)
- Fatty acids (1)
- Fbw7 (1)
- Fc receptor (1)
- Fear conditioning (1)
- Feasibility studies (1)
- Feature tracking (1)
- Feedback loop (1)
- Fehlerberichtssystem (1)
- Feline bartonellosis (1)
- FemNAT-CD (1)
- Female (1)
- Female adolescents (1)
- Female subjects (1)
- Females (1)
- Femoral neck (1)
- Fendrr (1)
- Ferritinophagy (1)
- Ferroptosis (1)
- Fertility counseling (1)
- Fetal bovine serum (1)
- Fetal heart (1)
- Fever (1)
- Fevers (1)
- Fibrinolytic (1)
- Fibroblast (1)
- Fibroblast growth factor (1)
- Fibrotest (1)
- Fibrous dysplasia (1)
- Fibulin-4 (1)
- Fibulin-5 (1)
- Field study (1)
- Filariasis (1)
- Filariosis (1)
- Filgrastim (1)
- Filler (1)
- Filovirus cell entry; attachment factors redundancy; SH-SY5Y cell line; host–pathogen interactions (1)
- Finevo (1)
- Finite Element Method (1)
- First experience with patients (1)
- First site of metastatic disease (1)
- First-line combination antiretroviral therapy (1)
- First-line regimen (1)
- Five-Konzept (1)
- Flavin mononucleotide (1)
- Fleas (1)
- FlexTouch (1)
- Flexibility (1)
- Flexible Endoscopic Evaluation of Swallowing (1)
- Fluid overload (1)
- Fluid therapy (1)
- Fluorescence (1)
- Fluorescence imaging (1)
- Fluorescence-in-situ-hybridization (FISH) (1)
- Fluorescent Probes (1)
- Foam rolling (1)
- Focal Adhesion Kinase (1)
- Focal onset seizure (1)
- Folic acid (1)
- Follicular lymphoma (1)
- Follow-up (1)
- Follow-up treatment (1)
- Follow-ups (1)
- Fondaparinux (1)
- Food and Drug Administration (1)
- Food effects (1)
- Foramen ovale (1)
- Forced expiratory volume in 1 s (1)
- Forensic examination (1)
- Forensic experts (1)
- Forensic pathology (1)
- Forensics (1)
- Forkhead box (1)
- Formation dance (1)
- Foxp1 (1)
- Fracture (1)
- Fracture models (1)
- Fracture risk (1)
- Fracture type (1)
- Frameshift (1)
- Francisella tularensis (1)
- Francisella tularensis subspecies holarctica (1)
- Frankfurt microsurgery course (1)
- Fresh frozen plasma (1)
- Frontobasal (1)
- Frontotemporal dementia (1)
- Fruit fly (1)
- Früherkennung (1)
- Frühgeborenes (1)
- Frühsommermeningoenzephalitis (1)
- Fuctional connectivity (1)
- Fukushima (1)
- Function (1)
- Functional ankle instability (1)
- Functional capacity (1)
- Functional mitral regurgitation (1)
- Functional outcome (1)
- Functional outcomes (1)
- Functionally-impaired elderly (1)
- Funding (1)
- FungiScope® registry (1)
- Funktionelle Bildgebung (1)
- Funktionelle NMR-Tomographie (1)
- Fusarium (1)
- Fusion Proteins, BCR-ABL (1)
- G-protein (1)
- G-protein-coupled receptors (1)
- G/P (1)
- G207 (1)
- G3BP (1)
- G3BP1 (1)
- G9a/EHMT2/KMT1C (1)
- GABA (1)
- GABAergic interneurons (1)
- GC–MS (1)
- GD2 (1)
- GDF11 (1)
- GFR (1)
- GHQ-28 (1)
- GIIb/IIIa-receptor (1)
- GLA deficiency (1)
- GLI inhibitors (1)
- GLUT1 (1)
- GM-CSF (1)
- GMP (1)
- GPR4 (1)
- GRADE (1)
- GRAND-SLAM (1)
- GRK2 (1)
- GRX1-roGFP2 (1)
- GSH (1)
- GSK2334470 (1)
- GSK3α (1)
- GSK3β (1)
- GTP cyclohydrolase (1)
- GVHD (1)
- GVL (1)
- Gaba (1)
- Gadopentate dimeglumine (1)
- Galaktografie (1)
- Galaktomosynthese (1)
- Gallbladder percutaneous drainage (1)
- Galleria mellonella (1)
- Games (1)
- Gamma-Band Activity (1)
- Gamma-aminobutyric acid (1)
- Ganglionic (1)
- Ganzheitsmedizin (1)
- Gan–Dou–Fu–Mu decoction (GDFMD) (1)
- Gap junctions (1)
- Gas gangrene (1)
- Gastric adenoma (1)
- Gastric motility (1)
- Gastroenterology (1)
- Gastroesophageal reflux disease (1)
- Gastroesophageal reflux disease symptoms (1)
- Gastrointestinal (1)
- Gastrointestinal cancer (1)
- Gastrointestinal neoplasm (1)
- Gastrointestinal tract (1)
- Gastroschisis (1)
- Gaucher disease type III (1)
- Gaucher’s disease (1)
- Gaussian graphical models (1)
- Gemcitabine (1)
- Gender analysis (1)
- Gender equality (1)
- Gender gap (1)
- Gender reassigning surgery (1)
- Gene (1)
- Gene engineering (1)
- Gene expression prediction (1)
- Gene microarray analysis (1)
- Gene polymorphism (1)
- Gene prediction (1)
- Gene sequencing (1)
- Gene set analysis (1)
- Gene/Regulation (1)
- GeneMANIA (1)
- General Practitioner (1)
- General clinical cardiology (1)
- General dental practice (1)
- General practice/family medicine (1)
- General practitioner (1)
- Generalized procrustes analysis (1)
- Generation Y (1)
- Generation time (1)
- Generic drugs (1)
- Genetic causes of cancer (1)
- Genetic heart disease (1)
- Genetic loci (1)
- Genetic networks (1)
- Genetic syndromes (1)
- Genetic techniques (1)
- Genome annotation (1)
- Genome editing (1)
- Genome-wide association study (1)
- Genomic instability (1)
- Genomic medicine (1)
- Genu valgum (1)
- Geographical disparities (1)
- Gerinnungsfaktor XIII (1)
- German (1)
- German PID-NET registry (1)
- Geschlecht (1)
- Gestagen-Monopräparate (1)
- Gestational age (1)
- Gestational diabetes (1)
- Gesundheitsamt (1)
- Gesundheitspolitische Zuständigkeit (1)
- Gesundheitswesen (1)
- Gezielte Therapie (1)
- Giant lymph node hyperplasia (1)
- Gimbaled tracking (1)
- Glabella (1)
- Gleason Grade Group (1)
- Gleason Grade group (1)
- Gleason Score (1)
- Gleason grade group (1)
- Gleason upgrading (1)
- Glioblastoma survival (1)
- Glivec® (1)
- Global networking (1)
- Global protein synthesis rates (1)
- Global warming (1)
- Glomerular Filtration Rate (1)
- Glomerular diseases (1)
- Glomerulonephritis (1)
- Glomerulosclerosis (1)
- Glucocorticoids (1)
- Glucose Transporter Type 1 (1)
- Glycogen synthase kinase 3 beta (1)
- Glycosphingolipids (1)
- Glyoxalase I (1)
- Goal-oriented care (1)
- Gold (1)
- Goserelin (1)
- Gradient boosting (1)
- Grading (1)
- Grado en medicina (1)
- Graft (1)
- Graft function (1)
- Graft quality (1)
- Graft survival (1)
- Gram negative bacteria (1)
- Gram-negative bacteria (1)
- Gram-positive infection (1)
- Granule cell (1)
- Granulocytes (1)
- Graph Machine Learning (1)
- Graph Neural Networks (1)
- Graph theory (1)
- Graphical LASSO (1)
- Grass pollen (1)
- Graves’ disease (1)
- Gravimetric method (1)
- Greater tuberosity fractures (1)
- Green arboreal alligator lizard (1)
- Greenhouse effect (1)
- Groin pain (1)
- Gross tumor volume optimization (1)
- Growth cone (1)
- Growth factor (1)
- Growth factor signalling (1)
- Großhirnrinde (1)
- Guidance (1)
- Guide profession (1)
- Guided bone regeneration (GBR) (1)
- Guided surgery (1)
- Guided tissue regeneration (1)
- Guided tissue regeneration (GTR) (1)
- Guideline adherence (1)
- Guiding growth (1)
- Gut (1)
- Gut bacteria (1)
- Gut-liver-axis (1)
- GvHD (1)
- GvL (1)
- Gαq/11 (1)
- H-Index (1)
- H3 receptor (1)
- H5N1 (1)
- HACA (1)
- HADS (1)
- HAEGARDA (1)
- HAI‐1 (1)
- HARS2 (1)
- HBV filaments (1)
- HBV genotypes (1)
- HBV reactivation (1)
- HBV surface protein (1)
- HBsAg (1)
- HCC marker (1)
- HCC recurrence (1)
- HCV treatment (1)
- HDAC and BET inhibitor (1)
- HDAC-inhibition (1)
- HDAC4 (1)
- HDR-brachytherapy (1)
- HEOR (1)
- HER2 c-erbB2 (1)
- HER2-positive (1)
- HER2/neu (ERBB2) (1)
- HES (1)
- HEV (1)
- HFrEF (1)
- HGF (1)
- HH (1)
- HIBCPP cells (1)
- HIF-1α (1)
- HIF-2 (1)
- HIF-2α (1)
- HIF-2α, erythropoietin (1)
- HIF1α (1)
- HIFU (1)
- HILI (1)
- HIPPO signalling (1)
- HIV serodiagnosis (1)
- HIV therapy (1)
- HIV-1 escape restriction (1)
- HIV-RNA (1)
- HLA DQ haplotypes (1)
- HLA antibodies (1)
- HLA class I loss (1)
- HLA class II (1)
- HLA peptidome (1)
- HLHS (1)
- HMA (1)
- HMGB1 (1)
- HODE (1)
- HOLEP (1)
- HOSO (1)
- HOTAIR (1)
- HPO (1)
- HPV infection (1)
- HPV-positive OPSCC (1)
- HRCT (1)
- HRas (1)
- HSC (1)
- HSP (hereditary spastic paraplegia) (1)
- HSPC (1)
- HSV type specific antibodies (1)
- HSV-2 (1)
- HSV-typenspezifische Antikörper (1)
- HT22 neurons (1)
- HUVEC (1)
- HVPG (1)
- Haematocrit (1)
- Haematologic diseases (1)
- Haematoma expansion (1)
- Haematopoietic stem cells (1)
- Haemodialysis (1)
- Haemodynamic monitoring (1)
- Haemophilia (1)
- Haemophilie A (1)
- Haemostatics (1)
- Halogenobenzimidazoles (1)
- Hand-foot syndrome (1)
- Haploidentical stem cell transplantation (1)
- Haplotypes (1)
- Hard-tissue trauma (1)
- Hard-to-reach population (1)
- Hardware erosion (1)
- Hashimoto’s thyroiditis (1)
- Hawaii Department of Health (1)
- HbA1c (1)
- HeLa cells (1)
- Head and neck Cancer (1)
- Head bandage (1)
- Head injury (1)
- Head neck cancer (1)
- Health care access (1)
- Health care resource utilization (1)
- Health care sector (1)
- Health education and awareness (1)
- Health information (1)
- Health literacy (1)
- Health risk analysis (1)
- Health sciences (1)
- Health services research [MeSH] (1)
- Health surveys (1)
- Health technology assessment (1)
- Health-related quality of life (1)
- Health-seeking behaviour (1)
- Healthcare (1)
- Healthcare personnel (1)
- Healthcare resource utilisation (1)
- Healthcare structure (1)
- Healthy Living Index (HLI) (1)
- Healthy men (1)
- Healthy stem cell donors (1)
- Health‐related quality of life (1)
- Health‑related quality of life (1)
- Heart defects (1)
- Heart rate (1)
- Heart regeneration (1)
- Heartrate (1)
- Heat Shock Protein (HSP) (1)
- Heat dissipation (1)
- Heat pain (1)
- Heat shock protein 27 (1)
- Hebbian plasticity (1)
- Hedgehog (1)
- Hedgehog pathway (1)
- Helpline (1)
- Hemagglutination inhibition assay (1)
- Hematocrit value (1)
- Hematologic adverse events (1)
- Hematoma (1)
- Hematopoietic stem and progenitor cells (HSPCs) (1)
- Hematopoietic stem cell (1)
- Hematopoietic stem cell transplant (1)
- Hematopoietic stem cell transplantation (1)
- Hematopoietic stem cells (1)
- Hematotoxicity (1)
- Hematoxylin staining (1)
- Hemispheric specialization (1)
- Hemobilia (1)
- Hemodilution (1)
- Hemodynamic management (1)
- Hemoglobin (1)
- Hemophilia A (1)
- Hemorrhagic shock (1)
- Hemosiderin (1)
- Hemostasis (1)
- Hemostatics (1)
- HepaRG cells (1)
- Heparan Sulfate (1)
- Heparinsensitivität (1)
- Hepatic encephalopathy (1)
- Hepatic stellate cell (1)
- Hepatitis B (1)
- Hepatitis B infection (1)
- Hepatitis B vaccination (1)
- Hepatitis B virus (1)
- Hepatitis C antibodies (1)
- Hepatitis C antigens (1)
- Hepatitis C, Chronic (1)
- Hepatitis c (1)
- Hepatocellular Carcinoma (1)
- Hepatocellular carcinoma (HCC) (1)
- Herbal medicine (1)
- Herbalife (1)
- Herbalife products (1)
- Herbs (1)
- Herbs induced liver injury (1)
- Herd immunity (1)
- Hereditary breast and ovarian cancer (1)
- Hereditary breast cancer (1)
- Hereditary ovarian cancer (1)
- Heregulin (1)
- Hernia recurrence (1)
- Hernia surgery (1)
- Herniated disk (1)
- Herpes Zoster Infektion (1)
- Heterologous prime-boost (1)
- Heterotopic pregnancy (1)
- Hexavalent vaccine (1)
- HhAntag (1)
- HiC (1)
- HiChIP (1)
- Hierarchical drift-diffusion modeling (1)
- Hif-1 alpha (1)
- Hif1α (1)
- Hig1 (1)
- High altitude (1)
- High-dose chemotherapy (1)
- High-income countries (1)
- High-intensity interval endurance training (1)
- High-risk cardiac surgery (1)
- High-risk patient (1)
- High-risk prostate cancer (1)
- High-throughput screening (1)
- Highly infectious diseases (1)
- Highwire (1)
- Himalayas (1)
- Hindu Kush Himalayas (1)
- Hip (1)
- Hip hemiarthroplasty (1)
- Hip revision (1)
- Hippo signaling (1)
- Hippocampal excitability (1)
- Hippocampal volume (1)
- Hirnforschung (1)
- Hirschsprung disease (1)
- Hispanic people (1)
- Hispanic–Latino race/ethnicity (1)
- Histological analysis (1)
- Histologie (1)
- Histone post-translational modifications (1)
- Histoplasma qPCR (1)
- Hmox1 (1)
- Hochansteckende Krankheiten (1)
- Hodgkin’s lymphoma (1)
- Holmium laser enucleation (1)
- Home Care Services [MeSH] (1)
- Homeostatic plasticity (1)
- Homicide (1)
- Homocysteine (1)
- Honolulu Queen’s Medical Center (1)
- Hormonal (1)
- Hormone receptor positive breast cancer (1)
- Horner's syndrome (1)
- Horses (1)
- Hospitalization (1)
- Hospitalizations (1)
- Host-directed therapies (1)
- Host-targeting agents (HTAs) (1)
- House dust mite allergy (1)
- Household contacts (1)
- Hrvaška (1)
- Hsp70 (1)
- Hsp90 inhibitor (1)
- HuR (1)
- Huh7 (1)
- Human (1)
- Human chorionic villi mesenchymal stromal cells (1)
- Human experimental pain models (1)
- Human immunodeficiency virus (HIV) (1)
- Human olfaction (1)
- Human pancreas (1)
- Human physiology (1)
- Human primary proximal tubular cells (1)
- Human prostate (1)
- Human retroelements (1)
- Human visual cortex (1)
- Humans (1)
- Humeral fractures (1)
- Humerus (1)
- Hungary (1)
- Hyaluronan (1)
- Hydrocephalus (1)
- Hydrofluoric acid (1)
- Hydromineral (1)
- Hydroxyapatite (1)
- Hydroxychloroquine (1)
- Hydroxycut (1)
- Hydroxyethyl starch (1)
- Hydroxyurea (1)
- Hymenoptera venom allergy (1)
- Hymenoptera venom immunotherapy (1)
- Hyperactivity (1)
- Hyperammonemic encephalopathy (1)
- Hyperscanning (1)
- Hypertensive disorders in pregnancy (1)
- Hypofractionated radiotherapy (1)
- Hyponatremia (1)
- Hypoxia inducible factor (1)
- Hypoxia inducible factor 1 alphal (1)
- Hypoxia-inducible factor-1α (HIF-1α) (1)
- Hypoxic responses (1)
- Hörrehabilitation (1)
- Hörrinde (1)
- I-FABP (1)
- I-PRF (1)
- IAP (1)
- IAP Proteins (1)
- IAP-IAP (1)
- ICAM-1 (1)
- ICG (1)
- ICH M13A draft guideline (1)
- ICL (1)
- ICL V4c (1)
- IDH1 inhibitor (1)
- IDO1 (1)
- IFA (1)
- IFN (1)
- IFN-β (1)
- IFN-γ expression (1)
- IFT (1)
- IGF (1)
- IGF-1 (1)
- IGF1 (1)
- IGRA (1)
- IKKε (1)
- IKZF1 (1)
- IL -17 (1)
- IL -23 (1)
- IL 23p19 knockout mouse (1)
- IL-11 (1)
- IL-12 (1)
- IL-13 (1)
- IL-15 (1)
- IL-17 (1)
- IL-17A (1)
- IL-18 binding protein (1)
- IL-18BP (1)
- IL-1b (1)
- IL-21 (1)
- IL-22 (1)
- IL-27 cytokine (1)
- IL-38 (1)
- IL10R (1)
- ILUVIEN (1)
- IMiD® (1)
- INR (1)
- IOL scleral Fixation (1)
- IPEX (1)
- IPS e.max system (1)
- IPSS (1)
- IR (1)
- IRES translation (1)
- IRF-3 (1)
- ISS (1)
- ITGA7 (1)
- IUIS classification 2017 (1)
- IV iron (1)
- IVA interference tandem mass spectrometry (1)
- IVD degeneration (IVDD) (1)
- IVDU (1)
- IVUS (1)
- Iceland (1)
- Idarucizumab (1)
- Idelalisib (1)
- Identifier (1)
- Identifikation (1)
- Identifizierung von Katastrophenopfern (1)
- Identity (1)
- Idiopathic pulmonary fibrosis (IPF) (1)
- IgA deficiency (1)
- IgE (1)
- IgG (1)
- IgG substitution therapy (1)
- IgG4-related disease (1)
- IgGAM (1)
- Ileostomy (1)
- Ileus (1)
- Illumina (1)
- Image processing (computer-assisted) (1)
- Imagery (1)
- Imaging (1)
- Imaging genetics (1)
- Imaging in LGG (1)
- Imaging, three-dimensional (1)
- Imdevimab (1)
- Immediate loading (1)
- Immediate placement (1)
- Immobilization (1)
- Immunbiology (1)
- Immunchemie (1)
- Immune Response (1)
- Immune checkpoint inhibitors (1)
- Immune complex vasculitis (1)
- Immune paralysis (1)
- Immune receptor signaling (1)
- Immune response (1)
- Immune status (1)
- Immunität <Medizin> (1)
- Immunoassay (1)
- Immunoassays (1)
- Immunocompromised (1)
- Immunodeficiency (1)
- Immunogenetics (1)
- Immunoglobulin Therapy (1)
- Immunoglobulins (1)
- Immunohistochemistry techniques (1)
- Immunological techniques (1)
- Immunologie (1)
- Immunology and Microbiology Section (1)
- Immunomodulatory agents (1)
- Immunomonitoring (1)
- Immunophenotyping (1)
- Immunosenescence (1)
- Immunostaining (1)
- Immunosuppressive Agents (1)
- Immunosuppressive agents (1)
- Immunosuppressive therapy (1)
- Immuno‑histochemistry (1)
- Immunsystem (1)
- Impella (1)
- Impfraten (1)
- Impfstoff (1)
- Impfung (1)
- Implant osseointegration (1)
- Implant-supported bars (1)
- Implantable cardioverter-defibrillator (1)
- Implementación (1)
- Implicit (1)
- Implicit Processing (1)
- Implicit Association Test (1)
- Implicit motives (1)
- Impoverishment (1)
- Impulse control (1)
- Impulse generator (1)
- In vivo electrophysiology (1)
- In-Hospital Emergencies (1)
- In-TIPS thrombosis (1)
- In-hospital cardiac arrest (1)
- In-line filtration (1)
- In-vivo (1)
- Inactivation (1)
- IncL (1)
- IncX (1)
- Incident reporting system (1)
- Incidental prostate cancer (1)
- Incomplete colonoscopy (1)
- Incontinence (1)
- Independent component analysis (1)
- Independent laboratories (1)
- Indeterminate biliary stricture (1)
- Index (1)
- Indication (1)
- Indication for fertility preservation (1)
- Indirect costs (1)
- Indirect treatment comparison (ITC) (1)
- Individual differences (1)
- Individualized intervention (1)
- Individualized therapy (1)
- Indocyanine green (1)
- Indoor air pollution (1)
- Induced membrane technique (1)
- Induced pluripotent stem cells (1)
- Induced sputum (1)
- Inducible nitric oxide synthase (iNOS) (1)
- Induction therapy (1)
- Inequality (1)
- Infant (1)
- Infant leukemia (1)
- Infants (1)
- Infarction (1)
- Infectious disease (1)
- Infectious disease epidemiology (1)
- Infektionsserologie (1)
- Inferior vena cava thrombus (1)
- Inflammasome (1)
- Inflammatory fibroid polyp (1)
- Inflammatory pattern (1)
- Inflow obstruction (1)
- Influenza vaccination (1)
- Information transfer (1)
- Infrared Raman (1)
- Infusion management (1)
- Inguinal hernia (1)
- Inguinal pain (1)
- Inherited arrhythmic syndrome (1)
- Injury Severity Score (ISS) (1)
- Inner ear therapy (1)
- Inpatient hospital cases (1)
- Inpatients (1)
- Inside-out Signaling (1)
- Insula (1)
- Insulin resistance (1)
- Insulin secretion (1)
- Insulin therapy (1)
- Integrated Pulmonary Index (1)
- Integrated multimodal training (1)
- Integrative Network Analysis (1)
- Integrins (1)
- Intelligence (1)
- Intelligence tests (1)
- Intensive care outcome (1)
- Intensive care unit (1)
- Intention attribution (1)
- Inter-study reproducibility (1)
- Interaction (1)
- Interdisciplinarity (1)
- Interferon-free HCV treatment (1)
- Interferon-α (1)
- Interferon-λ, (1)
- Interferons (1)
- Interleukin-10 (1)
- Interleukin-17A (1)
- Interleukin-18 (1)
- Interleukin-18 binding protein (1)
- Interleukin-22 binding protein (1)
- Interleukin-36 (1)
- Intermediate filaments (1)
- Intermediate-risk (1)
- International body passport (1)
- International normalized ratio (1)
- Internationaler Vergleich (1)
- Internet citation (1)
- Internet-based therapy (1)
- Interoperability (1)
- Interposition (1)
- Interpretation Bias (1)
- Intersectoral care (1)
- Interspecific competition (1)
- Interstitial lung diseases (ILD) (1)
- Interstitial pneumonia (1)
- Intervention (1)
- Intervention development (1)
- Interventional Trials (1)
- Interventional cardiology (1)
- Interventional oncological treatment (1)
- Intervertebral disc degeneration (1)
- Intervertebral disc displacement (1)
- Interview (1)
- Interviews (1)
- Intestinal failure-associated liver disease (1)
- Intestinal fistula (1)
- Intestinal metaplasia (1)
- Intestinal neoplasms (1)
- Intimal-medial thickness (1)
- Intra-abdominal infection (1)
- Intracellular pathogens (1)
- Intracerebral haemorrhage (1)
- Intracranial embolism (1)
- Intracranial haemorrhage (1)
- Intracranial hemorrhage (1)
- Intragastric balloon (1)
- Intraoperative blood salvage (1)
- Intraoperative procedure (1)
- Intraoperative test (1)
- Intraoral scanners (1)
- Intraosseous access (1)
- Intratumoral (1)
- Intratympanic drug delivery (1)
- Intravenous antibiotic therapy (1)
- Intravenous injections (1)
- Intravenous iron (1)
- Intrinsic Disorder (1)
- Intrinsic resistance (1)
- Intubation (1)
- Invasive candidiasis (1)
- Invasive fungal infection (1)
- Invasive fungal infections (1)
- Ionization State (1)
- Ipilimumab (1)
- Ireb2 (1)
- Ireland (1)
- Iron Overload (1)
- Iron chelation (1)
- Irregular vaccination (1)
- Ischemia-reperfusion injury (1)
- Ischemia–reperfusion injury (1)
- Isocitrate dehydrogenase (1)
- Isoflurane (1)
- Isoforms (1)
- Isoproterenol (1)
- Isothermal amplification (1)
- Isotope labeling (1)
- Issue 96 (1)
- Italy (1)
- Itpr1 (1)
- Ivor Lewis esophagectomy (1)
- Ixodes (1)
- JAK inhibition (1)
- JAK2V617F (1)
- JNK (1)
- JNK3 (1)
- Jak2(V617F) (1)
- Jaw surgery (1)
- Joint actions (1)
- Joint destruction (1)
- Joubert syndrome (1)
- Jumping (1)
- Jurkat (1)
- Juvenile myoclonic epilepsy (1)
- K-homology RNA-binding domain (1)
- K3EDTA plasma sampling (1)
- KAP (1)
- KCCQ (1)
- KCGS (1)
- KCNH2 (1)
- KCNJ2 mutation (1)
- KCNQ1 (1)
- KDIGO (1)
- KIF (1)
- KIF11 (1)
- KIR (1)
- KLHL11 (1)
- KLK5 (1)
- KOOS IV (1)
- KPS (1)
- KRAS (1)
- Kaisidis plate (1)
- Kallikrein inhibitor (1)
- Kappa (1)
- Karyotypes (1)
- Katherine (1)
- Kava (1)
- Kava hepatotoxicity (1)
- Keap1-Nrf2 (1)
- Keratinocytes (1)
- Ketogenic Diet (1)
- Ki-67/MIB1 (1)
- Ki67 transgenic c‐myc/TGFα mice (1)
- Kidney Transplantation (1)
- Kidney disease (1)
- Kidney diseases (1)
- Kidney neoplasm (1)
- Kidney transplant recipients (1)
- Kidneys (1)
- Kim-1 (1)
- Kinases (1)
- Kinder (1)
- Kindes- und Jugendalter (1)
- Kindheit (1)
- Kinematic posture analysis (1)
- Kinematics (1)
- Kinetochore (1)
- Knee joint sound (1)
- Knee osteoarthritis (1)
- Knee surgery (1)
- Knockout (1)
- Kolorektales Karzinom (1)
- Komorbidität (1)
- Kongress <Wandlitz, 1997> (1)
- Kontrazeption (1)
- Krait (1)
- Krankenversicherung (1)
- Krebsforschung (1)
- Kupffer cells (1)
- Kurzzeitgedächtnis (1)
- Kutner, Luis (1)
- Kynurenine (1)
- Körpermodifizierung (1)
- L1-norm SVM (1)
- L2 (1)
- LABAs (1)
- LAMP3 (1)
- LAMTOR1 (1)
- LAMTOR2 (1)
- LARS2 (1)
- LASS (1)
- LC-MS-Based Clinical Research (1)
- LC-MS-based lipid mediator analysis (1)
- LC-NE system (1)
- LC3 I/II (1)
- LC3B (1)
- LCD-Array (1)
- LCH (1)
- LC–MS/MS (1)
- LDHB (1)
- LDL (1)
- LDL-cholesterol (1)
- LEOSS (1)
- LFA-1 (1)
- LFP (1)
- LHRH receptor (1)
- LIR interaction, (1)
- LIVIN (1)
- LM11A 31 (1)
- LN229 (1)
- LNS (1)
- LOS (1)
- LPP (1)
- LQTS (1)
- LRBA (1)
- LSD1 (1)
- LSEC (1)
- LTB4 (1)
- LTBI (1)
- LUBAC (1)
- LUT (1)
- Label-free (1)
- Laboratory techniques and procedures (1)
- Laborpersonal (1)
- Lack of immunity (1)
- Lactate Dehydrogenase (1)
- Lactation (1)
- Lactic acidosis (1)
- Lactobacillus (1)
- Lafora disease (1)
- Laminin (1)
- LanCL2 (1)
- Landmark (1)
- Language delay (1)
- Laparoscopic fundoplication (1)
- Laparostomy (1)
- Laparotomy. Joel-Cohen (1)
- Large vessel occlusion (1)
- Laryngeal Tube (1)
- Laser interstitial thermal therapy (1)
- Laser navigation system (1)
- Lasers (1)
- Late Gadolinium Enhancement (LGE) (1)
- Late gadolinium enhancement (1)
- Late presentation (1)
- Latent transforming growth factor β-binding protein 4 (1)
- Lateral flow antigen testing (1)
- Lateral flow immunoassay (1)
- Lateral recess stenosis (1)
- Laterality (1)
- Le carcinome épidermoïde oral (1)
- Leadership (1)
- Learning algorithms (1)
- Learning outcomes (1)
- Leber congenital amaurosis (1)
- Lectin affinity plasmapheresis (1)
- Lecture (1)
- Lee type, functional outcome (1)
- Lee-type (1)
- Leflunomide (1)
- Left Ventricular Mass (1)
- Left atrial appendage closure (1)
- Left ventricular assist device (1)
- Left ventricular function (1)
- Left ventricular mass (1)
- Left ventricular non-compaction, (1)
- Leg alignment (1)
- Leg axis (1)
- Legal medicine (1)
- Legionella pneumophila (1)
- Leigh syndrome (1)
- Leishmaniasis (1)
- Lemperle (1)
- Lenalidomide (1)
- Length of stay (1)
- Lennox-Gastaut syndrome (1)
- Lennox–Gastaut syndrome (1)
- Lentiviral vectors (1)
- Les macrophages associés aux tumeurs (1)
- Lesion (1)
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)
- Leukocyte depletion filter (1)
- Leukocyte elastase (1)
- Leukocytes (1)
- Leukodystrophy (1)
- Leukotriene (1)
- Leukozyt (1)
- Lice (1)
- Lifestyle (1)
- Ligand post-insertion (1)
- Light sheet fluorescence microscopy (1)
- Lineage (1)
- Lineage tracing (1)
- Linkage (1)
- Lipedema (1)
- Lipid Transition Temperature (1)
- Lipid metabolism (1)
- Lipid peroxidation (1)
- Lipid signaling (1)
- Lipid solution (1)
- Lipid trafficking (1)
- Lipidol (1)
- Lipiodol (1)
- Lipodystrophy (1)
- Lipopolysaccharide-binding protein (1)
- Liposuction (1)
- Liquid filled MicroLion ion chamber array (1)
- Liquor cerebrospinalis (1)
- Lithium (1)
- Liver Fibrosis (1)
- Liver biopsy (1)
- Liver enzymes (1)
- Liver histology (1)
- Liver metastases (1)
- Liver resection (1)
- Liver transplant (1)
- Liver-Related Complications (1)
- Liver-related complications (1)
- LiverTox (1)
- LncRNA - long noncoding RNA (1)
- Loa loa (1)
- Local IgE (1)
- Local allergic rhinitis (1)
- Local control (1)
- Local field potential (1)
- Localized prostate cancer (1)
- Locally advanced (1)
- Lockdown (1)
- Loco-regional control (1)
- Locomotor circuit (1)
- Lokalrezidiv (1)
- Lomentospora prolificans (1)
- Long QT syndrome (1)
- Long interspersed nuclear elements (LINE) (1)
- Long non-coding RNA (1)
- Long noncoding RNA (1)
- Long term output (1)
- Long term result (1)
- Long-COVID (1)
- Long-term (1)
- Long-term care (1)
- Long-term continence (1)
- Long-term follow up (1)
- Long-term follow-up (1)
- Long-term results (1)
- Long-term-measurements (1)
- Longchain polyunsaturated fatty acids (1)
- Longitudinal analysis (1)
- Low birth weight infant (1)
- Low grade glioma (1)
- Low volume prep (1)
- Low-dose X-irradiation (1)
- Low-dose ionizing radiation (1)
- Low-dose radiation therapy (1)
- Low-grade glioma (1)
- Lower back pain (1)
- Lower limb deformities (1)
- Lpar2 (1)
- Ltbp-4 (1)
- Ltbp-4L (1)
- Ltbp-4S (1)
- Ltbp4 (1)
- Lucigenin (1)
- Luftverkehr (1)
- Lumbar Disk Degeneration (1)
- Lumbar spinal canal stenosis (1)
- Lumbar stenosis (1)
- Lumican (1)
- Lung (1)
- Lung adenocarcinoma (1)
- Lung development (1)
- Lung function (1)
- Lung neoplasms (1)
- Lung ultrasound (1)
- Lyme Disease (1)
- Lyme disease - Borreliosis (1)
- Lyme-Borreliose (1)
- Lymph node (1)
- Lymphadenopathy (1)
- Lymphangiectasia (1)
- Lymphangiogenesis (1)
- Lymphangioleiomyomatosis (1)
- Lymphedema (1)
- Lymphocyte (1)
- Lymphocyte subpopulations (1)
- Lymphoepithelioma (1)
- Lymphoid Neoplasia (1)
- Lymphoid tissues (1)
- Lymphom (1)
- Lymphoma Cells (1)
- Lymphomas (1)
- Lymphopenia Mortality (1)
- Lymphozyt (1)
- Lysosomal storage disease (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- M2-PK (1)
- MACE (1)
- MAGGIC score (1)
- MAIT cell (1)
- MAP Kinases (MAPKs) (1)
- MAP kinase (1)
- MCP (1)
- MCP-1 (1)
- MDD (1)
- MDM2 (1)
- MDR1 (1)
- MEDIC (1)
- MEIS (1)
- MEIS homeodomain protein (1)
- MEIS2 (1)
- MEK inhibitor (1)
- MELD (1)
- MEN1 (1)
- MET (1)
- MGMT (1)
- MGMT promoter (1)
- MID task (1)
- MK-0457 (1)
- MKP1 (1)
- ML-IAP (1)
- MLC tracking (1)
- MLL-rearranged leukemia (1)
- MLN8237 (1)
- MLV (1)
- MM-121 (1)
- MMF (1)
- MMP14 (1)
- MMP2 (1)
- MMPs (1)
- MN1 (1)
- MOLLI (1)
- MPA (1)
- MPM (1)
- MPN (1)
- MPN-U (1)
- MR-based histology (1)
- MR-proADM (1)
- MR-spectroscopy (1)
- MRI patterns of gliomas (1)
- MRI-negative epilepsy (1)
- MRP4 (1)
- MRT (1)
- MS (1)
- MSC-subsets (1)
- MSM (1)
- MT: Non-coding RNAs (1)
- MTCL (1)
- MTHFR-Mutation (1)
- MTHFR-mutation (1)
- MTOR inhibitor (1)
- MTRNR1 (1)
- MTRasym (1)
- MTT (1)
- MUTARS® RS Cup System (1)
- MUTARS® RS cup system (1)
- MVPA (1)
- MYCBP2 (1)
- MYCN amplification (1)
- Machine Learning (1)
- Machine learning algorithms (1)
- Machine teaching (1)
- Macrophage (1)
- Macrophage Transdifferentiation (1)
- Macular neovascularization (1)
- Magnet dislocation (1)
- Magnetencephalography (1)
- Magnetic resonance Imaging (1)
- Magnetic resonance imaging (MRI) (1)
- Magnetoencephalographie (1)
- Magnetoencephalography (1)
- Maintenance therapy (1)
- Maintenance treatment (1)
- Major Depressive Disorder (1)
- Major bleeding (1)
- Major infection after cardiac surgery (1)
- Makrophagen (1)
- Malariae (1)
- Malate Dehydrogenases (1)
- Male (1)
- Malignancy (1)
- Malignant meningioma (1)
- Malnutrition (1)
- Mamma (1)
- MammaPrint (1)
- Mammalian target of rapamycin (1)
- Mammaplasty (1)
- Mammary gland (1)
- Management (1)
- Manatee invariant (1)
- Manchester scar scale (1)
- Mandatory Vaccinations (1)
- Mandible (1)
- Mandibular gland (1)
- Mandibular gland proteomics (1)
- Mania (1)
- Manner of death (1)
- Manufacturing (1)
- Maple bark disease (1)
- Maple bark strippers’ lung (1)
- Mapping (1)
- Marginal grafts (1)
- Marginal integrity (1)
- Marker genes (1)
- Markov model (1)
- Masking effect (1)
- Mass disaster (1)
- Massenkatastrophe (1)
- Massive Online Open Course (1)
- Mastectomy (1)
- Mastoiditis (1)
- Matching-adjusted indirect comparison (MAIC) (1)
- Materials science (1)
- Maternal morbidity (1)
- Maternal separation (1)
- Mathematical biosciences (1)
- Mathematical functions (1)
- Mathematical methods (1)
- Mathematical model (1)
- Mathematical models (1)
- Maxillofacial reconstruction (1)
- Maxillofacial surgery (1)
- Maxillofacial trauma (1)
- Mcl-1 (1)
- MdM2 (1)
- Mean erythrocyte volume (1)
- Measles (1)
- Measurement equipment (1)
- Mechanical ankle instability (1)
- Mechanical ventilation (1)
- Meckel’s diverticulum (1)
- Median nerve (1)
- Medical (1)
- Medical Oncology (1)
- Medical Physics: Diagnostic (1)
- Medical communication (1)
- Medical ethics (1)
- Medical history (1)
- Medical hypoxia (1)
- Medical imaging (1)
- Medical implants (1)
- Medical management (1)
- Medical school (1)
- Medical staff (1)
- Medical student (1)
- Medical study (1)
- Medical traineeship (1)
- Medication changes (1)
- Medicine and health sciences (1)
- Meersseman test (1)
- Membrane Trafficking (1)
- Membrane assays (1)
- Membrane staining (1)
- Membrane-Phloretin Interaction (1)
- Mena/VASP (1)
- Meningioma (1)
- Mental disorder (1)
- Mental health disorders (1)
- Mental health problems (1)
- Mental health therapies (1)
- Menthol (1)
- Mesangial cells (1)
- Mesenchymal stem cell (1)
- Mesenchymal stem/stromal cells (1)
- Mesenchymal stromal cells (1)
- Mesenchymal stromal cells (MSC) (1)
- Mesh repair (1)
- Metaanalysis (1)
- Metabolic (1)
- Metabolic dysfunction (1)
- Metabolic labeling (1)
- Metabolic models (1)
- Metabolic vulnerabilities (1)
- Metabolism, Inborn Errors (1)
- Metabolomic profile (1)
- Metacognition (1)
- Metal clip (1)
- Metalloproteases (1)
- Metalloproteinases (1)
- Metastasis-directed therapy (1)
- Metastatic renal cell carcinoma (1)
- Metastatic tumors (1)
- Metformin (1)
- Methacholine challenge test (1)
- Methanol (1)
- Methicillin resistance (1)
- Method validation (1)
- Methods (1)
- Methotrexate (1)
- Methylation (1)
- Methylmercury Containing Inactivator (1)
- Methylphenidate (1)
- Mexican alligator lizards (1)
- Mgm1p (1)
- MiR-29 (1)
- MiSpEx Network (1)
- MiSpEx-network (1)
- Mice (1)
- Michael acceptor (1)
- Micro RNAs (1)
- Micro computed tomography (1)
- Micro-CT (1)
- MicroRNA-181a (1)
- MicroRNAs (miRNAs) (1)
- Microalgae (1)
- Microarray (1)
- Microbial mutation (1)
- Microbiology and Infectious Disease (1)
- Microbiology, Virology & Host Pathogen Interaction (1)
- Microenvironment (1)
- Microfilaremia (1)
- Microfluidics (1)
- Microgap (1)
- Microglia (1)
- Microglial cells (1)
- Micrognathia (1)
- Microparticles (1)
- Microphones (1)
- Microphysiological models (1)
- Microplastic (1)
- Microsatellite instability (1)
- Microstates (1)
- Microstructural impairment (1)
- Microtubule (1)
- Mid-intestinal bleeding (1)
- Midbrain/brainstem expression changes (1)
- Middle East respiratory syndrome coronavirus (1)
- Midkine (1)
- Midline laparotomy (1)
- Midwifery (1)
- Migrant health (1)
- Mild chronic inflammation (1)
- Mild cognitive impairment (1)
- Mild hypoxia (1)
- Mindfulness (1)
- Mineralization (1)
- Mini-monovision (1)
- Minimal core of imaging (1)
- Minimal invasive (1)
- Minimal invasive dentistry (1)
- Minimally invasive surgical procedures (1)
- Minimally invasive transforaminal interbody fusion (1)
- Mislocalised proteins (1)
- Mitochondrial Apoptosis (1)
- Mitochondrial Metabolism (1)
- Mitochondrial Permeability Transition (1)
- Mitochondrial Transport (1)
- Mitochondrial amino acid tRNA synthetases (1)
- Mitochondrial disease (1)
- Mitochondrial disorder (1)
- Mitochondrial function (1)
- Mitochondrial proteins (1)
- Mitochondrial respiration (1)
- Mitochondrial shuttles (1)
- Mitomycin C (1)
- Mitoxantrone (1)
- Mixed Lipid Phases (1)
- Mixed hearing loss (1)
- Mmp12 (1)
- Model Organism (1)
- Model organisms (1)
- Moderating factors (1)
- Modified FDI criteria (1)
- Molar tooth sign (1)
- Mole-rat (1)
- Molecular Biology (1)
- Molecular Chaperone (1)
- Molecular diagnosis (1)
- Molecular diagnostic testing (1)
- Molecular diagnostics (1)
- Molecular genetics (1)
- Molecular glue (1)
- Molecular marker (1)
- Molecular matched therapy (1)
- Molecular mimicry (1)
- Molecular signatures (1)
- Molecular subtype (1)
- Molecular therapy (1)
- Molecularly targeted therapy (1)
- Monacolin K (1)
- Monetary incentive delay (1)
- Mongolian spot (1)
- Monoacylglycerol lipase (1)
- Monoclonal antibody (mAb) (1)
- Monocyte gene expression (1)
- Monocytes and macrophages (1)
- Monolithic crown (1)
- Monosaccharide Transport Proteins (1)
- Monte Carlo method (1)
- Monte Carlo simulation (1)
- Mood (1)
- Morphological modeling (1)
- Morphologie (1)
- Mosquito (1)
- Mosquito crop (1)
- Mosquito-plant interaction (1)
- Motility (1)
- Motility disorder (1)
- Motivating factor (1)
- Motivation (1)
- Motor neuron disease (1)
- Motor skills (1)
- Motor-cognitive (1)
- Mouse model (1)
- Moviprep (1)
- Mucomaix® matrix (1)
- Mucopolysaccharidoses (1)
- Multi-Omics (1)
- Multi-center (1)
- Multi-modal feedback (1)
- Multi-motive grid (1)
- Multi-nucleated cardiomyocytes (1)
- Multi-resistant pathogens (1)
- Multi-stakeholder approach (1)
- Multi-syndrome classification (1)
- Multidetector Computed Tomography (1)
- Multidisciplinary management (1)
- Multidrug-resistance (1)
- Multidrug-resistant bacteria (1)
- Multidrug-resistant organisms (1)
- Multidrug-resistant tuberculosis (1)
- Multilevel two-part modelling (1)
- Multiligament instability (1)
- Multimedication (1)
- Multimodal Modeling (1)
- Multimodal imaging (1)
- Multimorbid patients (1)
- Multinomial logistic regression (1)
- Multinucleated giant cells (1)
- Multiomics (1)
- Multiparametric MRI (1)
- Multiplate (1)
- Multiple Sclerosis (1)
- Multiple Transport Systems (1)
- Multiple myeloma (1)
- Multiple trauma (1)
- Multiple-indication review (1)
- Multiplex immunoassay (1)
- Multisensory (1)
- Multiset independent component analysis (1)
- Muscarinic acetylcholine receptor (1)
- Muscle (1)
- Muscle analysis (1)
- Muscle atrophy (1)
- Muscle damage (1)
- Muscle pain (1)
- Muscle tissue (1)
- Muscular diseases (1)
- Musculoskeletal (1)
- Musculoskeletal abnormalities (1)
- Musculoskeletal diseases (1)
- Musculoskeletal mechanics (1)
- Musculoskeletal problems (1)
- Musculoskeletal ultrasound (1)
- Music (1)
- Music chair concepts (1)
- Musical rhythm (1)
- Musician (1)
- Musician-specific seating position (1)
- Mutation databases (1)
- Mycobacteria (1)
- Mycobacterium avium complex (1)
- Mycoses (1)
- Myelin or myeloarchitecture (1)
- Myelodysplastic syndrome (1)
- Myelofibrosis (1)
- Myeloperoxidase (1)
- Myeloproliferative disease (1)
- Myiasis (1)
- Myocardial infarction (MI) (1)
- Myocardial injury (1)
- Myocardial remodeling (1)
- Myocardial revascularization (1)
- Myocardial segmentation (1)
- Myonecrosis (1)
- Myopia (1)
- Myotonic dystrophy (1)
- Mφs (1)
- N-Acetylaspartate (1)
- N-acetyl-L-cysteine (1)
- N-acetylcysteine (1)
- N-cadherin (1)
- N-cadhérine (1)
- N-glycosylation (1)
- N-hydroxysuccinimide (1)
- N-methyl-D-aspartate receptor (1)
- N-myc (1)
- N2 (1)
- N471D strumpellin knock-in mice (1)
- N501Y (1)
- NAD + Analogues (1)
- NAD+-Analogs (1)
- NADP+ Analogues (1)
- NADPH oxidase 4 (1)
- NAD⊕-Isomer (1)
- NAFL (1)
- NCAM (1)
- NCH93 (1)
- NCOA4 (1)
- NDBI (1)
- NDNF interneurons (1)
- NDR1 (1)
- NDUFA6 (1)
- NDUFAF8 (1)
- NEAT1 (1)
- NEAT2 (1)
- NET (1)
- NETs (1)
- NF-kB (1)
- NF-ĸB (1)
- NF-кB (1)
- NFAT (1)
- NFkB (1)
- NGS (1)
- NGS sequencing (1)
- NHE (1)
- NHEJ (1)
- NIS (1)
- NK Receptor (1)
- NK cell subset (1)
- NK cell subsets (1)
- NK receptors (1)
- NKG2A blocking (1)
- NKT cell (1)
- NLPHL (1)
- NLRP3 inflammasomes (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- NMDAR subunit GluN2B (1)
- NMO-IgG (1)
- NOD2 (1)
- NOS-I (1)
- NOS1AP (1)
- NOXA (1)
- NPC disease (1)
- NPH insulin (1)
- NPSR1 (1)
- NR4A2 (1)
- NR4A3 (1)
- NRAS (1)
- NS1608 (1)
- NS3 protease inhibitor (1)
- NS3-4A protease inhibitor (1)
- NS3/4A protease inhibitors (PI) (1)
- NS5A inhibitors (1)
- NS5B polymerase inhibitor (1)
- NSAIDs (1)
- NSBB (1)
- NSC350625 (1)
- NSE (1)
- NSF (1)
- NSG mice (1)
- NSTEMI (1)
- NTDs (1)
- NTM (1)
- NURF (1)
- NVBP (1)
- NXF1 (1)
- Nachsorge (1)
- Nachweisverfahren (1)
- Nadelstichverletzungen (1)
- NanoBone (1)
- Nanocrystalline (1)
- Nanoparticles (1)
- Nanoplastic (1)
- Nanopore (1)
- National catalogue of competence-based learning objectives in dentistry (1)
- Native T1 (1)
- Native T1 mapping (1)
- Natriuretic peptide (1)
- Natural Killer (NK) Cell (1)
- Natural killer cells (1)
- Nav channel activity (1)
- Nav1.7 (1)
- Nd:YAG laser capsulotomy (1)
- Necroptosis (1)
- Necrosis (1)
- Necrosis (Necrotic Death) (1)
- Necrotic area (1)
- Necrotizing fasciitis (1)
- Needs Assessment [MeSH] (1)
- Needs assessment [MeSH] (1)
- Negative appendectomy rate (1)
- Negative staining (1)
- Neglected tropical diseases (1)
- Negligence (1)
- Nek1 (1)
- Neoadjuvant radiochemotherapy (1)
- Neoadjuvant systemic therapy (1)
- Neoadjuvant therapy (1)
- Neoadjuvant treatment (1)
- Neonatal (1)
- Neonatal brain damage (1)
- Neonatal intensive care unit (1)
- Neonatal morbidity (1)
- Neonatal outcome (1)
- Neonatal surgery outcome (1)
- Neonatal urea cycle disorders (1)
- Neoplasm staging (1)
- Nephrons (1)
- Nerves (1)
- Nervous system diseases (1)
- Nesplora Aquarium (1)
- Network Neuroscience (1)
- Network analysis (1)
- Network model (1)
- Neugeborenes (1)
- Neural coding (1)
- Neural function (1)
- Neural goal function (1)
- Neural networks (1)
- Neuro-ophthalmology (1)
- NeuroSAFE (1)
- Neurobiology of disease and regeneration (1)
- Neuroblastoma (1)
- Neurochemistry (1)
- Neurodegenerative diseases (1)
- Neurodegenerative syndromes (1)
- Neurodevelopment (1)
- Neurodevelopmental disorder (1)
- Neurodevelopmental disorders (1)
- Neuroendocrine cancer (1)
- Neuroendocrine tumor (1)
- Neuroepithelial (1)
- Neuroepithelial tumor (1)
- Neurofeedback (1)
- Neurofilament light chain (1)
- Neurogenesis (1)
- Neuroligins (1)
- Neuromuscular exercise (1)
- Neuromyelitis optica (1)
- Neuronal dendrites (1)
- Neuronal homeostasis (1)
- Neuronal networks (1)
- Neuronal nitric oxide synthase (1)
- Neuronal plasticity (1)
- Neurooncology (1)
- Neuropathic pain (1)
- Neurophysiologie (1)
- Neurophysiology (1)
- Neuropilin (1)
- Neuropsychiatric disorders (1)
- Neuropsychological testing (1)
- Neuropsychologie (1)
- Neuropsychology (1)
- Neurosurgery (1)
- Neurovascular damage (1)
- Neurovascular lesion (1)
- Neutrophils (1)
- Nevus of Ito (1)
- Nevus of Ota (1)
- New Developments (1)
- New E3-ligase ligands (1)
- Next generation sequencing (1)
- NfL (1)
- Nfe2l2 (1)
- Niche (1)
- Niche differentiation (1)
- Nicolaides-Baraitser syndrome (1)
- Nimotuzumab (1)
- Nkx2-5 (1)
- Nociception (1)
- Nodular lymphocyte predominant Hodgkin lymphoma (1)
- Non-Hodgkin lymphoma (1)
- Non-RCT (1)
- Non-abusive head trauma (NAHT) (1)
- Non-alcoholic fatty liver disease (1)
- Non-allergic-rhinitis (1)
- Non-aneurysmal (1)
- Non-apoptotic functions (1)
- Non-clear cell renal cell cancer (1)
- Non-coding RNAs (1)
- Non-cylindrical folds (1)
- Non-diffractive EDOF-IOL (1)
- Non-expert MRI (1)
- Non-falciparum (1)
- Non-invasive brain stimulation (1)
- Non-neuronal cholinergic system (1)
- Non-nucleoside polymerase inhibitors (NNI) (1)
- Non-operative (1)
- Non-perimesencephalic (1)
- Non-responder (1)
- Non-small-cell lung cancer (1)
- Non-trauma (1)
- Non-tuberculous mycobacteria (1)
- Non-urothelial (1)
- Non-vitamin K antagonist oral anticoagulants (1)
- Nonaerosolizing treatment (1)
- Noncoding RNA (1)
- Noninferiority (1)
- Nonoperative management (1)
- Nonpenetrating (1)
- Nonsteroidal anti-inflammatory drugs (1)
- Nontuberculous mycobacteria (1)
- Nonunion (1)
- Non–small-cell lung cancer (1)
- Noradrenergic (1)
- Nordic questionnaire (1)
- Norepinephrine (1)
- Normative modeling (1)
- Notch (1)
- Notch signaling (1)
- Novel treatment target (1)
- Nox inhibition (1)
- NoxA1 (1)
- Nrf-2 (1)
- Nucleolus (1)
- Nucleophosmin-1 (1)
- Nucleus pulposus cells (1)
- Nukleinsäureamplifikationstest (NAT) (1)
- Null responder (1)
- Number of platelets (1)
- Numerical simulation (1)
- Nurses (1)
- Nutrition risk stratification (1)
- Nymphs (1)
- O-GlcNAcylation (1)
- OA (1)
- OECD performance standards (1)
- OGR1 (1)
- OGTT (1)
- OHIP-G14 (1)
- OHRQoL (1)
- ONC201 (1)
- OPRM1 methylation (1)
- OPS (1)
- OR time (1)
- ORP (1)
- OSA (1)
- OSPE (1)
- OTU domain-containing protein 7B (OTUD7B) (1)
- OXA-23 (1)
- OXA-484 (1)
- OXA-58 (1)
- OXPHOS (1)
- Oberflächenantigen-Mutante (1)
- Object perception (1)
- Object vision (1)
- Objectives (1)
- Observational studies (1)
- Obsessive-compulsive disorder (1)
- Obstetric care (1)
- Obstetrics (1)
- Occlusion (1)
- Occupational Accidents (1)
- Occupational disease (1)
- Occupational exposure (1)
- Occupational medicine (1)
- Oceanic boundlessness (1)
- Ocular findings (1)
- Ocular trauma (1)
- Ocular tuberculosis (1)
- Oesophageal cancer (1)
- Oesophagogastric cancer oxaliplatin (1)
- Off-pump surgery (1)
- Okinawa (1)
- Okinawa diet (1)
- Older adult (1)
- Older adults (1)
- Older patient (1)
- Older patients (1)
- Oldest-old (1)
- Olfactory diagnostics (1)
- Olfactory groove meningioma (1)
- Oligodendroglioma (1)
- Oligometastatic (1)
- Omega lipids (1)
- Omicron variant BA.1 (1)
- Omics (1)
- Omphalocele (1)
- Oncogenes (1)
- Oncologic surgery (1)
- Oncolytic adenovirus (1)
- Oncolytic virus (1)
- Oncotargets (1)
- One health (1)
- One-leg stand (1)
- Online Survey (1)
- Online education (1)
- Online-Magazine (1)
- Opacity (1)
- Open Science (1)
- Open abdomen (1)
- Open pulmonary tuberculosis (1)
- Open source concept (1)
- Operation/Chirurgie (1)
- Ophthalmoplegia (1)
- Opinion (1)
- Opioid system (1)
- Oposterior urethral valve (1)
- Oppositional defant disorder (1)
- Oppositional defiant disorder (1)
- Opsoclonus-myoclonus syndrome (1)
- Optic nerve atrophy (1)
- Optical coherence tomography angiography (1)
- Optical lenses (1)
- Oral Health Impact Profile (OHIP) (1)
- Oral and maxillofacial surgery (1)
- Oral and maxillofacial trauma (1)
- Oral food challenge (1)
- Oral immunotherapy (OIT) (1)
- Oral implantology (1)
- Oral therapy (1)
- Orbital fracture (1)
- Organ allocation (1)
- Organ failure (1)
- Organ injury (1)
- Organ motion (1)
- Organ rinse (1)
- Organ shortage (1)
- Organ support (1)
- Organ-confined (1)
- Organoids (1)
- Organs at Risk (1)
- Oroantral communication (1)
- Orphan disease (1)
- Orthodontic tooth movement (1)
- Orthodontist (1)
- Orthopaedics (1)
- Oryctolagus cuniculus (1)
- Oscillating saws (1)
- Osimertinib (1)
- Osmosensing (1)
- OspE (1)
- Ossifying fibroma (1)
- Osteocalcin (1)
- Osteoinduction (1)
- Osteonecrosis (1)
- Osteoporosis diagnosis (1)
- Oswestry Disability Score (1)
- Otorhinolaryngological (1)
- Outcome assessment [MeSH] (1)
- Ovale (1)
- Ovarian cancer treatment (1)
- Ovarian carcinoma (1)
- Over-the-scope clip (1)
- Overall survival (1)
- Overweight (1)
- Overwintering (1)
- Oxa1/YidC/Alb3 Membrane Insertases (1)
- Oxaliplatin (1)
- Oxidative phosphorylation (1)
- Oxygen (1)
- Oxygen consumption (1)
- Oxygen extraction fraction (1)
- Oxygen uptake (1)
- Oxygen-derived free radicals (1)
- P-gp (1)
- P1NP (1)
- P600 (1)
- PAC-1 (1)
- PAD-test (1)
- PAH (1)
- PAI-1 (1)
- PAM (1)
- PAPR (1)
- PAR (1)
- PARK4 (1)
- PARK6 (1)
- PARK7 (1)
- PARP (1)
- PATZ1 (1)
- PAX3/FOXO1 (1)
- PBBM (1)
- PBMC (peripheral blood mononuclear cells) (1)
- PBPK simulation (1)
- PBSC (1)
- PBX (1)
- PBX1 (1)
- PC12 cells (1)
- PC12 neuronal differentiation (1)
- PCA (1)
- PCP (1)
- PCSK9 protein (1)
- PCV (1)
- PD-1 inhibitor (1)
- PD1/ PDL1 (1)
- PDCD4 (1)
- PDD - Assessment - Screening (1)
- PDE inhibition (1)
- PDE‐5‐inhibitor (1)
- PDI (1)
- PDK1 (1)
- PDPK1 (1)
- PD‑L1 (1)
- PEA-15 (1)
- PEGylated PLGA (PLGA-PEG) (1)
- PEI (1)
- PELICAN (1)
- PEM-technology (1)
- PET (1)
- PF-06273340 (1)
- PFL (1)
- PFOA (1)
- PFOS (1)
- PGC-1α (1)
- PGE2 (1)
- PHR1 (1)
- PI3K inhibitor (1)
- PI3K/mTor inhibition (1)
- PID prevalence (1)
- PIF pocket (1)
- PKA (1)
- PKCε (1)
- PKD (1)
- PKD/IC (1)
- PLAGL1 (1)
- PLGA (1)
- PLK1 (1)
- PLK1 inhibitors (1)
- PLX4032 (1)
- PLX4720 (1)
- PM (1)
- PMA (1)
- PMF (1)
- PMI (1)
- PMMA (1)
- POCT (1)
- POLG (1)
- POR (1)
- PPAR (1)
- PPAR-γ (1)
- PPARγ (1)
- PPTC7 (1)
- PRF (1)
- PRG-1 (1)
- PRG5 (1)
- PRLTS3 (1)
- PROM (1)
- PROMISE (1)
- PRRT (1)
- PRRT2 (1)
- PTCH (1)
- PTCH-1 (1)
- PTDM (1)
- PTEN inducible kinase 1 (1)
- PTK2B (1)
- PTM (1)
- PTSD (1)
- PUMA (1)
- PV (1)
- PV loop (1)
- PWI (1)
- PXA (1)
- PYGL (1)
- PacBio SMRT sequencing (1)
- Paediatric Investigation Plan (1)
- Paediatric cancer (1)
- Paediatric oncology (1)
- Paediatric research (1)
- Paediatric trauma patients (1)
- Paediatrics (1)
- Pain scale MWA (1)
- Pain sensation (1)
- Palacos reaction (1)
- Palliative Care [MeSH] (1)
- Pancreas transplantation (1)
- Pancreatic islet (1)
- Pancreatic neuroendocrine tumor (1)
- Pancreatic surgery (1)
- Pancreatitis (1)
- Pancreatoduodenectomy (1)
- Pandemie (1)
- Panel testing (1)
- Panic disorder (1)
- Papillon-Lefèvre syndrome (1)
- Par-4 (1)
- Paracetamol (1)
- Paracoccus denitrificans (1)
- Parainfluenza (1)
- Paraneoplastic neurological syndromes (1)
- Paraneoplastic syndrome (1)
- Parapneumonic pleural effusion (1)
- Parasympathetic (1)
- Parcellation (1)
- Parent support (1)
- Parkinson diagnosis (1)
- Parkinsons disease (1)
- Particle load reduction (1)
- Particle number size distribution (1)
- Particle size distribution (1)
- Particle toxicity (1)
- Particles (1)
- Particulates (1)
- Patellofemoral Joint (1)
- Pathogen reduction (1)
- Pathogenicity (1)
- Pathogens (1)
- Pathologic changes (1)
- Pathological complete response (1)
- Pathologists (1)
- Pathology Section (1)
- Pathophysiology (1)
- Patient Blood Management (1)
- Patient Outcome Assessment (1)
- Patient Outcome Assessment [MeSH] (1)
- Patient Reported Outcome Measures [MeSH] (1)
- Patient and public Involvement (1)
- Patient care (1)
- Patient care planning (1)
- Patient education (1)
- Patient information (1)
- Patient information materials (1)
- Patient isolation (1)
- Patient knowledge (1)
- Patient outcome assessment (1)
- Patient participation (1)
- Patient perspective (1)
- Patient preferences (1)
- Patient reported outcomes (1)
- Patient satisfaction (1)
- Patient*inneninformation (1)
- Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (1)
- Patient-centered care (1)
- Patient-centred care (1)
- Patient-reported outcomes (1)
- Patientenverfügung (1)
- Pattern recognition receptors (1)
- Patterns of care (1)
- Pause (1)
- Pdgfrβ (1)
- Pediatric fracture (1)
- Pediatric neuroimaging (1)
- Pediatric oncology (1)
- Pediatric orthopedic (1)
- Pediatric sarcoma (1)
- Pediatric stem cell transplantation (1)
- Pediatric surgery (1)
- Pediatrics (1)
- Pediatrics [MeSH] (1)
- Peer teaching (1)
- Peer-feedback (1)
- Peer-teaching (1)
- Peg3 (1)
- Pegylated liposomal doxorubicin (1)
- Pelargonium sidoides questionable hepatotoxicity (1)
- Pelvic (1)
- Pentaglobin (1)
- Pentose Pathway (1)
- Peptides and proteins (1)
- Per1−/−-mice (1)
- Perceived stigma (1)
- Percutaneous (1)
- Percutaneous endoscopic gastrostomy (1)
- Percutaneous pinning (1)
- Percutaneous ultrasound (1)
- Performing Artists (1)
- Peri-implant disease (1)
- Pericardial effusion (1)
- Pericarditis (1)
- Perilymph (1)
- Perimesencephalic (1)
- Periodic (1)
- Periodontal disease (1)
- Periodontal diseases (1)
- Periodontal therapy (1)
- Periodontal trauma (1)
- Periodontitis grades B and C (1)
- Peripheral blood smears (1)
- Peripheral vascular disease (1)
- Periprocedural anticoagulation (1)
- Peritoneal macrophages (1)
- Peritumoural oedema (1)
- Peri‑implantitis (1)
- Peroxidase (1)
- Perrault syndrome (1)
- Persistence SARS-CoV-2 antibodies (1)
- Persistent organic pollutants (1)
- Personal medicine (1)
- Personal protective equipment (1)
- Personal stigma (1)
- Personalised medicine (1)
- Personalisierte translationale Therapie (1)
- Personality (1)
- Personality disorder (1)
- Personality inventory (1)
- Personalized Medicine (1)
- Pertussis (1)
- Pessar (1)
- Peutz–Jeghers syndrome (1)
- Pfannenstiel (1)
- Pgrmc1 (1)
- Phakic (1)
- Phalangeal fractures (1)
- Phantom study (1)
- Phantoms (imaging) (1)
- Pharm-fMRI (1)
- Pharmaco-nutrition (1)
- Pharmacodynamic (1)
- Pharmacokinetics (1)
- Pharmacological treatment (1)
- Pharmacometrics (1)
- Pharmacotherapy (1)
- Pharmacovigilance (1)
- Pharmacy setting (1)
- Pharyngeal reflex (1)
- Phase 2 (1)
- Phase 3 (1)
- Phase 3 trial (1)
- Phase I clinical trial (1)
- Phase I trials (1)
- Phase II trial (1)
- Phase rotors (1)
- Phase-IV research (1)
- Phase-reset (1)
- Phenotypic plasticity (1)
- Phenylketonuria (PKU) (1)
- Philadelphia Chromosome (1)
- Philadelphia Chromosome-positive leukemia (1)
- Philadelphia chromosome-positive acute leukemia (1)
- Phlyctenule (1)
- Phospho-soda (1)
- Phospho-tau (1)
- Phosphohydrolases (1)
- Phospholipids (1)
- Photoaffinity Labeling (1)
- Physical and mental health (1)
- Physical comorbidities (1)
- Physical fitness (1)
- Physical self-perception (1)
- Physical therapist (1)
- Physician report (1)
- Physician-assisted suicide (1)
- Physics (1)
- Phytochemicals (1)
- Pierre Robin sequence (1)
- PillCamColon2 (1)
- Pilocytic astrocytoma (1)
- Pim-1 (1)
- Pinhole IOL (1)
- Pink esthetic score (1)
- Piriform cortex (1)
- Placental growth factor (1)
- Placental organoids (1)
- Planning target volume (1)
- Plasma fibronectin (1)
- Plasma transfusion (1)
- Plasma usage (1)
- Plasmacytoid dendritic cell (1)
- Plasmapheresis (1)
- Plasminogen (1)
- Plastic endoprosthesis (1)
- Plastic pollution (1)
- Plastics (1)
- Platelet (1)
- Platelet dysfunction (1)
- Platelet lysate (1)
- Platelet releasate (1)
- Platzierung (1)
- Play (1)
- Pleasure (1)
- Plectin (1)
- Pleural empyema (1)
- Plk1 (1)
- Plus-end (1)
- Pneumococcal conjugate vaccine (1)
- Point of care (1)
- Point-of-care wound diagnostics (1)
- Polarity index (1)
- Police (1)
- Poliomyelitis (1)
- Polo-like kinase 3 (1)
- Poly-Pore (1)
- PolySUMOylation (1)
- Polygenic risk score (1)
- Polyhexanide (1)
- Polymerase Chain Reaction (PCR) (1)
- Polyposis syndrome (1)
- Polyps (1)
- Polysomnography (1)
- Polyunsaturated fatty acid mediators (1)
- Polyunsaturated fatty acids (1)
- Ponatinib (1)
- Pooling (1)
- Poor solubility (1)
- Population dynamics (1)
- Population-based screening (1)
- Porin regulation (1)
- Portal (1)
- Portugal (1)
- Portuguese population (1)
- Posaconazole serum level (1)
- Position paper (1)
- Positron-emission tomography (1)
- Post mortem examination (1)
- Post mortem interval (1)
- Post surgery pain (1)
- Post treatment (1)
- Post-cesarean (1)
- Post-mortem genetic screening (1)
- Post-offence drinking (1)
- Post-processing (1)
- Post-thaw recovery (1)
- Post-transplant (1)
- Post-traumatic stress disorder (1)
- Posterior Cerebral (1)
- Posterior cruciate ligament (1)
- Postmortem (1)
- Postmortem interval (1)
- Postoperative anatomy (1)
- Postoperative infections (1)
- Postoperative nutritional management (1)
- Posttranslational modification (1)
- Posttraumatische Belastungsstörung (1)
- Postural sway (1)
- Posture (1)
- Potassium channel Kir2.1 (1)
- Potassium iodide (1)
- Powered air-purifying respirator (1)
- Practical training (1)
- Practice (1)
- Practice-based research network (1)
- Praeklampsie (1)
- Pre-economic effects (1)
- Pre-emptive immunotherapy (1)
- Pre-operative radiotherapy (1)
- Pre-treatment drug resistance mutations (1)
- PreS1 deletion (1)
- Precision (1)
- Precision medicine (1)
- Precision oncology (1)
- Preclinical (1)
- Preclinical drug development (1)
- Precompetitive development (1)
- Prediction of locoregional recurrence (1)
- Predictive Modeling (1)
- Predictive medicine (1)
- Predictive model (1)
- Predictive processing (1)
- Predictors (1)
- Prenatal ultrasonographic detection rate (1)
- Preoperative diagnostics (1)
- Preoperative radiochemotherapy (1)
- Prepontine (1)
- Presbyopia (1)
- Pressure distribution (1)
- Pressure measuring plate (1)
- Pressure pain (1)
- Presynaptic vesicles (1)
- Pre‐Ligand Assembly Domain (PLAD) (1)
- Primary Care Health Centre (1)
- Primary breast lymphoma (1)
- Primary health care [MeSH] (1)
- Primary molars (1)
- Primary prophylaxis (1)
- Primary sclerosing cholangitis (1)
- Primärversorgung (1)
- Principal component analysis (1)
- Procedural skills (1)
- Produkte zur Desinfektion (1)
- Professional dance (1)
- Professions (1)
- Proficiency testing (1)
- Profiling Transthiolation Activity (1)
- Profilometry (1)
- Progesteron (1)
- Progesterone (1)
- Prognosefaktoren (1)
- Prognostic biomarker (1)
- Prognostic models (1)
- Programming languages (1)
- Promoters (1)
- Propensity score matching (1)
- Proposal (1)
- Prospective randomized Analysis (1)
- Prostaglandin (1)
- Prostate Cancer (1)
- Prostate cancer cell lines (1)
- Prostate-specific membrane antigen (1)
- Prosthetic rehabilitation (1)
- Proteasomes (1)
- Protective factors (1)
- Protein (1)
- Protein Domains (1)
- Protein Expression (1)
- Protein Folding (1)
- Protein Kinase Inhibitors (1)
- Protein Motifs (1)
- Protein Structure (1)
- Protein Targeting (1)
- Protein aggregates (1)
- Protein complex (1)
- Protein degradation (1)
- Protein domains (1)
- Protein interactions (1)
- Protein kinase (1)
- Protein tyrosine modification (1)
- Protein-Lipid Interaction (1)
- Protein-translocation (1)
- Proteinkinase (1)
- Proteins (1)
- Proteomic analysis (1)
- Proteostasis (1)
- Protestantism (1)
- Prothrombin complex concentrate (1)
- Prothrombinmutation (1)
- Protocol (1)
- Proton density (1)
- Prototypes (1)
- Proximal (1)
- Proximal humeral fracture (1)
- Prädiktivfaktoren (1)
- Pseudarthrosis (1)
- Pseudo HE-images (1)
- Pseudophakia (1)
- Pseudoprogression (1)
- Psoriatic arthritis (1)
- Psychiatric traits (1)
- Psychiatrie (1)
- Psychiatry (1)
- Psycho-oncology (1)
- Psychodynamic psychotherapy (1)
- Psychological stress (1)
- Psychometric evaluation (1)
- Psychometrics (1)
- Psychopathologie (1)
- Psychopathology (1)
- Psychophysics (1)
- Psychosocial (1)
- Pteridine (1)
- Public and occupational health (1)
- Publication (1)
- Publication output (1)
- Pulmonary artery pressure (1)
- Pulmonary disease, chronic obstructive (1)
- Pulmonary edema (1)
- Pulmonary failure (1)
- Pulmonary hypoplasia (1)
- Pulse contour analysis (1)
- Pulse pressure variation (1)
- Pulsed SILAC (1)
- Pumpkin seeds (1)
- Pupillometry (1)
- Purdue Pegboard (1)
- Pyogenic (1)
- Pyogenic spondylodiscitis (1)
- Pyruvate (1)
- Python (1)
- QOL (1)
- QT measurement (1)
- Qb-Test (1)
- QbTest® (1)
- Qualitative Research [MeSH] (1)
- Qualitative research [MeSH] (1)
- Qualitative study (1)
- Quality control (1)
- Quality indicators (1)
- Quality management (1)
- Quality of Health Care [MeSH] (1)
- Quality of health care [MeSH] (1)
- Quality, performance, safety and outcomes (1)
- Quantitative (q)T2 mapping (1)
- Quantitative Imaging (1)
- Quantitative features (1)
- Quantitative magnetic resonance imaging (1)
- Quantitative research (1)
- Quantitative sensory testing (1)
- Quantitative trait (1)
- Quantitative trait loci (1)
- Quantra (1)
- Quarantine (1)
- Quasi-longitudinal study (1)
- Questionnaire - Psychometrics - Diagnostics (1)
- Quinine (1)
- Quinolinate phosphoribosyltransferase (1)
- Quinolinic acid (1)
- Quinolones (1)
- R (1)
- R programming language (1)
- R software (1)
- RAD001 (1)
- RAF (1)
- RARP (1)
- RAS (1)
- RAS pathway (1)
- RBC (1)
- RBC-depletion (1)
- RBFOX1 (1)
- RCC (1)
- RD cells (1)
- REM sleep (1)
- REMS (1)
- RESLES (1)
- RET (1)
- RGAG1 (1)
- RH30 cells (1)
- RIP (1)
- RIP1 (1)
- RIPK1 (1)
- RMS (1)
- RNA Biology (1)
- RNA chaperone (1)
- RNA extraction (1)
- RNA polymerase (1)
- RNA polymerase inhibitors (1)
- RNA processing (1)
- RNA processing machinery (1)
- RNA sequencing (1)
- RNA stability (1)
- RNA turnover (1)
- RNA virus (1)
- RNA viruses (1)
- RNA, long noncoding (1)
- RNA-binding protein (1)
- RNA-templated DNA repair (1)
- RNA/MicroRNA (1)
- RNAP II (1)
- RNActive (1)
- RNAi (1)
- RNAi and CRISPR screens (1)
- RNAseq analysis (1)
- RND (1)
- ROC analyses (1)
- ROC analysis (1)
- ROC-Analysen (1)
- ROS generation (1)
- ROS/RNS (1)
- ROS1 (1)
- RPE65 (1)
- RT-PCR-detection (1)
- RT-qPCR (1)
- RTS (1)
- RUFY (1)
- RUNX1/ETO (1)
- Rab proteins (1)
- Rabbit (1)
- Rac1 (1)
- Race (1)
- Radial artery (1)
- Radiation Oncology (1)
- Radiation exposure (1)
- Radiation induced diarrhoea (1)
- Radiation necrosis (1)
- Radical cystectomy (1)
- Radical nephrectomy (1)
- Radiofrequency (1)
- Radiofrequency ablation (1)
- Radioiodine therapy (1)
- Radioiodine uptake test (1)
- Radiological assessment (1)
- Radiology (1)
- Radiology and imaging (1)
- Radiosurgery (1)
- Radiyal arter (1)
- Ragulator complex (1)
- Ramadan (1)
- Raman spectroscopy (1)
- Ramucirumab (1)
- Ramón y Cajal (1)
- Randomisation (1)
- Randomised controlled trial (1)
- Randomised trial (1)
- Randomized (1)
- Randomized Controlled Trial (1)
- Randomized trial (1)
- RapL (1)
- Rapamycin (1)
- Rapid diagnostic test (1)
- Rapid eye movement sleep behavior disorder (1)
- Rare Diseases (1)
- Rare disease (1)
- Rational use (1)
- Rcf1 (1)
- Re-exploration (1)
- Re-exposure (1)
- Re-injury (1)
- Reactogenicity (1)
- Readmission (1)
- Ready-made mouthguard (1)
- Real world (1)
- Real world study (1)
- Real-time MRI (1)
- Real-time phase contrast (1)
- Real-time polymerase chain reaction (PCR) tests (1)
- Real-world data (1)
- Real-world evidence (1)
- RealTime (1)
- Rearing temperature (1)
- Recall rate (1)
- Receptor physiology (1)
- Receptors/Nuclear (1)
- Reconstructed human epidermis (1)
- Reconstruction (1)
- Rectal neoplasms (1)
- Recurrent episodes (1)
- Red blood cells (1)
- Red yeast rice (1)
- Red-lipped arboreal alligator lizard (1)
- Redox (1)
- Redox dependent epigenetic modifications (1)
- Redox modification (1)
- Redox-sensitive GFP (1)
- Redox-sensitive transcription factor (1)
- Redundancy (1)
- Reference (1)
- Referral (1)
- Refractive changes (1)
- Refractive lense exchange (1)
- Refractory AML (1)
- RegJoint™ (1)
- Regenerative medicine (1)
- Region (1)
- Regret (1)
- Regulatory T cells (1)
- Regulatory agencies. (1)
- Regulatory framework (1)
- Regulatory networks (1)
- Rehabilitation outcome (1)
- Rehabilitationsergebnis (1)
- Rehospitalization (1)
- Reintervention (1)
- Rejection (1)
- Relapse (1)
- Relapse surveillance (1)
- Relapsed ALL (1)
- Relative quantification (1)
- Release of mtDNA and mtRNA (1)
- Remote ischemic conditioning (1)
- Remote monitoring (1)
- Renal cancer (1)
- Renal function (1)
- Renal lesions (1)
- Renal replacement therapy (1)
- Renal vein thrombus (1)
- Repatriation of corpses (1)
- Reperfusion (1)
- Replication study (1)
- Repositioning drugs (1)
- Representative survey (1)
- Reproducibility/stability (1)
- Research data (1)
- Research design (1)
- Research investment (1)
- Research patterns (1)
- Research trends (1)
- Research validity (1)
- Resection (1)
- Reservoir function (1)
- Residential care (1)
- Residual myometrial thickness (1)
- Resilience (1)
- Resin composites (1)
- Resistenz (1)
- Resource competition (1)
- Respimat® Soft Mist™ Inhaler (1)
- Respiratory Syncytial Virus (1)
- Respiratory infections (1)
- Respiratory signs and symptoms (1)
- Respiratory syncytial virus (1)
- Respiratory tract diseases (1)
- Response (1)
- Response control (1)
- Response criteria (1)
- Responsibility of healthcare policy (1)
- Resting state (1)
- Restricted posture (1)
- Resuscitation (1)
- Reticulon (1)
- Retina (1)
- Retinal degeneration (1)
- Retinal diseases (1)
- Retinoic acid (1)
- Retro-IDEAL (1)
- Retrospective studies (1)
- Retrospective study (1)
- Return to play (1)
- Return to sports (1)
- Return to work (1)
- Reverse electron transfer (1)
- Reverse transcription polymerase chain reaction (1)
- Review (1)
- Reward anticipation (1)
- Reward system (1)
- Rh Antigens (1)
- Rhabdomyoma (1)
- Rheumatology (1)
- Rho GTPases (1)
- Rho-kinase (1)
- Rho/Rho-kinase (1)
- RhoA (1)
- RhoGTPases (1)
- Ribosomal RNA (1)
- Ribosomal S6 phosphorylation (1)
- Ribosomal translation (1)
- Ribosomes (1)
- Richtlinie (1)
- Ridge preservation (1)
- Riftia pachyptila (1)
- Right hemisphere (1)
- Risikofaktoren (1)
- Risikokommunikation (1)
- Risk communication (1)
- Risk prediction (1)
- Risk reduction (1)
- Risk-stratification (1)
- Robotic Radiosurgery (1)
- Robotic tracking (1)
- Robotic-assisted radical prostatectomy (1)
- Rodents (1)
- Roe deer (1)
- Rolandic Spikes (1)
- Roma women (1)
- Rora (1)
- Roughness (1)
- Round window membrane (1)
- Roussel Uclaf Causality Assess- ment Method (RUCAM) (1)
- Routinely Collected Health Data [MeSH] (1)
- Roux-en-Y gastric bypass (1)
- Rtn3 (1)
- Ruijs-Aalfs syndrome (1)
- Rush (1)
- Rush protocol (1)
- Rush-SIT (1)
- Ruxolitinib (1)
- Ryanodine (1)
- S. cerevisiae (1)
- S100 calcium‑binding protein B (1)
- S100b (1)
- S1P1 receptor (1)
- S1P1–5 (1)
- S1P5 (1)
- S1PR1 (1)
- S1PR4 (1)
- S1PR5 (1)
- SAGE (1)
- SAH (1)
- SAH close (1)
- SAMHD1 knockout mouse (1)
- SAMHD1 phosphorylation (1)
- SAP (1)
- SARS (1)
- SARS CoV 2 (1)
- SARS coronavirus (1)
- SARS-COV-2 (1)
- SARS-CoV (1)
- SARS-CoV-2 Pneumonia (1)
- SARS-CoV-2-specific T cells (1)
- SARS-CoV2 (1)
- SARS-CoV‑2 (1)
- SAVI (1)
- SCA2 (1)
- SCA34 (1)
- SCA38 (1)
- SCD14 (1)
- SCMR (1)
- SCN5A (1)
- SCT (1)
- SDF-1 (1)
- SDH (1)
- SDS (1)
- SEAP (1)
- SEC (1)
- SEC-ICP-DRC-MS (1)
- SEER (1)
- SELEX (1)
- SENP6 (1)
- SERS (1)
- SF-12 (1)
- SGPL1 (1)
- SGPL1 knockout cell line (1)
- SH- (S-S)-Groups (1)
- SH-SY5Y neuroblastoma cells (1)
- SHH (1)
- SIADH (1)
- SIDS (1)
- SILAC (1)
- SIRPalpha (1)
- SKALE score (1)
- SKI II (1)
- SLAM-seq (1)
- SLC20A1 (1)
- SLC6a3 (1)
- SLC7A11 (1)
- SLUG (1)
- SMAD (1)
- SMAD signaling (1)
- SMOC1 (1)
- SNORD95 (1)
- SNP (1)
- SOCS (1)
- SOFA (1)
- SPARTAN (1)
- SPG8 (1)
- SPPL3 (1)
- SPRTN (1)
- SPSS (1)
- SR protein (1)
- SR-BI (1)
- SRSF3 (1)
- SRSF7 (1)
- SSTI (1)
- ST2L (1)
- STAMPE2 (1)
- STAT5 (1)
- STDP (1)
- STIR (1)
- SUD (1)
- SUDEP (1)
- SUMO chains (1)
- SUMO1-3 (1)
- SUMOylation (1)
- SUN1 (1)
- SUN2 (1)
- SUV (1)
- SW480 Cell (1)
- SW480 cells (1)
- SWATH (1)
- Saccades (1)
- Saccadometry (1)
- Safety culture (1)
- Safety equipment (1)
- Safety learning (1)
- Safety perspectives (1)
- Salivary gland cancer (1)
- Salivary gland carcinoma (1)
- Salivary gland diseases (1)
- Salmonella choleraesuis (1)
- Salmonella infection (1)
- Salt inducible kinase 2 (SIK2) (1)
- Salvage therapy (1)
- Sampling protocol (1)
- Sandfly (1)
- Sanger Sequencing (1)
- Sapacitabine (1)
- Sarcoidosis (1)
- Sarcomas (1)
- Sarcopenia (1)
- Sarcophagidae (1)
- Satisfaction (1)
- Saudi Arabia (1)
- Scalp defect (1)
- ScanWatch (1)
- Scanner models (1)
- Scedosporium spp. (1)
- Scheduling of radiotherapy (1)
- Schizophrenie (1)
- School support (1)
- Schwangerschaft (1)
- Science structure (1)
- Scientifi c competence (1)
- Scientific community (1)
- Scientific publishing (1)
- Scientometria (1)
- Scientometric analysis (1)
- Scientometrics (1)
- Scientometry (1)
- Sclerostin (1)
- Sclerotic glomeruli (1)
- Screening guidelines (1)
- Screening-ELISA (1)
- Screeningfragebogen (1)
- Scrofulous keratitis (1)
- Seasonal variation (1)
- Seattle heart failure model (1)
- Second donation (1)
- Second stage of labor (1)
- Second-line treatment (1)
- Secondary injury cascades (1)
- Secondary prevention (1)
- Secretion (1)
- Sedation (1)
- Sedatives (1)
- Selection bias (1)
- Selective autophagy (1)
- Selenium (1)
- Selenium administration in gynecologic radiation oncology (1)
- Selenoproteins (1)
- Self-assessment (1)
- Self-efficacy (1)
- Self-esteem (1)
- Self-expandable TAVI (1)
- Self-expandable metal stent (SEMS) (1)
- Self-expandable metal stents (1)
- Self-expandable metal stents complications (1)
- Self-management support (1)
- Self-myofascial release (1)
- Self-report (1)
- Semicontinuous (1)
- Semitendinosus tendon autograft (1)
- Sensorimotor processing (1)
- Sensorimotor training (1)
- Sensory Neuroscience (1)
- Sensory neuron (1)
- Sensory perception (1)
- Sensory systems (1)
- Separation of ADP-Binding Enzymes (1)
- Sepsis-bundle (1)
- Septic shock (1)
- Sequelae (1)
- Sequence (1)
- Sequence alignment (1)
- Sequence motif analysis (1)
- Sequencing (1)
- Sequential (1)
- Seribantumab (1)
- Serine proteases (1)
- Serious injured children (1)
- Seroconverter (1)
- Seroepidemiology (1)
- Serology (1)
- Seroprevalence (1)
- Serotype 3 (1)
- Serum biomarker (1)
- Severe bacterial infection (1)
- Severe blood loss (1)
- Severe malaria (1)
- Severity of illness index (1)
- Sexual Dysfunctions (1)
- Sexual child abuse (1)
- Sexual violence (1)
- Sexuelle Dysfunktionen (1)
- Sexuelle Gewalt (1)
- Sexueller Kindesmissbrauch (1)
- Shannon index (1)
- Shared information (1)
- Sharp injuries (1)
- Sharpin (1)
- Shinisaurus crocodilurus (1)
- Sholl analysis (1)
- Shone’s complex (1)
- Shoulder joint (1)
- Shoulder luxation (1)
- Shunt (1)
- Sickle Cell Disease (1)
- Side effect (1)
- Side effects (1)
- Siderosis (1)
- Signal Recognition Particle (1)
- Signal Transduction (1)
- Signal intensity (1)
- Signal transduction (1)
- Signaling ROS (1)
- Signaling pathway (1)
- Signs and symptoms (1)
- Silicosis (1)
- Silver diamine fluoride (1)
- Simulation and modeling (1)
- Simultaneous (1)
- Single nucleotide polymorphism (1)
- Single positive core biopsy (1)
- Single-Molecule Localization Microscopy (SMLM) (1)
- Single-cell RNA sequencing (1)
- Single-cell RNA-seq (1)
- Single-cell RNA-sequencing (1)
- Single-treatment (1)
- Skeletal health (1)
- Skeletal joints (1)
- Skeletal muscle (1)
- Skeletal muscles (1)
- Skills training (1)
- Skin fibroblast (1)
- Skin irritation test (1)
- Skin manifestation (1)
- Skin morphology (1)
- Skp (1)
- Skull base (1)
- Slc11a2 (1)
- Slc25a37 (1)
- Sleep deprivation (1)
- Slow Cortical Potentials, SCP (1)
- Smac mimetic (1)
- Smac mimetics (1)
- Smad (1)
- Small Leucine-rich Proteoglycan (SLRP) (1)
- Small RNA analysis (1)
- Small aperture IOL (1)
- Small bowel atresia (1)
- Small bowel endoscopy (1)
- Small molecules (1)
- Small vessel disease (1)
- Small- and medium-sized enterprises (1)
- Small-bowel endoscopy (1)
- Small-cell lung cancer (1)
- Smart nebulizer (1)
- Smartwatch (1)
- Smooth muscle (1)
- Smooth muscle cell (1)
- Smooth muscle cells (1)
- Snakebite (1)
- Social Media (1)
- Social Phobia (1)
- Social brain (1)
- Social cognition (1)
- Social communication (1)
- Social decision-making (1)
- Social determinants (1)
- Social differences (1)
- Social information processing (1)
- Social neuroscience (1)
- Social phobia (1)
- Social research (1)
- Social sciences (1)
- Social skills training (1)
- Social support (1)
- Sociocognitive predictors (1)
- Sociodemographic characteristics (1)
- Socioeconomic analysis (1)
- Socioeconomic indices (1)
- Socket healing (1)
- Socket preservation (1)
- Sodium chloride (1)
- Soft tissue healing (1)
- Soft tissue infection (1)
- Soft tissue sarcoma (1)
- Soft-tissue sarcoma (1)
- Software (1)
- Software tool (1)
- Software tools (1)
- Solar insolation (1)
- Solidworks 2015 (1)
- SoloSTAR (1)
- Solomon Island skink (1)
- Soluble epoxide hydrolase (1)
- Somatization (1)
- Sonography (1)
- Source reconstruction (1)
- Spa water (1)
- Spanish National Health System (1)
- Sparse models (1)
- Spatial Attention (1)
- Species identification (1)
- Speciesidentification (1)
- Specific Synthesis (1)
- Specimen preparation and treatment (1)
- Spectral library (1)
- Spectraldomain OCTA (1)
- Spectrin (1)
- Speech discrimination (1)
- Speech signal processing (1)
- Sphere Formation Assay (1)
- Sphingolipid (1)
- Sphingosine 1-phosphate (1)
- Sphingosine-1-phosphate (1)
- Sphk1 (1)
- Sphk2 (1)
- Spinal fractures (1)
- Spinal injuries (1)
- Spinal surgery (1)
- Spine Register (1)
- Spine care (1)
- Spine density (1)
- Spine fractures (1)
- Spine infection (1)
- Spinocerebellar ataxia (1)
- Spinocerebellar ataxia type 2 (1)
- Splanchnic Hemodynamics (1)
- Spleen (1)
- Splice variants (1)
- Spondylitis (1)
- Spondyloarthritis (1)
- Spondylodiscitis (1)
- Spondylolisthesis (1)
- Spontaneous bacterial peritonitis (1)
- Sports (1)
- Spot sign (1)
- Sprachverstehen (1)
- Spread of Excitation (1)
- Sputum smear-negative (1)
- StUbL (1)
- Stability (1)
- Stage at presentation (1)
- Stakeholder participation (1)
- Standard dataset (1)
- Standard reference values (1)
- Standard risk (1)
- Standardized operating procedures (1)
- Standards of care (1)
- Standardverfahren (1)
- Staphylococcus aureus (1)
- Starvation (1)
- Static MRI (1)
- Statin (1)
- Stationäre Krankenhausfälle (1)
- Statistical analysis (1)
- Statistical methods (1)
- Steatosis (1)
- Stem cell dose (1)
- Stem cell enumeration (1)
- Stenosis (1)
- Stenotrophomonas maltophilia (1)
- Stentoplasty (1)
- Sterblichkeit (1)
- Stereotactic ablative body radiotherapy (1)
- Stereotactic radiosurgery (1)
- Steroid (1)
- Sterols (1)
- Stigma (1)
- Stigma scale (1)
- Stimulant (1)
- Stimulation experiments (1)
- Stimulus-secretion coupling (1)
- Sting challenge (1)
- Stoma (1)
- Stoppa approach (1)
- Streptomyces hydrogenans (1)
- Stress and resilience (1)
- Stress resilience (1)
- Stress vulnerability/resilience genes (1)
- Stringed bow player (1)
- Stroke Risk (1)
- Stroke genetics (1)
- Stroke prevention (1)
- Stroke unit (1)
- Stroke volume variation (1)
- Stromal cell (1)
- Structural MRI (1)
- Structural genomics (1)
- Structured reporting (1)
- Structured written feedback (1)
- Students (1)
- Sub-segmentation (1)
- Sub-zero exposure (1)
- Subacute cerebellar degeneration (1)
- Subarachnoid Hemorrhage (1)
- Subcutaneous (1)
- Subependymal giant cell astrocytoma (1)
- Subgroup identification (1)
- Subjective effects (1)
- Subpopulation (1)
- Subregions (1)
- Substances for disinfection (1)
- Subterranean (1)
- Subventricular zone (1)
- Sudden Cardiac Death (SCD) (1)
- Sudden infant death syndrome (1)
- Sugar feeding (1)
- Suicidal behavior (1)
- Suicidal ideation (1)
- Suicidal thoughts (1)
- Suicidality (1)
- Suicide attempt (1)
- Sulfasalazine (1)
- Sulfhydryl Groups (1)
- Sulfhydryl-reactivity (1)
- Sulfur metabolism (1)
- Sulphoraphane (1)
- Sunlight (1)
- Superinfection (1)
- Supplemental parenteral nutrition (1)
- Supplementation (1)
- Support vector machine (1)
- Supportivtherapie (1)
- Supraglottic Airway Devices (1)
- Supraspinatus tendon (1)
- Supratentorial (1)
- Supraventricular arrhythmias (1)
- Surface (1)
- Surgical ICU (1)
- Surgical blood loss (1)
- Surgical education (1)
- Surgical risk (1)
- Surgical site infection (1)
- Surgical site occurrence (1)
- Surgical therapy (1)
- Surrogate endpoint (1)
- Surveys (1)
- Survival data (1)
- Suspension (1)
- Sustainable Development (1)
- Sustained attention (1)
- Sustained virologic response (1)
- Sustained virological response (1)
- Sustained virological response (SVR) (1)
- Swallowing (1)
- Sweat osmolality (1)
- Sweat secretion rate (1)
- Swept-source OCTA (1)
- Switzerland (1)
- Sycamore (1)
- Syk Kinase (1)
- Syllables (1)
- Symmetrical blocked occlusion (1)
- Sympathetic (1)
- Sympathetic nervous system (1)
- Sympathicolysis (1)
- Symptome (1)
- Symptoms (1)
- Synapse (1)
- Synapses (1)
- Synaptic dysfunction (1)
- Synaptic organizer (1)
- Synaptopodin (1)
- Synaptosomal preparation (1)
- Syncope (1)
- Syndecan-1 (1)
- Synergy (1)
- Synovial inflammation (1)
- Synthetic (1)
- Synthetic biology (1)
- Syrian hamster (1)
- Systemic inflammatory response (1)
- Systemic lupus erythematosus (1)
- Systemic treatment (1)
- Systems & Computational Biology (1)
- Systems biology (1)
- Systems medicine (1)
- T Cell Biology (1)
- T Cells (1)
- T cell receptor (1)
- T cell receptors (1)
- T cell response (1)
- T cell/histiocyte rich large B cell lymphoma (1)
- T helper 17 cells (1)
- T helper cell differentiation (1)
- T-ALL (1)
- T-DM1 (1)
- T-bet (1)
- T-cell development (1)
- T-cell homeostasis (1)
- T-cell homing (1)
- T-cell niche (1)
- T-cell receptor (TCR) (1)
- T-cell targeting (1)
- T-lymphocytes (1)
- T-tubule system (1)
- T-wave alternans (1)
- T1 (1)
- T1 and T2 mapping (1)
- T1 mapping (1)
- T2 (1)
- T84 colon carcinoma cells (1)
- TALE-homdomain protein (1)
- TAM (1)
- TAMs (1)
- TAPSE (1)
- TAVR (1)
- TAX1BP1 (1)
- TB-therapy (1)
- TBI (1)
- TC stenosis (1)
- TCR signaling cascade (1)
- TDAG8 (1)
- TEER (1)
- TEM (1)
- TEPT (1)
- TEVAR (1)
- TG-186 (1)
- TG-43 (1)
- TGF-beta (1)
- TGF-α (1)
- TGFB-induced factor homeobox 1 (1)
- TGIF (1)
- TGR(mREN2)27 (1)
- THRLBCL (1)
- THV (1)
- TIA-1 (1)
- TIC10 (1)
- TIGAR (1)
- TILs (1)
- TIM23 (1)
- TIMP2 (1)
- TIRADS (1)
- TL AOSIS (1)
- TLR (1)
- TLR2/6 (1)
- TLR4 (1)
- TLR7 (1)
- TLR8 (1)
- TMC435 (1)
- TME (1)
- TMEM126B (1)
- TMS (1)
- TMS-EEG (1)
- TNF inhibitors (1)
- TNF-α (1)
- TNFR1 (1)
- TOR inhibitor (1)
- TOR signalling (1)
- TOR1A (1)
- TP53 (1)
- TP53 mutation status (1)
- TP53-induced glycolysis and apoptosis regulator (1)
- TPR (1)
- TRAPP (1)
- TRIM25 (1)
- TRIMs (1)
- TRP Channels (1)
- TRP2 (1)
- TRPM8 (1)
- TRPV4 (1)
- TSC-associated neuropsychiatric disorders (1)
- TSC22D3 (1)
- TSP-4 (1)
- TTFields (1)
- TTW nodules (1)
- TUR-P (1)
- TURP (1)
- TVT (1)
- TWINKLE (1)
- TWNK (1)
- Taekwondoka (1)
- Tagging (1)
- Tailored medicine (1)
- Tailored therapy (1)
- Takotsubo Syndrome (1)
- Tamoxifen (1)
- Tamponade (1)
- Tar (1)
- Targeted delivery (1)
- Targeted sequencing (1)
- Targeted tumor therapy (1)
- Tas2r126 (1)
- Tas2r135 (1)
- Tas2r143 (1)
- Tattoo (1)
- Tau (1)
- Tau acetylation (1)
- Tax effect (1)
- Taxane (1)
- Taxonomy (1)
- Tea (1)
- Technical data (1)
- Technicians (1)
- Technique (1)
- Telomere length (1)
- Telomeres (1)
- Tempo-parietal junction (1)
- Temporal lobe epilepsy (1)
- Temporomandibular joint (1)
- Temporomandibular joint dysfunction (1)
- Temsirolimus (1)
- Tendon incontinence repair (1)
- Tendon transplantation (1)
- Term birth (1)
- Terminal ileitis (1)
- Test assay (1)
- Testing (1)
- Testosterone (1)
- Tet-inducible system (1)
- Tetanus (1)
- Tetrahydrobiopterin (1)
- Texture analysis (1)
- Tfrc (1)
- Tgfβ (1)
- Th1 polarization (1)
- Thalidomide (1)
- Therapeutic adherence (1)
- Therapeutic anticoagulation (1)
- Therapeutic competence (1)
- Therapeutics (1)
- Therapie (1)
- Therapies (1)
- Therapy response (1)
- Thermal spring water (1)
- Thermodilution (1)
- Thermogenesis (1)
- Thermoplasma (1)
- Thermoplasma acidophilum Membranes; Tetraetherlipids (1)
- Thiol redox modification (1)
- Thoracic aortic aneurysm (1)
- Thorax (1)
- Three-dimensional back scan (1)
- Three-dimensional echocardiography (1)
- Thrombophilie (1)
- Thrombose (1)
- Thrombosis/hypercoagulable states (1)
- Thrombotic microangiopathy (1)
- Thromboxane (1)
- Thumb carpometacarpal joint osteoarthritis (1)
- Thymocytes (1)
- Thymus (1)
- Thyroid Cancer Cells (1)
- Thyroid disease (1)
- Tick-Borae (1)
- Tick-Born Diseases (1)
- Tick-Borne diseases (1)
- Tick-borne diseases (1)
- Tick-borne encephalitis (1)
- Ticks (1)
- Time in therapeutic range (TTR) (1)
- Time of death (1)
- Time optimization (1)
- Time series (1)
- Time to treatment failure (1)
- Time trend (1)
- Timing (1)
- Tinnitus (1)
- Tissue expander (1)
- Tissue microarray (1)
- Tissue microarray (TMA) (1)
- Tissue stiffness (1)
- Tissue-specificity (1)
- Tobacco (1)
- Tocilizumab (1)
- Toll-like Receptor (TLR) (1)
- Toll-like receptor (TLR) 6 (1)
- Toll-like receptors (1)
- Toluidine blue (1)
- Tomosynthese (1)
- Tonsil (1)
- Tools and ressources (1)
- Tooth Development (1)
- Tooth segmentation (1)
- Tooth transplantation (1)
- Topoisomerase (1)
- Total colonoscopy (1)
- Total elbow arthroplasty (1)
- Total hip arthroplasty (1)
- Total hip replacement (1)
- Total operating room time (1)
- Touchscreen (1)
- Toxic liver disease (1)
- Toxicology (1)
- Toxins (1)
- Tozasertib (1)
- Tracheal Intubation (1)
- Traditional Chinese Medicine (TCM) (1)
- Traditional Indian Medicine (1)
- Trafficking (1)
- Trail (1)
- Traits of medical students (1)
- Trajectories (1)
- Tranexamic acid (1)
- Transarterial Chemoembolization (1)
- Transcatheter Aortic Valve Implantation (1)
- Transcatheter based aortic valve implantation (1)
- Transcatheter stage 1 (1)
- Transcranial direct current stimulation (1)
- Transcription factor (1)
- Transcription regulation (1)
- Transcriptional control (1)
- Transcriptional regulatory elements (1)
- Transcriptome (1)
- Transcriptome analysis (1)
- Transcriptome microarray (1)
- Transcriptomics (1)
- Transdifferentiation (1)
- Transduction (1)
- Transesophageal echocardiography (1)
- Transfer learning (1)
- Transfer model (1)
- Transferases (1)
- Transformation (1)
- Transfusion practice (1)
- Transgender (1)
- Transgenic SK-2 mice (1)
- Transgenic mice (1)
- Transient (1)
- Transient elastography (1)
- Transient ischemic attack (1)
- Transition invariant (1)
- Transitional cell carcinoma (1)
- Transitional fractures 3D printing (1)
- Transjugular Intrahepatic Portosystemic Shunt (1)
- Transjugular intrahepatic portosystemic shunt (1)
- Translation (1)
- Translation initiation (1)
- Translation proteomics (1)
- Translational (1)
- Translationsregulation (1)
- Transmembrane communication (1)
- Transplant logistics (1)
- Transplantation (1)
- Transplantation Centers (1)
- Transportation (1)
- Transurethral resection of the prostate (1)
- Trastuzumab (1)
- Trauma centre (1)
- Trauma surgery (1)
- TraumaRegister DGU® (1)
- TraumaRegister DGU® (TR-DGU) (1)
- Traumatic dental injury (1)
- Traumatology (1)
- Travel regulations (1)
- Travel times (1)
- Travellers (1)
- Treatment effectiveness (1)
- Treatment management (1)
- Treatment modification (1)
- Treatment protocol (1)
- Treatment rates (1)
- Treatment response (1)
- Trees (1)
- Triamcinolone acetonide (1)
- Trichuris suis ova (1)
- Trimeric autotransporter adhesins (1)
- Triple negative (1)
- Triple therapy (1)
- Triple-negative breast cancer (1)
- Trisomy 21 (1)
- Trk (1)
- TrkC (1)
- Trousseau’s syndrome (1)
- Trueness (1)
- Truncating mutation (1)
- Truncus arteriosus (1)
- Tuberous sclerosis complex (1)
- Tubers (1)
- Tularemia (1)
- Tumor cell (1)
- Tumor growth (1)
- Tumor heterogeneity (1)
- Tumor infiltrating lymphocytes (1)
- Tumor interstitial fluid pressure (1)
- Tumor obstruction (1)
- Tumor subtype (1)
- Tumor suppressor protein (1)
- Tumor therapy (1)
- Tumor volume (1)
- Tumorsphere Formation (1)
- Tumour biomarkers (1)
- Turkish (1)
- Tween20 (1)
- Twist (1)
- Two-hit hypothesis (1)
- Type 1 diabetes (1)
- Type 2 Diabetes mellitus (1)
- Type three hypersensitivity (1)
- Tyrosine kinase inhibitor (1)
- Tyrosine kinase inhibitor (TKI) (1)
- Tyrosine kinase inhibitor mTOR inhibition (1)
- Tyrosine kinases (1)
- Tyrosinemia (1)
- T‑DM1 (1)
- U-87MG (1)
- UBA domain (1)
- UDP-glucose ceramide glycosyltransferase (1)
- UHPLC-MS (1)
- ULBP4 (1)
- UPPS (1)
- UPR (1)
- USA (1)
- USP28 (1)
- USP32 (1)
- USP9X (1)
- UTUC (1)
- UVA (1)
- UWB diagnostics (1)
- Ubiquitin (1)
- Ubiquitin kinase PINK1 (1)
- Ubiquitin ligase (1)
- Ubiquitin signaling (1)
- Ubiquitin-binding module (1)
- Ultra microscopy (1)
- Ultra-rush protocol (1)
- Ultraschall (1)
- Ultrasonic nebulizer (1)
- Ultrasound imaging (1)
- Umbilical cord (1)
- Uncertainty (1)
- Underfeeding (1)
- Undergraduate (1)
- Undergraduate education (1)
- Undergraduate training (1)
- Undergraduates (1)
- Understanding (1)
- Undiagnosed patients (1)
- Unilateral hip osteoarthritis (1)
- Unique information (1)
- United States (1)
- Upgrading (1)
- Upper airway infection (1)
- Upper respiratory tract infection (1)
- Urachal cancer (1)
- Urachus carcinoma (1)
- Urban (1)
- Ureter (1)
- Urinary continence (1)
- Urinary incontinence (1)
- Urine (1)
- Urologic tumors (1)
- Urological oncology (1)
- Urothelial cancer (1)
- Urothelial carcinoma (1)
- Urothelial cells (1)
- Usutu virus (1)
- Uterus (1)
- Uveal melanoma (1)
- VARGADO (1)
- VASP (1)
- VBM (1)
- VE-cadherin (1)
- VEGF receptor 2 internalization and signaling (1)
- VEGFA (1)
- VEGFR (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- VF (1)
- VGAT-ChR2 (1)
- VHH (1)
- VHL (1)
- VIM (1)
- VIP (1)
- VIP1 (1)
- VIS (1)
- VISTA (1)
- VLA4 (1)
- VPA-analogues (1)
- VPAC1 (1)
- VT (1)
- VUS (1)
- VX-2 (1)
- VX680 (1)
- Vaccination breakthrough (1)
- Vaccine breakthrough (1)
- Vacuoles (1)
- Vaginal breech delivery (1)
- Vaginal delivery (1)
- Vagus nerve (1)
- Vagus nerve stimulation (1)
- Validity (1)
- Value-added effect (1)
- Valvular cardiomyopathy (1)
- Variant of concern (1)
- Variceal bleeding (1)
- Vascular biology (1)
- Vascular cognitive disorder (VCD) – Paranoid hallucinatory syndrome – Late-onset trauma-related symptoms – Depression – Assertive community treatment (ACT) (1)
- Vascular disease (1)
- Vascular emergencies (1)
- Vascular endothelial growth factor A (1)
- Vascular endothelial growth factor receptor 2 (1)
- Vascular permeability (1)
- Vasculogenesis (1)
- Vasospasm (1)
- Vector mosquito (1)
- Vector-borne infections (1)
- Vein (1)
- Veino-lymphatic separation (1)
- Vemurafenib (1)
- Venous Thromboembolism (1)
- Venous thromboembolism (1)
- Venous thrombosis (1)
- Ventilators (1)
- Ventricular arrhythmia (1)
- Ventricular arrhythmias (1)
- Ventricular tachyarrhythmia (1)
- Ventricular tachyarrhythmic event (1)
- Venöse Thrombose/Genetik (1)
- VeroE6‐eGFP cells (1)
- Versorgungsstruktur (1)
- Vertebral augmentation (1)
- Vertebral body (1)
- Vertebral body stenting (1)
- Vertebral fracture (1)
- Vertigo (1)
- Vespid venom allergy (1)
- Vibroarthrography (1)
- Victimization (1)
- Video rasterstereography (1)
- Video-oculography (1)
- Videolaryngoscopy (1)
- Videorasterstereography (1)
- Vincristine (1)
- VirB (1)
- Viral core (1)
- Viral hepatitis (1)
- Viral oncology (1)
- Viral replication (1)
- Virchow-Robin Spaces (1)
- Virological failure (1)
- Virological testing (1)
- Virologie (1)
- Virology (1)
- Virotherapy (1)
- Virtual implant planning (1)
- Virtual noncalcium reconstructions (1)
- Virtual patients (1)
- Virulence (1)
- Virus trapping (1)
- Virusisolierung (1)
- Viruslast (1)
- Visual Perception (1)
- Visual impairments (1)
- Visual system (1)
- Visual-field localizer (1)
- Vitamin (1)
- Vitamin K antagonists (1)
- Vitreous opacity (1)
- Vitreous samples (1)
- Voltage attenuation (1)
- Volume overload (1)
- Volume reduction of thyroid nodules (1)
- Volumetric analysis (1)
- Volumetric indexes (1)
- Volunteer donor (1)
- Von Hippel–Landau (1)
- Voriconazole (1)
- Voxel-based morphometry (1)
- WASH complex subunit 5 (1)
- WIPI2 (1)
- WIPI2b (1)
- WNT (1)
- WRNIP1 (1)
- WT1 (1)
- WYE-354 (1)
- Wait and see (1)
- Wakefulness (1)
- Wastewater-based epidemiology (WBE) (1)
- Water chemistry (1)
- Water contamination (1)
- Watertight Dural closure (1)
- Weak bases (1)
- Wearable cardioverter‐defibrillator (1)
- Web 2.0 (1)
- Weight distribution (1)
- Weight loss (1)
- West Nile fever (1)
- West Nile neuroinvasive disease (1)
- West Nile virus (1)
- Western Blotting (1)
- Western blot (1)
- Western diet (1)
- Westphal-Paradigm (1)
- White matter hyperintensity (1)
- Whole genome association (1)
- Whole slide images (1)
- Wilms tumor (1)
- Wilson disease (WD) (1)
- Wing morphometry (1)
- Winter survival (1)
- Withings (1)
- WoMo score (1)
- Women in medicine (1)
- Women in science (1)
- Work shadowing (1)
- Working memory capacity (1)
- Workplace (1)
- Workstation comparison (1)
- Wound healing potential (1)
- Wounds and injuries (1)
- X-ray Crystallography (1)
- X-ray computed (1)
- XCL1/XCR1 axis (1)
- XL probe (1)
- Xenorhabdus (1)
- YB-1 (1)
- YK-4-279 (1)
- YM155 (1)
- YWHAE (1)
- YWHAZ (1)
- Yamane (1)
- Yarrowia lipolytica (1)
- Yeast-2-Hybrid (1)
- Yellow fluorescent protein (1)
- Yoga (1)
- Zeckenübertragene Erkrankungen (1)
- Zentrifugalanalysator (1)
- Zervixverkürzung (1)
- Zika (1)
- Zika Virus (1)
- Zika vaccine (1)
- Zirconia (1)
- Zuckerkandl’s tubercle (1)
- Zymosan-induced peritonitis (1)
- [18F]FET PET (1)
- aGVHD (1)
- abdominal aortic aneurysm (1)
- abdominal imaging (1)
- abemaciclib (1)
- ablation techniques (1)
- abnormal tumor vasculature (1)
- abscisic acid (1)
- abscopal effect (1)
- abuso (1)
- academic (1)
- academic medicine (1)
- acarboxyprothrombin (1)
- acceptable change limit (1)
- accidental falls [MeSH] (1)
- accidents (1)
- acetabular fracture (1)
- acetylation (1)
- acetylcholine receptors (1)
- acetylcholinesterase (1)
- acetylcholinesterase (AChE) inhibition (1)
- acetylcholinesterase inhibition (1)
- acid dentine lysate (1)
- acid sphingomyelinase (ASMase; Smpd1) (1)
- acne inversa (1)
- acneiform skin toxicity (1)
- acoustic radiation force impulse (1)
- acoustic radiation force impulse imaging (1)
- acquired LQT syndrome (1)
- acquired drug resistance (1)
- acriflavine (1)
- actin cytoskeleton (1)
- actin dynamics (1)
- action (1)
- action sounds (1)
- action-effect association (1)
- activated clotting time measurement (1)
- activated factor XIII (1)
- activation receptors (1)
- active/deactive transition (1)
- activities of daily life (1)
- activity-based benefits (1)
- actography (1)
- acute and chronic graft versus host disease (a/c GVHD) (1)
- acute attacks (1)
- acute cholecystitis (1)
- acute chronic inflammation (1)
- acute decompensation of cirrhosis (1)
- acute exacerbations of COPD (1)
- acute infections (1)
- acute inflammation (1)
- acute leukemia (1)
- acute liver failure (1)
- acute liver injury (1)
- acute lung injury (ALI) (1)
- acute lymphatic leukemia (1)
- acute lymphoblastic leukaemia (1)
- acute myeloid leukemia (AML) (1)
- acute pain (1)
- acute stroke (1)
- acute stroke care (1)
- acute-on-chronic liver failure (ACLF) (1)
- acute‐on‐chronic liver failure (1)
- adaptation plan (1)
- adaptive cardiac remodelling (1)
- adaptive immune escape (1)
- adaptive immunity (1)
- additive manufacturing (1)
- adeno-associated virus (1)
- adenocarcinoma (1)
- adenomatous polyposis (1)
- adenosine receptors (1)
- adeno‐associated virus (1)
- adiabatic saturation (1)
- adiponectin (1)
- adipose tissue (1)
- adipose tissue-derived stem cell (1)
- adipose-derived mesenchymal stem/stromal cells (1)
- adipose-derived stem cells (1)
- adipose-derived stem cells (ASCs) (1)
- adiposity (1)
- adjustment disorder (1)
- adjuvant radiotherapy (1)
- adolescent (1)
- adolescentes (1)
- adolescents’ health (1)
- adoptive cell therapy (1)
- adoptive immunotherapy (1)
- adrenal insuffciency (1)
- adrenergic therapy (1)
- adrenoceptors (1)
- adult and elderly patients (1)
- adult attention deficit/hyperactivity disorder (adult ADHD) (1)
- adult congenital heart disease (1)
- advance directive (1)
- advanced (1)
- advanced breast cancer (1)
- advanced glycation end products (1)
- advanced melanoma (1)
- adverse effects (1)
- adversity (1)
- aerobic exercise (1)
- aerodynamics (1)
- aerosol (1)
- aesthetics (1)
- affective disorder (1)
- affective disorders (1)
- affinity purification (1)
- affordance (1)
- aftercare structures (1)
- aged [MesH] (1)
- agent-based modeling (1)
- agent-based models (1)
- aggressiveness (1)
- agility (1)
- agonists (1)
- agreeableness (1)
- air abrasive (1)
- air pollution (1)
- air pouch (1)
- airborne bacteria (1)
- airway (1)
- airway remodeling (1)
- alcohol dehydrogenase (ADH) (1)
- alcohol metabolism (1)
- alcohol use disorder (AUD) (1)
- alcoholic fatty liver disease (1)
- alcoholic hepatitis (1)
- alcoholic liver injury (1)
- aligners (1)
- aliphatic halogenated hydrocarbons (1)
- alkaloid (1)
- all-ceramic (1)
- alleles (1)
- allergen immunotherapy (1)
- allergic rhinitis (1)
- allergy (1)
- alloHSCT (1)
- allocation (1)
- allogeneic (1)
- allogeneic donor (1)
- allogeneic hematological stem cell transplantation (1)
- allogeneic hematopoietic stem cell transplantation (aHSCT) (1)
- allogeneic stem cell transplant (1)
- allogeneic transplantation (1)
- allostasis (1)
- allosteric inhibition (1)
- allosteric regulation (1)
- alpelisib (1)
- alpha peak (1)
- alpha receptor (1)
- alpha-fetoprotein (1)
- alpha-galactosidase A deficiency (1)
- alpha7 nicotinic acetylcholine receptor (1)
- alphaSynuclein (1)
- alpharetroviral vector (1)
- alpinia zerumbet (1)
- alteplase (1)
- alternative 3′ end processing (1)
- alternative matrices (1)
- alternative oxidase (1)
- alternative splicing (1)
- alveolar macrophages (1)
- alzheimer disease (1)
- ambiguity (1)
- amblyopia (1)
- ameloblastoma (1)
- amide proton transfer (1)
- amino acid PET (1)
- amisulpride (1)
- amlexanox (1)
- amoeboid (1)
- amoxicillin/metronidazole (1)
- amygdala (1)
- amygdalin (1)
- amyloid beta-peptides (1)
- amyotrophic lateral sclerosis (1)
- anaemia walk-in clinic (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- anal carcinoma (1)
- anaphylactic reactions (1)
- anastomotic leakage (1)
- anatomy (1)
- anatomy and histology (1)
- anesthesia (1)
- anesthesiology (1)
- aneurysm (1)
- angio-immunogenic switch (1)
- angioedema control test (1)
- angiokeratoma diffuse (1)
- angioplasty (1)
- angiopoietin-2 (1)
- angiopoietin-like 3 (ANGPTL3) (1)
- angiopoietins (1)
- angiostasis (1)
- animal host (1)
- annual bleeding rate (1)
- anorectal malformation (1)
- anoxygenic phototrophic sulfur bacteria (1)
- antenatal characteristics (1)
- antenatalne značilnosti (1)
- anterior chamber depth changes (1)
- anti-CD3 antibody (1)
- anti-EGFR therapy (1)
- anti-GD2 immunotherapy (1)
- anti-HBc (1)
- anti-bacterial agents (1)
- anti-cancer therapy (1)
- anti-chronic myeloid leukemia (1)
- anti-citrullinated protein antibodies (1)
- anti-diabetes (1)
- anti-epileptic drug (1)
- anti-idiotypes (1)
- anti-inflammatory (1)
- anti-inflammatory agent (1)
- anti-inflammatory agents (1)
- anti-inflammatory drug (1)
- anti-inflammatory effects (1)
- anti-neural autoantibodies (1)
- anti-retroviral agents (1)
- anti-skin aging (1)
- anti-tumor activity (1)
- antiadhesive composites (1)
- antiangiogenic therapy (1)
- antiangiogenic therapy resistance (1)
- antibacterial composites (1)
- antibacterial therapy (1)
- antibiotic (1)
- antibiotic prophylactic therapy (1)
- antibiotic prophylaxis (1)
- antibiotic treatment (1)
- antibiotics (1)
- antibody (1)
- antibody tests (1)
- anticancer agents (1)
- anticholinergic burden (1)
- anticipation (1)
- anticoagulant (1)
- anticoagulants (1)
- anticonvulsant (1)
- anticonvulsant activity (1)
- antidepressants (1)
- antifibrotic therapy (1)
- antifungal activity (1)
- antifungal agents (1)
- antifungal combination therapy (1)
- antifungal host response (1)
- antifungal management (1)
- antifungal prophylaxis (1)
- antigen (1)
- antigen detection (1)
- antigenic variation (1)
- antigens of infectious origin (1)
- antihelix shaping (1)
- antihormone therapy (1)
- antimicrobial activity (1)
- antimicrobial stewardship (1)
- antioxidant activity (1)
- antioxidant defense (1)
- antiproliferative activity (1)
- antireflux surgery (1)
- antiresorptive agents (1)
- antiseizure (1)
- antisense oligonucleotides (1)
- antisynthetase antibodies (1)
- antisynthetase syndrome (1)
- antitumor immunity (1)
- antiviral agents (1)
- antiviral peptide (1)
- antiviral signaling (1)
- anxiety disorders (1)
- aortic aneurysm (1)
- aortic root replacement (1)
- aortic valve repair (1)
- aortic valve-sparing (1)
- apex (1)
- aphrodisin (1)
- apical constriction (1)
- apical junction (1)
- apical polarity (1)
- apigenin (1)
- apixaban (1)
- apolipoprotein B (1)
- apps (1)
- aprotinin (1)
- aptamer modeling (1)
- aquaporin 1 (1)
- aquaporin-4 (AQP4) antibody (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- arachidonate 15-lipoxygenase (1)
- arachidonic acid (AA) (1)
- arbeitsbedingte Infektionen (1)
- archaea (1)
- archaeosomes (1)
- architecture (1)
- arm (1)
- aromatics (1)
- arsenic trioxide (1)
- arterial hypertension (1)
- arterial stiffness (1)
- artery (1)
- artesunate (ART) (1)
- articular cartilage (1)
- articular chondrocytes (1)
- articulatory motor cortex (1)
- artifacts (1)
- artificial feeding (1)
- artificial intelligence (AI) (1)
- artificial neural networks (1)
- aryl hydrocarbon receptor (1)
- asparaginyl endopepdidase (AEP) (1)
- aspiration (1)
- assay development (1)
- assembly (1)
- assembly factor (1)
- associative memory (1)
- asthma phenotypes (1)
- astrocyte (1)
- astrocyte heterogeneity (1)
- astroglia (1)
- asymmetric hearing (1)
- asymptomatic (1)
- asymptomatic temporal encephaloceles (1)
- at-risk mental state (1)
- ataxia (1)
- ataxia score (1)
- athletes (1)
- athletic training (1)
- atomic power (1)
- atopic dermatitis (1)
- atopy (1)
- atrial septostomy (1)
- atrophy (1)
- attachment (1)
- attention deficit hyperactivity disorder (1)
- attention deficit/hyperactivity disorder (ADHD) (1)
- attention modulation (1)
- attention-deficit/hyperactivity disorder (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- attention-deficit/hyperactivitydisorder (1)
- attractiveness (1)
- atypical EGFR mutations (1)
- audition (1)
- auditory (1)
- auditory development (1)
- auditory fMRI (1)
- auditory prediction (1)
- augmentation materials (1)
- authentication (1)
- authorship (1)
- autistic disorder (1)
- auto-structure (1)
- autoantigen (1)
- autobiographical memories (1)
- autogenous tooth roots (1)
- autograft (1)
- autoimmune disease (1)
- autoimmune encephalitis (1)
- autoimmune encephalomyelitis (1)
- autoimmune polyglandular syndrome type 2 (1)
- autoimmune thyroiditis (1)
- autoimmune-mediated psychosis (1)
- automated patch-clamp (1)
- automatic environmental tobacco smoke emitter (1)
- automatic handwriting analysis (1)
- automatic scene classification (1)
- autophagic cell death (1)
- autophagy inhibition (1)
- autophagy-dependent cell death (1)
- autopsy (1)
- autoreactivity (1)
- autovaccine (1)
- avelumab (1)
- aviscumine (1)
- awake surgery (1)
- axon (1)
- azacitidine (1)
- azaindole (1)
- azoospermia (1)
- b-cell lymphomas (1)
- back pain (1)
- back scan (1)
- bacteremia (1)
- bacterial leakage (1)
- bacterial translocation (1)
- bacterial viability (1)
- bacteriophages (1)
- bacterium (1)
- baicalein (1)
- balanced state (1)
- ball (1)
- ballet (1)
- balloon pulmonary angioplasty (1)
- bariatric surgery (1)
- baroreflex (1)
- barriers to implementation (1)
- basal cell carcinoma (1)
- basal insulin (1)
- basic leucine zipper transcription factor ATF-like (1)
- basic mechanisms (1)
- basilar artery occlusion (BAO) (1)
- basonuclin 2 (1)
- bats (1)
- beads (1)
- beam quality correction factors (1)
- behavioral adverse events (1)
- behavioral inhibition (1)
- behavioral performance (1)
- behavioural rhythms (1)
- belimumab (1)
- benchmarking (1)
- bendamustine (1)
- benfooxythiamine (1)
- berotralstat (1)
- best medical treatment (1)
- beta band (1)
- beta blockade (1)
- beta-band activity (1)
- beta-blocker (1)
- beta-lactamases (1)
- beta2-adrenoceptor (1)
- betamethasone dipropionate (1)
- beta‐trace protein (1)
- bicuspid aortic valve (1)
- biglycan (1)
- bilateral (1)
- bile (1)
- bile acids (1)
- bile duct stenosis (1)
- biliary cirrhosis (1)
- binary search procedure (1)
- binaural cochlear implants (1)
- binding (1)
- binocular vision (1)
- bio-absorbable mesh (1)
- bioacoustics (1)
- bioactive lipids (1)
- bioactive phospholipids (1)
- bioactive phytochemicals (1)
- bioactivity (1)
- bioavailability (1)
- biobank (1)
- biochanin A (1)
- biochemical recurrence (1)
- biochemical relapse free survival (1)
- biochemistry (1)
- bioequivalence (1)
- bioimaging (1)
- biological maturation (1)
- biological mesh (1)
- biological transport (1)
- biological treatments (1)
- biologically inspired computing (1)
- biologicals (1)
- biologization (1)
- biomarker study (1)
- biomechanics (1)
- biomolecular analysis (1)
- biopsy naïve (1)
- biorelevant dissolution (1)
- biotin deficiency (1)
- bipolar disorders (1)
- birch pollen allergoid (1)
- bistable (1)
- bladder cancer (BCa) (1)
- bladder dose (1)
- bladder exstrophy-epispadias complex (1)
- bladder neck stenosis (1)
- blastic plasmacytoid dendritic cell neoplasm (1)
- bleomycin (1)
- blinatumomab (1)
- blood borne infection (1)
- blood cell mutations (1)
- blood coagulation (1)
- blood coagulation factor XIII (1)
- blood concentrates (1)
- blood consumption (1)
- blood culture (1)
- blood donor (1)
- blood donor screening (1)
- blood flow recovery (1)
- blood hiv rna (1)
- blood loss (1)
- blood safety (1)
- blood-cerebrospinal fluid barrier (1)
- bloodborne viruses (1)
- bloodstream infections (1)
- blow flies (1)
- blow fly (1)
- blutübertragbare Infektionskrankheiten (1)
- bmal1 (1)
- body dysmorphic disorder (1)
- body posture (1)
- body sway (1)
- body weight distribution (1)
- bone augmentation (1)
- bone barrow (1)
- bone chips (1)
- bone damage (1)
- bone loss (1)
- bone marrow (1)
- bone marrow derived mononuclear cells (1)
- bone marrow metastasis (1)
- bone marrow mononuclear cells (1)
- bone morphogenetic protein-2 (1)
- bone morphogenetic proteins (BMPs) (1)
- bone substitute material (1)
- bone substitutes (1)
- bone tissue (1)
- bone tissue engineering (1)
- bone tissue regeneration (1)
- bone-marrow (1)
- bone-regeneration (1)
- bone‐screw (1)
- bone–implant interface (1)
- booster (1)
- borrelia mayonii (1)
- bottom-up (1)
- bowel dysfunction (1)
- bowel management (1)
- brachytherapy imaging methods (1)
- brain (1)
- brain anatomy (1)
- brain disorders (1)
- brain infection (1)
- brain injury (1)
- brain oscillations (1)
- brain phosphorylome (1)
- brain shift (1)
- brain signal complexity (1)
- brain structure (1)
- brainmass (1)
- brainsize (1)
- branched-chain amino acids (BCAA) (1)
- breakpoint cluster region (1)
- breast (1)
- breast cancer diagnosis (1)
- breast cancer systemic therapy (1)
- breast cancer treatment (1)
- breast tumor (1)
- breech (1)
- broad-range qPCR (1)
- broadly neutralizing antibodies (1)
- bromodomain and extraterminal (BET) protein (1)
- bronchial allergen challenge (1)
- bronchial allergen provocation (1)
- bronchial epithelium (1)
- bronchiolitis obliterans syndrome (1)
- bronchodilator (1)
- buccal mucosa (1)
- buccal mucosal graft urethroplasty (1)
- bullying (1)
- bundle (1)
- buparlisib (1)
- burden of disease (1)
- burkholderia (1)
- burkholderia cepacia complex infections (1)
- burns (1)
- butyrylcholinesterase (1)
- bypass (1)
- c-MET (1)
- c-MYC (1)
- c-kit (1)
- c1orf124 (1)
- cBioPortal (1)
- cFLIP (1)
- cGAS-STING (1)
- cHL (1)
- cIAP1 (1)
- cIAP1 BIR (1)
- cIAP1/2 (1)
- cabazitaxel (1)
- cadherin (1)
- caesarean scar (1)
- caesarean section (1)
- calbindin (1)
- calcification score (1)
- calcipotriol (1)
- calcium handling (1)
- calcium-independent phospholipase A2β (1)
- calcium-sensor (1)
- caloric restriction (1)
- calretinin-knock out (1)
- cancer and drug vulnerabilities (1)
- cancer care (1)
- cancer care providers (1)
- cancer cell malignancy (1)
- cancer cells (1)
- cancer drug (1)
- cancer immunobiology (1)
- cancer information (1)
- cancer metastases (1)
- cancer patients (1)
- cancer screening (1)
- cancer surveillance (1)
- candidate genes (1)
- candidemia (1)
- cannabidiol (1)
- cannabinoid receptor type 1 (1)
- cannabinoid receptors (1)
- cannabinoids (1)
- cannabis (1)
- canonical (1)
- canonical/non-canonical (1)
- cap-dependent translation (1)
- car indoor (1)
- carbapenem-resistant Gram-negative bacteria (CRGN) (1)
- carbon oxides (COx) (1)
- carbon tetrachloride (1)
- carboxyfluorescein (1)
- carcinoma (1)
- cardiac I/R injury (1)
- cardiac arrest (1)
- cardiac autonomic regulation (1)
- cardiac differentiation (1)
- cardiac events (1)
- cardiac ischaemia‐reperfusion (1)
- cardiac magnetic (1)
- cardiac magnetic resonance (1)
- cardiac myocytes (1)
- cardiac regeneration (1)
- cardiac rehabilitation (1)
- cardiac remodeling (1)
- cardiac reprogramming (1)
- cardiocerebral resuscitation (1)
- cardiomegaly (1)
- cardiomyocyte apoptosis (1)
- cardiomyocyte proliferation (1)
- cardiomyocytes (1)
- cardiomyopathy (1)
- cardiopulmonary resuscitation (1)
- cardiothoracic surgery (1)
- cardiovascular diseases (1)
- cardiovascular magnetic resonance (1)
- cardiovascular management (1)
- cardiovascular pharmacology (1)
- cardiovascular precision medicine (1)
- cardiovascular risk factors (1)
- cardiovascular system (1)
- career promotion (1)
- carnitine supplementation (1)
- carotid (1)
- carpal tunnel syndrome (1)
- carrion (1)
- cartilage oligomeric matrix protein (1)
- cartilage trauma (1)
- case reports (1)
- case study (1)
- case-control study (1)
- casein kinase 2 (1)
- caspase 8 (1)
- castration resistance (1)
- cataract surgery workflow (1)
- catecholamine excess (1)
- cathepsin L inhibitor (1)
- catheter (1)
- catheter removal (1)
- catheterization/diagnostic interventional (1)
- causality assessment (1)
- cd4 count determination procedure (1)
- cdk (1)
- cdk2/cyclin A (1)
- ceRNA (1)
- celery (1)
- cell adhesion (1)
- cell and focal adhesion (1)
- cell barrier integrity (1)
- cell culture (1)
- cell cycle arrest (1)
- cell cycling (1)
- cell differentiation (1)
- cell fate (1)
- cell fusion (1)
- cell growth (1)
- cell heterogeneity (1)
- cell identity (1)
- cell line (1)
- cell lines (1)
- cell proliferation regulating inhibitor of protein phosphatase 2A (1)
- cell salvage (1)
- cell signaling (1)
- cell survival (1)
- cell survival mechanisms (1)
- cell transplantation (1)
- cellular heterogeneity (1)
- cellular immunology (1)
- cellular inflammatory response (1)
- cellular reaction (1)
- cellular response (1)
- cellular signalling (1)
- cellular therapies (1)
- cellular therapy (1)
- cellular toxicity (1)
- centenarians (1)
- central nervous system infection (1)
- central spasticity (1)
- centrifugation (1)
- ceramide synthase (1)
- ceramide synthase (CERS2/CERS1) (1)
- cerclage (1)
- cerebellar mutism (1)
- cerebello-dentato-thalamo-cortical pathway (1)
- cerebral imaging (1)
- cerebral infarct (1)
- cerebral ischemia (1)
- cerebral metastasis (1)
- cerebral palsy (1)
- cerebral pseudoprogression (1)
- cerebral radiation necrosis (1)
- cerebral sinus and vein thrombosis (CVT) (1)
- cerebral vasospasm (CVS) (1)
- ceritinib (1)
- cerumen (1)
- cervical shortening (1)
- cervical spine (1)
- cervico-thoracic junction (1)
- cetuximab (1)
- cetuximab-bevacizumab therapy sequence (1)
- ch14.18/CHO (1)
- chamomile (1)
- changes immune activation (1)
- channelrhodopsin (1)
- chaperone-mediated autophagy (1)
- chaperones (1)
- characterization (1)
- charged particles (1)
- checklist (1)
- checkpoint inhibition (1)
- checkpoint proteins (1)
- chelation therapy (1)
- chelator (1)
- chemical-induced proximity (1)
- chemoattractant (1)
- chemoconvulsant (1)
- chemoembolization (1)
- chemogenomic set (1)
- chemokine (1)
- chemokine receptor 4 (1)
- chemokine receptors (1)
- chemokines: CYP2D6 model (1)
- chemoprevention (1)
- chemoprotection (1)
- chemorefractory metastatic colorectal cancer (1)
- chemosensory cells (1)
- chemotherapeutic drug resistance (1)
- chemotherapeutics (1)
- chemotherapeutics-treated (1)
- chemotherapy regimen (1)
- chemotherapy-resistance (1)
- chernobyl (1)
- chest injury (1)
- child abuse and neglect (1)
- child maltreatment (1)
- childhood (1)
- childhood abuse (1)
- childhood epilepsy (1)
- chimeric antigen receptor (CAR) (1)
- chimeric antigen receptor t-cell therapy (1)
- chimeric antigen receptors (1)
- chloroplasts (1)
- cholecystectomy (1)
- cholestasis (1)
- cholinergic system (1)
- cholinesterase (1)
- chondrocyte (1)
- chondrocytes (1)
- chromaffin cell (1)
- chromatin (1)
- chromatin immunoprecipitation (1)
- chromosomal breaks (1)
- chromosomal instability (1)
- chromosomal integration (1)
- chromosomal translocations (1)
- chromosome alignment (1)
- chromosome instability (1)
- chromosome segregation (1)
- chronic (1)
- chronic care (1)
- chronic colitis (1)
- chronic coronary artery disease (1)
- chronic hypoxia (1)
- chronic illness (1)
- chronic infections (1)
- chronic kidney disease (CKD) (1)
- chronic liver disease (1)
- chronic liver disease (CLD) (1)
- chronic myeloid leukemia (CML) (1)
- chronic total occlusion (1)
- chronic viral hepatitis (1)
- chronobiology (1)
- chronotype (1)
- cigarette smoke (1)
- cigarette strength (1)
- cigarettes (1)
- cigarillos (1)
- cilia (1)
- circadian variation (1)
- circulating miRNA (1)
- circulation (1)
- cisplatin sensitivity (1)
- classical conditioning (1)
- classification (1)
- classification of bone defects (1)
- clean room (1)
- clear cell renal cell carcinoma (1)
- clear cell sarcoma (1)
- clear lens exchange (1)
- clear or almost clear skin (1)
- climate change genomics (1)
- clindamycin (1)
- clinical (1)
- clinical cases (1)
- clinical competency (1)
- clinical decision support (1)
- clinical decision-making (1)
- clinical features (1)
- clinical high at-risk mental state (1)
- clinical history (1)
- clinical management (1)
- clinical node positive (1)
- clinical outcome (1)
- clinical pathways (1)
- clinical practice (1)
- clinical relevance (1)
- clinical stage (1)
- clinical teaching (1)
- clinical tool (1)
- clinically relevant dissolution specifications (1)
- cloacae (1)
- cloacal malformation (1)
- clonal dominance (1)
- clonal haematopoiesis (1)
- clonal hematopoiesis (1)
- clonal transfer (1)
- clopidogrel (1)
- cluster analysis (1)
- cluster of differentiation 4 (CD4) (1)
- cluster-randomized controlled trial (1)
- clusteranalysis (1)
- cluttering (1)
- co-crystallization (1)
- coaching (1)
- coagulation (1)
- coauthor ship (1)
- cocaine (1)
- cochlea (1)
- cochlear implants (1)
- coffee (1)
- cognitive ability (1)
- cognitive aging (1)
- cognitive control (1)
- cognitive decline (1)
- cognitive deficits (1)
- cognitive fluency (1)
- cognitive functions (1)
- cognitive impairment (CI) (1)
- cognitive interventions (1)
- cognitive models (1)
- cognitive states (1)
- cognitively stimulating leisure activities (1)
- cohort study (1)
- cold atmospheric plasma (1)
- cold induced pain (1)
- cold tolerance (1)
- colitis (1)
- collaborative feedback (1)
- collagen I (1)
- collagen VI (1)
- collagen adhesion (1)
- collagen degradation marker (1)
- collagen membranes (1)
- collagen type I (1)
- collagen-based biomaterial (1)
- collagen-based matrix (1)
- collateral growth (1)
- collateral sprouting (1)
- collective cell migration (1)
- collective dynamics (1)
- colloid (1)
- colon cancer cells (1)
- colon carcinoma (1)
- colonization (1)
- colony formation (1)
- colorectal cancer liver metastases (CRLM) (1)
- column chromatography (1)
- combination (1)
- combination immunotherapy (1)
- combination therapies (1)
- combination treatment (1)
- combined immunodeficiency (1)
- combined modality therapy (1)
- common genetic variation (1)
- common neighbor (1)
- common variant (1)
- common variants (1)
- communication (1)
- community violence exposure (1)
- compaction (1)
- comparative pathology (1)
- comparative study (1)
- competitive peptide (1)
- complement dependent cytotoxicity (1)
- complement; patients (1)
- complementary information (1)
- complementary/alternative medicine (CAM) (1)
- complete response (1)
- complex I deficiency (1)
- complex coronary interventions (1)
- complexity theory (1)
- compound screen (1)
- comprehensive care (1)
- computational biology (1)
- computational functional genomics (1)
- computational intelligence (1)
- computational knowledge-discovery (1)
- computational modeling (1)
- computational models (1)
- computational neuroimaging (1)
- computational neuroscience (1)
- computational pathology (1)
- computational techniques (1)
- computer tomography (1)
- computer vision (1)
- computer-assisted drug therapy (1)
- concentric (1)
- concurrent (1)
- concurrent TMS--fMRI (1)
- conditioning (1)
- conduit (1)
- cone-beam computed tomography (CBCT) (1)
- cone-beam computer tomography (1)
- confidence (1)
- congenic mice (1)
- congenital deafness (1)
- congenital disorders of autophagy (1)
- congenital duodenal obstruction (1)
- conical coupling (1)
- connectional fingerprint (1)
- connective tissue graft (1)
- connective tissue growth factor (1)
- conometric connection (1)
- consciousness (1)
- consensus classification (1)
- consensus data set (1)
- consensus paper (1)
- conservative dentistry (1)
- consolidation treatment (1)
- contact heat evoked potentials (CHEPS) (1)
- contact lens solution (1)
- contamination (1)
- continuing education (1)
- continuity of care (1)
- continuous glucose monitoring (1)
- contraception (1)
- contralateral delay activity (1)
- control of menstrual bleeding (1)
- controlled nuclear import (1)
- conventional laparoscopic (1)
- conventional/traditional transarterial chemoembolization (cTACE) (1)
- convolution neural network (1)
- cooling deactivation (1)
- cooling period (1)
- coordination (1)
- copeptin (1)
- copper free strain-promoted azide alkyne cycloaddition (SPAAC) (1)
- copy number polymorphism (1)
- cord clamping (1)
- core expression (1)
- cornea donor (1)
- corneas (1)
- coronally advanced flap (1)
- coronary (1)
- coronary artery bypass surgery (1)
- coronary calcium (1)
- coronary computed-tomography angiography (CCTA) (1)
- coronary disease (1)
- coronary imaging (1)
- coronary plaques (1)
- coronavirus disease 2019 (1)
- correlation (1)
- corrosion (1)
- cortex, gray matter (1)
- cortex-based alignment (1)
- cortical folding (1)
- cortical impact (1)
- cortical layers and areas (1)
- cortical malformation (1)
- cortical network (1)
- cortical networks (1)
- cortical slices (1)
- cortical thickness (1)
- corticomuscular coherence (CMC) (1)
- corticospinal tracts (1)
- corticosteroid drugs (1)
- corticosteroids (1)
- cost analysis (1)
- cost containment (1)
- cost of illness (1)
- cost-of-illness (1)
- costimulation (1)
- costs (1)
- counseling (1)
- counselling (1)
- coupling (1)
- courting behavior (1)
- covalent drugs (1)
- cranberry (1)
- crestal bone loss (1)
- crime scene (1)
- crista junction (1)
- cristae (1)
- criteria (1)
- critical care unit (1)
- critical ill patients (1)
- critical periods (1)
- critical-size defect (1)
- cross reactivity (1)
- cross-border (1)
- cross-frequency coupling (1)
- cross-linking (1)
- cross-modal plasticity (1)
- cross-sectional study (1)
- crowns (1)
- cryoelectron microscopy (1)
- cryogenic electron microscopy (1)
- cryotherapy (1)
- crystalloid (1)
- culpa asociada a trauma (1)
- cumulative dose (1)
- curriculum (1)
- cutaneous T cell lymphoma (1)
- cuticular hydrocarbons (1)
- cyclic depsipeptide (1)
- cyclic nucleotide analogues (1)
- cyclic nucleotide binding proteins (1)
- cyclin D1 (1)
- cyclin Y (1)
- cycling (1)
- cyclins (1)
- cyclooxygenase 1 (COX-1) (1)
- cyclooxygenase 2 (1)
- cyclooxygenase 2 (COX-2) (1)
- cyclooxygenase-2 (1)
- cyclopentenone prostaglandins (1)
- cyclophilin A (1)
- cyclophosphamide (1)
- cyclosporine (1)
- cystatin C (1)
- cytarabin (1)
- cytarabine dose (1)
- cytochrome P450 (1)
- cytochrome P450 enzymes (1)
- cytochrome P450 reductase (1)
- cytochrome c oxidase (complex IV) (1)
- cytochrome c oxidase I (COI) (1)
- cytokine gene expression (1)
- cytokine release syndrome (1)
- cytokine storm (1)
- cytokine(s) (1)
- cytokine, angiogenesis (1)
- cytoskeleton (1)
- cytosolic free calcium (1)
- cytotoxic T lymphocyte (1)
- cytotoxic immunotherapy (1)
- cytotoxic lymphocytes (1)
- dNTP pools (1)
- dabigatran (1)
- daily activity protocols (1)
- damage associated molecular pattern (1)
- damage-associated molecular pattern (1)
- dance teacher (1)
- dapagliflozin (1)
- data analysis (1)
- data management (1)
- data modeling (1)
- data quality (1)
- data quality check (1)
- data repositories (1)
- data sharing (1)
- day clinic (1)
- de novo transcription (1)
- deaf white cat (1)
- death (1)
- death rates (1)
- death receptor (1)
- debridement (1)
- debris (1)
- decision aids (1)
- decision support systems (1)
- decision tree (1)
- decision-making (1)
- declaration of tobacco ingredients (1)
- decomposition (1)
- decompressive craniectomy (1)
- deconvolution (1)
- decorin (1)
- decorrelation (1)
- dedifferentiation (1)
- deep learning (1)
- deep mutational scanning (1)
- deep neural network (1)
- deep sedation (1)
- deep vein thrombosis (1)
- default mode network (1)
- defect configuration (1)
- deferred treatment (1)
- degradation (1)
- delayed auditory feedback (1)
- delayed cerebral ischemia (DCI) (1)
- delayed cholecystectomy (1)
- delayed diagnosis (1)
- delayed treatment (1)
- delayed wound healing (1)
- deletion 5q (1)
- delivery mode (1)
- delta (1)
- delta-9-tetrahydrocannabinol (1)
- demineralized bone matrix (1)
- dendrite (1)
- dendrite morphogenesis (1)
- dendritic cell (1)
- dendritic cell–tumor cell fusion (1)
- dendritic inhibition (1)
- denervation (1)
- dengue vector (1)
- density equalizing mapping (1)
- dental abutment (1)
- dental academic degrees (1)
- dental educationcation (1)
- dental emergency treatment (1)
- dental health professional (1)
- dental school (1)
- dental treatment concept (1)
- dentin adhesives (1)
- dentistry (1)
- dentist’s chair design (1)
- depolymerization (1)
- depressive symptoms (1)
- depressive symptoms clusters (1)
- deprivation (1)
- deproteinized bovine bone matrix (DBBM) (1)
- depth perception (1)
- dermatology (1)
- desmoplastic small round cell tumor (1)
- desmoplastic stroma (1)
- deswelling (1)
- detection task (1)
- deubiquitinating enzyme (1)
- deubiquitinating enzymes (1)
- deubiquitylation (deubiquitination) (1)
- devastated bladder outlet (1)
- device handling (1)
- diabetes complication (1)
- diabetes therapy (1)
- diabetic macular edema (1)
- diabetic neuropathy (1)
- diagnostic biomarkers (1)
- diagnostic imaging (1)
- diagnostic method (1)
- diagnostic test (1)
- diagnostic window (1)
- diagnostisches Fenster (1)
- dialysis (1)
- diaphragm development (1)
- diarrhoeal disease (1)
- diastolic function (1)
- diclofenac (1)
- differential expression (1)
- differentiated thyroid carcinoma (1)
- diffuse large B cell lymphoma (1)
- diffuse low-grade glioma (1)
- diffuse marrow involvement (1)
- diffusion MRI (1)
- diffusion microstructure (1)
- diffusion tensor imaging (DTI) (1)
- diffusion-weighted magnetic resonance imaging (1)
- digestive tract (1)
- digital age determination (1)
- digital decision-support (1)
- digital one-piece casting (1)
- digital pathology (1)
- digital pressing technology (1)
- digital workflow (1)
- dihydrocannabidiol (1)
- dihydroceramides (1)
- dimethylfumarate (1)
- dipeptide (1)
- diphtheria toxin (1)
- diplopia (1)
- direct antiviral (1)
- direct antiviral agents (1)
- direct-acting antiviral (DAA) treatment (1)
- direct-acting antivirals (DAAs) (1)
- directed disulfide bond formation (1)
- directed forgetting (1)
- directly acting antiviral agents (1)
- disasters (1)
- discoidin domain-containing receptor (1)
- discomfort/pain (1)
- discontinuation (1)
- discontinuous dose dependency (1)
- disease modelling (1)
- disease outbreaks (1)
- disease vectors (1)
- disease-free survival (1)
- disease-modifying antirheumatic drugs (1)
- disease-modifying therapy (1)
- disordered iron metabolism (1)
- disposable insulin pens (1)
- disruptive behaviour disorder (1)
- dissemination (1)
- dissimilatory sulfite reductase (1)
- distal pronephric outlet obstruction (1)
- distraction (1)
- distributed analysis (1)
- distributed computation (1)
- diuretics (1)
- diurnal (1)
- dobutamine stress (1)
- docetaxel (DX) resistance (1)
- docking studies (1)
- doctoral degrees (1)
- dog study (1)
- donor deferral (1)
- donor recruitment (1)
- donor retention (1)
- donor safety (1)
- dopamine transporter (1)
- doppler (1)
- dorsal attention network (1)
- dorsal auditory stream (1)
- dose response curve (1)
- dosimetry (1)
- dosing accuracy (1)
- double immune checkpoint inhibition (1)
- double inversion recovery (DIR) (1)
- double negative (1)
- double orifice mitral valve (1)
- double-pigtail stents (1)
- doublecortin (1)
- downgrading (1)
- drilling tool design (1)
- drinking (1)
- drospirenone (1)
- drug (1)
- drug abstinence (1)
- drug delivery (1)
- drug hepatotoxicity (1)
- drug interaction (1)
- drug metabolism and distribution (1)
- drug repurposing (1)
- drug resistance and invasiveness (1)
- drug screening (1)
- drug targets (1)
- drug therapy (1)
- drug-coated balloon (1)
- drug-eluting balloon (1)
- drug-eluting beads TACE (DEB-TACE) (1)
- drug-induced liver injury (DILI) (1)
- druggable genome (1)
- drugs (1)
- drug‐resistant epilepsy (1)
- drug–drug interactions (1)
- drug–gene interactions (1)
- drug–g–gene interactions (1)
- dsr genes (1)
- dual antiplatelet therapy (1)
- dual bronchodilators (1)
- dual-energy (1)
- dynamic 18F-FDG PET/CT (1)
- dynamic causal modeling (1)
- dynamic connectivity (1)
- dynamic stimuli (1)
- dynamic system (1)
- dysbetalipoproteinemia (1)
- dysbiosis (1)
- dysferlin (1)
- dysferlinopathy (1)
- dysfibrinogenemia (1)
- dyssynchrony analysis (1)
- e-Health (1)
- e-Learning (1)
- e-scooter (1)
- eLearning (1)
- eNOS (1)
- eNPP2 (1)
- ePTFE membrane (1)
- early cholecystectomy (1)
- early continence (1)
- early detection (1)
- early epilepsy (1)
- early infection (1)
- early loss (1)
- early myocardial damage (EMD) (1)
- early onset (1)
- early recognition (1)
- early tumor stages (1)
- early-onset prostate cancer (1)
- eccentric (1)
- echo planar imaging (1)
- economy (1)
- ectopic pregnancy (1)
- edema (1)
- edentulous (1)
- editorials (1)
- edoxaban (1)
- educational cases (1)
- educational measurement (1)
- educational theory (1)
- effect mechanism (1)
- effective lens position (1)
- effectiveness (1)
- efferocytosis (1)
- efficiency (1)
- efflux pump (1)
- egg sampling (1)
- egr-1 (1)
- eicosanoid (1)
- eight disorders (1)
- ejection fraction (EF) (1)
- elastin (1)
- electric scooter (1)
- electrical coupling (1)
- electrical stimulation (1)
- electroanatomical mapping (1)
- electroconvulsive therapy (1)
- electrode design (1)
- electroencephalography (EEG) (1)
- electroencephalography (EEG), EEG reference choices, event-related potentials (ERP), independent component analysis (ICA), pain research, contact heat evoked potentials (CHEPS) (1)
- electromagnetic navigation bronchoscopy (EMN, ENB) (1)
- electron transfer (1)
- electron transfer chain (1)
- electronic adherence measurement (1)
- electronic diaries (1)
- electronic pen (1)
- electrophiles (1)
- electrophilic fatty acids (1)
- electrophoresis (1)
- element speciation (1)
- eligibility (1)
- elite athlete (1)
- elite athletes (1)
- eltrombopag (1)
- embodiment (1)
- embolization (1)
- emergence (1)
- emergent self-organizing maps (1)
- emicizumab (1)
- emotion (1)
- emotional climate (1)
- emotional information processing (1)
- empagliflozin (1)
- empowerment (1)
- emulsion diffusion (1)
- enamel matrix derivatives (1)
- encephalopathy (1)
- encoding strategies (1)
- end of life care (1)
- endocarditis (1)
- endodontic curriculum (1)
- endodontic education (1)
- endodontics (1)
- endogenous clock (1)
- endometrial cancer (1)
- endometriosis (1)
- endophytes (1)
- endoscopic retrograde cholangiography (1)
- endoscopy (1)
- endothelial activation (1)
- endothelial barrier (1)
- endothelial dysfunction (1)
- endothelial function (1)
- endothelial nitric-oxide synthase (1)
- endothelial receptor expression (1)
- endothelial to mesenchymal transition (1)
- endothelin (1)
- endothelin receptor type A antagonist (1)
- endothelium (1)
- endotoxemia (1)
- endotoxins (1)
- endourology (1)
- endovascular recanalization (1)
- endovascular thrombectomy (1)
- enforced viral replication (1)
- english (1)
- ensemble cNN (1)
- enterobacter infections; pseudomonas aeruginosa; epidemiology (1)
- enterocytes (1)
- enterovirus (1)
- entomological evidence (1)
- envelope technique (1)
- environment (1)
- enzyme activity assay (1)
- eosinophil cationic protein (1)
- eosinophilic cholangitis (1)
- eosinophils (1)
- epidermis (1)
- epididymitis (1)
- epidural (1)
- epigenetic memory (1)
- epigenome (1)
- epigenomics (1)
- epilepsy surgery (1)
- epileptic encephalopathies (1)
- epiregulin (1)
- episodic memory (1)
- epithelial cells (1)
- epithelial mesenchymal transition (1)
- epithelial-to-mesenchymal transition (EMT) (1)
- epithelial‐mesenchymal transition (1)
- epitope mapping (1)
- epoxyeicosatrienoic acid (1)
- ergometry (1)
- erosions (1)
- erythropoiesis (1)
- erythropoietin (1)
- erythropoietin (EPO) (1)
- escape mutations (1)
- essential thrombocythemia (ET) (1)
- essential tremor (1)
- esterification (1)
- estrogen (1)
- ethanol (1)
- ethical trade-off (1)
- ethyl pyruvate (1)
- eutheria (1)
- evaluation practice (1)
- event logs (1)
- event-based (1)
- event-related potentials (ERP) (1)
- everyday life (1)
- everyday tasks (1)
- evidence-based guideline (1)
- evoked response (1)
- ex vivo expansion (1)
- ex vivo model (1)
- ex vivo stimulation (1)
- ex-Gaussian analysis (1)
- excess fluid volume (1)
- excitability (1)
- exclusion of very low profiles (1)
- executive control (1)
- executive functions (1)
- exercise on prescription (1)
- exercise physiology (1)
- exercise testing (1)
- exercise training (1)
- exome sequencing (1)
- exosome (1)
- experimental human pain models (1)
- experimental pain models (1)
- expert review (1)
- expert witness statement (1)
- explainable AI (1)
- exponential model (1)
- exposure (1)
- expressed emotion (1)
- expression studies (1)
- extensive surgery (1)
- extensively drug-resistant (1)
- external fixation (1)
- external joint moments (1)
- extracellular chromatin (1)
- extracellular signal-regulated kinase (1)
- extracting solvents (1)
- extraction socket healing (1)
- extraskeletal (1)
- extremity (1)
- eye movement (1)
- eye movements (1)
- eye tracking (1)
- eye tracking (ET) (1)
- eye-tracking (1)
- fMLP (1)
- face (1)
- face inversion effect (1)
- face-name association task (1)
- facial EMG (1)
- facial emotion recognition (1)
- facial expressions of emotion (1)
- facial muscle activity (1)
- facial nerve functional outcome (1)
- facial prosthesis (1)
- factor IX (1)
- factor V Leiden mutation (1)
- factor VIII (1)
- factor VIII (FVIII) (1)
- factor XIII (1)
- faecal microbiota transfer (1)
- falls (1)
- false memory (1)
- familial amyloid nephropathy with urticaria and deafness (1)
- familial colorectal cancer (1)
- familial infantile epilepsy (1)
- family-friendly universities (1)
- famotidine (1)
- fasting insulin (1)
- fat (1)
- fat grafting (1)
- fat pad resection (1)
- fatty acid (1)
- fatty acid elongase (Elovl1/4/5) (1)
- fatty acid synthesis (1)
- fatty acids (1)
- fear conditioning (1)
- fear extinction (1)
- fear generalization (1)
- fear learning (1)
- feasibility study (1)
- febrile neutropenia (1)
- fecal incontinence (1)
- fecal microbiota transfer (1)
- fecal occult blood test (1)
- federated feasibility queries (1)
- feedback (1)
- feedback control (1)
- feeder cells (1)
- feeding (1)
- female health (1)
- females (1)
- femoropopliteal segment (1)
- ferret (1)
- ferric derisomaltose (1)
- ferritin (1)
- ferritinophagy (1)
- ferroportin (1)
- ferumoxytol (1)
- fetal loss (1)
- fetal weight estimation (1)
- fiber orientations (1)
- fibrin (1)
- fibrin-glue-spray technique (1)
- fibrocytes (1)
- fibrogenesis (1)
- fibromodulin (1)
- fibronectin (1)
- fibrosarcoma (1)
- fibrosis imaging (1)
- fibrotest (1)
- fidaxomicin (1)
- fimaporfin (1)
- finger tapping (1)
- fingolimod (1)
- first-line chemotherapy (1)
- first-time shoulder dislocation (1)
- fitness (1)
- fixation (1)
- fixed partial dentures (1)
- fizička aktivnost; (1)
- flavivirus entry factor (1)
- fluid (1)
- fluid shear stress (1)
- fluocinolone acetonide (1)
- fluorescence (1)
- fluorescence in situ hybridization (FISH) (1)
- fluorescent dye (1)
- fluorine (1)
- focal adhesion kinase (1)
- focal cortical dysplasia (1)
- focal cortical dysplasia (FCD) (1)
- focal seizures (1)
- follow‑up (1)
- fondaparinux (1)
- fondaparinux sodium (1)
- foreign body reaction (1)
- forensics (1)
- formalin-fixed and paraffin-embedded tissue (FFPE) (1)
- formalin-fixed paraffin-embedded (FFPE) samples (1)
- formula diet (1)
- fortgeschritten (1)
- fourth (1)
- fractional anisotropy (1)
- fractionation (1)
- fracture strength (1)
- fracture strength equation (1)
- fragile-X-associated tremor-ataxia syndrome (1)
- fragment screening (1)
- fragment-size analyses (ACE2; CQ11) (1)
- free flap (1)
- free gingival graft (1)
- free leptin index (FLI) (1)
- freeze avoidance (1)
- frequency of attacks (1)
- fresh frozen plasma (1)
- frontal cortex (1)
- fronto-temporal lobar dementia (1)
- fronto-temporal-lobar-dementia (1)
- frontotemporal dementia (1)
- frontotemporal lobar degeneration (1)
- full-arch restoration (1)
- full-contour crown restorations (1)
- full-contour zirconia (1)
- fully human (1)
- fumonisin B1 (1)
- function (1)
- function, sorting (1)
- functional MRI (1)
- functional connectome acute (1)
- functional imaging (1)
- functional magnetic resonance imaging (fMRI) (1)
- fundoplication (1)
- fungal infection (1)
- fungal pathogens (1)
- fungal sinusitis (1)
- fungal sugar (1)
- fungi (1)
- fungus (1)
- furcation involvement (1)
- further education (1)
- fusion kinase (1)
- fäkaler okkulter Stuhltest (1)
- gRNA library (1)
- gadobutrol (1)
- gadolinium (1)
- gadolinium enhancing lesion (1)
- gadolinium‐based contrast agent (1)
- gait symmetry (1)
- galactography (1)
- galactomannan (1)
- galactomosynthesis (1)
- gallbladder cancer (1)
- gallbladder cancer xenografts (1)
- gallstone disease (1)
- galunisertib monohydrate (LY2157299) (1)
- gangliosides (1)
- gap junction protein alpha 4-genotype (1)
- gargle lavage (1)
- gas chromatography-mass spectrometry (1)
- gasotransmitters (1)
- gastric (1)
- gastric surgery (1)
- gastro-oesophageal junction cancer (1)
- gastroesophageal reflux (1)
- gastrointestinal (1)
- gastrointestinal stromal tumours (1)
- gastrointestinal tract (1)
- gefitinib (1)
- gel (1)
- gel spacer injection (1)
- gemcitabine (1)
- gender difference (1)
- gender differences (1)
- gender dysphoria (1)
- gender equality (1)
- gender equality plan (1)
- gender studies (1)
- gender-affirming hormone therapy (1)
- gene delivery (1)
- gene expression analysis (1)
- gene expression profiling (1)
- gene expression profiling (GEP) (1)
- gene vectors (1)
- general anaesthesia (1)
- general practitioner (1)
- general practitioners (1)
- generic preparedness (1)
- genes (1)
- genetic generalized epilepsy (1)
- genetic markers (1)
- genetic model (1)
- genetic phenotypes (1)
- genetic polymorphisms (1)
- genetic predisposition (1)
- genetic rearrangements (1)
- genetic variability (1)
- genetic variants (1)
- genetically caused iron imbalance (1)
- genetics and genomics (1)
- gene×environment interactions (1)
- genome editing (1)
- genome-wide (1)
- genome-wide association study (1)
- genomic classifiers (1)
- genomic instability (1)
- genotype (1)
- genotype G (1)
- genotype determination (1)
- geriatric medicine (1)
- geriatric patients (1)
- geriatrics (1)
- germ cell tumors (1)
- germinal center (1)
- gestational hypertension (1)
- gingival recession therapy (1)
- gland extracts (1)
- glial activation (1)
- glial fibrillary acidic protein (1)
- glioblastoma (GBM) (1)
- glioblastoma cells (1)
- glioblastoma stem-like cells (1)
- glioblastoma survival (1)
- glioma microenvironment (1)
- glioma stem-like cells (1)
- glioma-associated oncogene homolog (1)
- gliomas (1)
- gliomatosis cerebri growth pattern (1)
- global diversity (1)
- global health (1)
- global mapping (1)
- global warming (1)
- globosides (1)
- glomerulus (1)
- glucocorticoid (1)
- glucocorticoids (1)
- glucosamine (1)
- glucose (1)
- glucose and lipid metabolism (1)
- glucose-6-phosphate dehydrogenase (1)
- glucosylceramide (1)
- glucosylceramides (1)
- glutamate metabolism (1)
- glutamine (1)
- glutathione peroxidase 4 (1)
- glycation (1)
- glycobiology (1)
- glycoconjugate (1)
- glycoproteins (1)
- glycosaminoglycan (1)
- glycosyltransferase (1)
- gold nanoparticles (1)
- good manufacturing practice (1)
- gossypol (1)
- governance (1)
- gp100 (1)
- graft (1)
- graft perfusion (1)
- graft rejection (1)
- graft-versus host (1)
- graft-versus-host disease (1)
- graft-versus-tumor effect (1)
- graft-vs-host disease (1)
- gram-negative bacteria (1)
- granule polarization (1)
- granulocyte (1)
- granulocytecolony stimulating factor (1)
- granulocytemacrophage colony-stimulating factor (1)
- granuloma (1)
- granulomas (1)
- granulomatous inflammation (1)
- graphic 3D models (1)
- gravity (1)
- gray matter (1)
- gray matter changes (1)
- gray‐white matter blurring (1)
- great height (1)
- green fluorescent protein (1)
- green tea extract (1)
- grey matter volume (1)
- grinding (1)
- grisel syndrome (1)
- grounded theory (1)
- growth hormone (1)
- guanidine alkaloid (1)
- guidance (1)
- guided tissue regeneration (1)
- guidelines (1)
- guinea pig (1)
- gut microbiota (1)
- gyrification (1)
- h-index (1)
- hMOF/KAT8 (1)
- haNK (1)
- habitat (1)
- habituation (1)
- haematologic malignancies (1)
- haemophilic arthropathy (1)
- haemostasis (1)
- hair cell (1)
- hand area (1)
- hanging donors (1)
- haplo-identical (1)
- haploidentical (1)
- harassment (1)
- harmine (1)
- harmonization (1)
- hatching (1)
- head to head (1)
- head-and-neck cancer (1)
- head-to-head (1)
- headache (1)
- health apps (1)
- health behavior (1)
- health care personnel (1)
- health data (1)
- health database (1)
- health economics (1)
- health education (1)
- health information interoperability (1)
- health insurance data (1)
- health literacy (1)
- health related quality of life (1)
- health services accessibility (1)
- health services research (1)
- health-care personnel (1)
- health-relatedquality of life (1)
- healthcare (1)
- healthcare professional (1)
- healthcare system (1)
- healthcare systems (1)
- healthy control (1)
- healthy subjects (1)
- health‐related quality of life (1)
- hearing nerve (1)
- heart neoplasms (1)
- heart rate control (1)
- heart rate variability (1)
- heat (1)
- heat stress (1)
- hedgehog (1)
- hedgehog signaling pathway (1)
- helminths (1)
Institute
- Medizin (5154) (remove)
Objectives: Large-scale clinical studies investigating associations between intestinal microbiota signatures and human diseases usually rely on stool samples. However, the timing of repeated stool sample collection cannot be predefined in longitudinal settings. Rectal swabs, being straightforward to obtain, have the potential to overcome this drawback. Therefore, we assessed the usability of rectal swabs for microbiome sampling in a cohort of hematological and oncological patients.
Study design: We used a pipeline for intestinal microbiota analysis from deep rectal swabs which was established and validated with test samples and negative controls. Consecutively, a cohort of patients from hematology and oncology wards was established and weekly deep rectal swabs taken during their admissions and re-admissions.
Results: Validation of our newly developed pipeline for intestinal microbiota analysis from rectal swabs revealed consistent and reproducible results. Over a period of nine months, 418 rectal swabs were collected longitudinally from 41 patients. Adherence to the intended sampling protocol was 97%. After DNA extraction, sequencing, read pre-processing and filtering of chimeric sequences, 405 of 418 samples (96.9%) were eligible for further analyses. Follow-up samples and those taken under current antibiotic exposure showed a significant decrease in alpha diversity as compared to baseline samples. Microbial domination occurred most frequently by Enterococcaceae (99 samples, 24.4%) on family level and Enterococcus (90 samples, 22.2%) on genus level. Furthermore, we noticed a high abundance of potential skin commensals in 99 samples (24.4%).
Summary: Deep rectal swabs were shown to be reliable for microbiome sampling and analysis, with practical advantages related to high sampling adherence, easy timing, transport and storage. The relatively high abundance of putative skin commensals in this patient cohort may be of potential interest and should be further investigated. Generally, previous findings on alpha diversity dynamics obtained from stool samples were confirmed.
Polypharmacy is associated with a risk of negative health outcomes. Potentially inappropriate medications, interactions resulting from contradicting medical guidelines, and inappropriate monitoring, all increase the risk. This process evaluation (PE) of the AdAM study investigates implementation and use of a computerized decision-support system (CDSS). The CDSS analyzes medication appropriateness by including claims data, and hence provides general practitioners (GPs) with full access to patients’ medical treatments. We based our PE on pseudonymized logbook entries into the CDSS and used the four dimensions of the Medical Research Council PE framework. Reach, which examines the extent to which the intended study population was included, and Dose, Fidelity, and Tailoring, which examine how the software was actually used by GPs. The PE was explorative and descriptive. Study participants were representative of the target population, except for patients receiving a high level of nursing care, as they were treated less frequently. GPs identified and corrected inappropriate prescriptions flagged by the CDSS. The frequency and intensity of interventions documented in the form of logbook entries lagged behind expectations, raising questions about implementation barriers to the intervention and the limitations of the PE. Impossibility to connect the CDSS to GPs’ electronic medical records (EMR) of GPs due to technical conditions in the German healthcare system may have hindered the implementation of the intervention. Data logged in the CDSS may underestimate medication changes in patients, as documentation was voluntary and already included in EMR.
Background: Interventional studies on polypharmacy often fail to significantly improve patient-relevant outcomes, or confine themselves to measuring surrogate parameters. Interventions and settings are complex, with many factors affecting results. The AdAM study’s aim is to reduce hospitalization and death by requiring general practitioners (GPs) to use a computerized decision-support system (CDSS). The study will undergo a process evaluation to identify factors for successful implementation and to assess whether the intervention was implemented as intended.
Objective: To evaluate our complex intervention, based on the Medical Research Council’s guideline dimensions.
Research Questions:
We will assess implementation (reach, fidelity, dose, tailoring) by asking: (1) Who took part in the intervention (proportion of GPs using the CDSS, proportion of patients enrolled in them)? Information on GPs’ and patients’ characteristics will also be collected. (2) How many and which medication alerts were dealt with? (3) Was the intervention implemented as intended? (4) On what days did GPs use the intervention tool?
Methods: The process evaluation is part of a stepped-wedge cluster-randomized controlled trial. Characteristics of practices, GPs and patients using the CDSS will be compared with the non-participating population. CDSS log data will be analyzed to evaluate how the number of medication alerts changed between baseline and 2 months later, and to identify the kind of alerts that were dealt with. Comparison of enrolled patients on weekdays versus weekends will shed light on GPs’ use of the CDSS in the absence or presence of patients. Outcomes will be presented using descriptive statistics, and significance tests will be used to identify associations between them. We will conduct subgroup analyses, including time effects to account for software improvements.
Discussion: This study protocol is the basis for conducting analyses of the quantitative process evaluation. By providing insight into how GPs conduct medication reviews, the evaluation will provide context to the trial results and support their interpretation. The evaluation relies on the proper documentation by GPs, potentially limiting its explanatory power.
Background: Two large clinical trials have shown a reduced rate of breast cancer development in high-risk women in the initial 5 years of follow-up after use of aromatase inhibitors (MAP.3 and International Breast Cancer Intervention Study II [IBIS-II]). Here, we report blinded long-term follow-up results for the IBIS-II trial, which compared anastrozole with placebo, with the objective of determining the efficacy of anastrozole for preventing breast cancer (both invasive and ductal carcinoma in situ) in the post-treatment period.
Methods: IBIS-II is an international, randomised, double-blind, placebo-controlled trial. Postmenopausal women at increased risk of developing breast cancer were recruited and were randomly assigned (1:1) to either anastrozole (1 mg per day, oral) or matching placebo daily for 5 years. After treatment completion, women were followed on a yearly basis to collect data on breast cancer incidence, death, other cancers, and major adverse events (cardiovascular events and fractures). The primary outcome was all breast cancer.
Findings: 3864 women were recruited between Feb 2, 2003, and Jan 31, 2012. 1920 women were randomly assigned to 5 years anastrozole and 1944 to placebo. After a median follow-up of 131 months (IQR 105–156), a 49% reduction in breast cancer was observed for anastrozole (85 vs 165 cases, hazard ratio [HR] 0·51, 95% CI 0·39–0·66, p<0·0001). The reduction was larger in the first 5 years (35 vs 89, 0·39, 0·27–0·58, p<0·0001), but still significant after 5 years (50 vs 76 new cases, 0·64, 0·45–0·91, p=0·014), and not significantly different from the first 5 years (p=0·087). Invasive oestrogen receptor-positive breast cancer was reduced by 54% (HR 0·46, 95% CI 0·33–0·65, p<0·0001), with a continued significant effect in the period after treatment. A 59% reduction in ductal carcinoma in situ was observed (0·41, 0·22–0·79, p=0·0081), especially in participants known to be oestrogen receptor-positive (0·22, 0·78–0·65, p<0·0001). No significant difference in deaths was observed overall (69 vs 70, HR 0·96, 95% CI 0·69–1·34, p=0·82) or for breast cancer (two anastrozole vs three placebo). A significant decrease in non-breast cancers was observed for anastrozole (147 vs 200, odds ratio 0·72, 95% CI 0·57–0·91, p=0·0042), owing primarily to non-melanoma skin cancer. No excess of fractures or cardiovascular disease was observed.
Interpretation: This analysis has identified a significant continuing reduction in breast cancer with anastrozole in the post-treatment follow-up period, with no evidence of new late side-effects. Further follow-up is needed to assess the effect on breast cancer mortality.
Funding: Cancer Research UK, the National Health and Medical Research Council Australia, Breast Cancer Research Foundation, Sanofi Aventis, and AstraZeneca.
Platelets participate in the development of liver fibrosis in animal models, but little is known about the benefit of antiplatelet agents in preventing liver fibrosis in humans. We therefore explored the relationship between the use of antiplatelet agents and liver fibrosis in a prospective cohort study of patients at high risk of liver fibrosis and cardiovascular events. Consecutive patients undergoing elective coronary angiography at the University Hospital Frankfurt were prospectively included in the present study. Associations between use of antiplatelet agents (acetyl salicylic acid, P2Y12 receptor antagonists) and liver fibrosis were assessed in regression models, and the relationship between platelet‐derived growth factor beta (PDGF‐β) serum concentration, platelets, liver fibrosis, and use of antiplatelet agents was characterized. Out of 505 included patients, 337 (67%) received antiplatelet agents and 134 (27%) had liver fibrosis defined as a FibroScan transient elastography (TE) value ≥7.9 kPa. Use of antiplatelet agents was inversely associated with the presence of liver fibrosis in univariate and multivariate analyses (multivariate odds ratio [OR], 0.67; 95% confidence interval [CI], 0.51‐0.89; P = 0.006). Use of antiplatelet agents was also inversely associated with FibroTest values (beta, –0.38; SD beta, 0.15; P = 0.02). Furthermore, there was a significant correlation between platelet counts and PDGF‐β serum concentration (rho, 0.33; P < 0.0001), but PDGF‐β serum levels were not affected by antiplatelet agents. Conclusion: There is a protective association between the use of antiplatelet agents and occurrence of liver fibrosis. A randomized controlled trial is needed to explore causality and the potential of antiplatelet agents as antifibrotic therapy in patients at risk for liver fibrosis progression.
Patients with acute myeloid leukemia (AML) are often exposed to broad-spectrum antibiotics and thus at high risk of Clostridioides difficile infections (CDI). As bacterial infections are a common cause for treatment-related mortality in these patients, we conducted a retrospective study to analyze the incidence of CDI and to evaluate risk factors for CDI in a large uniformly treated AML cohort. A total of 415 AML patients undergoing intensive induction chemotherapy between 2007 and 2019 were included in this retrospective analysis. Patients presenting with diarrhea and positive stool testing for toxin-producing Clostridioides difficile were defined to have CDI. CDI was diagnosed in 37 (8.9%) of 415 AML patients with decreasing CDI rates between 2013 and 2019 versus 2007 to 2012. Days with fever, exposition to carbapenems, and glycopeptides were significantly associated with CDI in AML patients. Clinical endpoints such as length of hospital stay, admission to ICU, response rates, and survival were not adversely affected. We identified febrile episodes and exposition to carbapenems and glycopeptides as risk factors for CDI in AML patients undergoing induction chemotherapy, thereby highlighting the importance of interdisciplinary antibiotic stewardship programs guiding treatment strategies in AML patients with infectious complications to carefully balance risks and benefits of anti-infective agents.
Use of drug-eluting balloon coronary intervention prior to living donor kidney transplantation
(2014)
Background: Kidney transplantation is the gold standard of therapy in patients with terminal renal insufficiency. Living donor transplantation is a well-established option in this field. Enlarging the donor's pool implicates the acceptance of an increased rate of comorbidities. Among them, coronary artery disease is a growing problem. An increasing number of patients, undergoing living donation, receive antiplatelet therapies due to coronary disease.
Case presentation: Here we report about the perioperative treatment with a drug-eluting balloon in a patient with major cardiac risk factors who underwent kidney transplantation.
Conclusion: At the current time no recommendation can be given for the routine use of drug-eluting balloons.
Abstract:
Snakebite is an important medical emergency in rural Nepal. Correct identification of the biting species is crucial for clinicians to choose appropriate treatment and anticipate complications. This is particularly important for neurotoxic envenoming which, depending on the snake species involved, may not respond to available antivenoms. Adequate species identification tools are lacking. This study used a combination of morphological and molecular approaches (PCR-aided DNA sequencing from swabs of bite sites) to determine the contribution of venomous and non-venomous species to the snakebite burden in southern Nepal. Out of 749 patients admitted with a history of snakebite to one of three study centres, the biting species could be identified in 194 (25.9%). Out of these, 87 had been bitten by a venomous snake, most commonly the Indian spectacled cobra (Naja naja; n = 42) and the common krait (Bungarus caeruleus; n = 22). When both morphological identification and PCR/sequencing results were available, a 100% agreement was noted. The probability of a positive PCR result was significantly lower among patients who had used inadequate “first aid” measures (e.g. tourniquets or local application of remedies). This study is the first to report the use of forensic genetics methods for snake species identification in a prospective clinical study. If high diagnostic accuracy is confirmed in larger cohorts, this method will be a very useful reference diagnostic tool for epidemiological investigations and clinical studies.
Author Summary:
Snakebite is an important medical problem in sub-tropical and tropical regions, including Nepal where tens of thousands of people are bitten every year. Snakebite can result in life-threatening envenoming, and correct identification of the biting species is crucial for care providers to choose appropriate treatment and anticipate complications. This paper explores a number of methods, including molecular techniques, to assist care providers in identifying the species responsible for bites in rural Nepal. Out of 749 patients with a history of snakebite, the biting species could be identified in 194 (25.9%). Out of these, 87 had been bitten by a venomous snake, most commonly cobras (n = 42) and kraits (n = 22). This study is the first to report the use of molecular techniques for snake species identification. The diagnostic accuracy of this method appears high but needs to be confirmed in larger studies.
There are many tools available that are used to evaluate a radiotherapy treatment plan, such as isodose distribution charts, dose volume histograms (DVH), maximum, minimum and mean doses of the dose distributions as well as DVH point dose constraints. All the already mentioned evaluation tools are dosimetric only without taking into account the radiobiological characteristics of tumors or OARs. It has been demonstrated that although competing treatment plans might have similar mean, maximum or minimum doses they may have significantly different clinical outcomes (Mavroidis et al. 2001). For performing a more complete treatment plan evaluation and comparison the complication-free tumor control probability (P+) and the biologically effective uniform dose (D ) have been proposed (Källman et al. 1992a, Mavroidis et al. 2000). The D concept denotes that any two dose distributions within a target or OAR are equivalent if they produce the same probability for tumor control or normal tissue complication, respectively (Mavroidis et al. 2001)...
Background: A growing interest exists in using polymeric nanoparticles (NPs) especially functionalized with surface-active substances as carriers across the blood brain barrier (BBB) for potentially effective drugs in traumatic brain injury (TBI). However, the organ distribution of intravenous administrated biodegradable and non-biodegradable NPs coated with different surfactants, how much of the administrated dose reach the brain parenchyma in areas with intact and opened BBB after trauma, as well as whether they elicit an inflammatory response is still to be clarified.
Methods: The organ distribution, brain penetration and eventual inflammatory activation of polysorbate-80 (Tw80) and sodium-lauryl-sulfate (SDS) coated poly l-lactide (PLLA) and perfluorodecyl acrylate (PFDL) nanoparticles were evaluated after intravenous administration in rats prior and after undergoing controlled cortical impact (CCI).
Results: A significant highest NP uptake at 4 and 24 hs was observed in the liver and spleen, followed by the brain and kidney, with minimal concentrations in the lungs and heart for all NPs. After CCI, a significant increase of NP uptake at 4 hs and 24 hs was observed within the traumatized hemisphere, especially in the perilesional area, although NPs were still found in areas away from CCI and the contralateral hemisphere in similar concentrations as in non-CCI subject. NPs were localized in neurons, glial and endovascular cells. Immunohistochemical staining against GFAP, Iba1, TNFα and IL1β demonstrated no glial activation or neuroinflamatory changes.
Conclusions: Tw80 and SDS coated biodegradable (PLLA) and non-biodegradrable (PFDL) NPs reach the brain parenchyma in both areas of traumatized and undamaged brain with disrupted and intact BBB, even though a high amount of them are retained in the liver and the spleen. No inflammatory reaction is elicited by these NPs within 24 hs after application. These preliminary promising results postulate the effectiveness and safety of these NPs as drug-carriers for the treatment of TBI.
Uncertainty is a central theme in the illness experiences of older cancer patients throughout their illness trajectory. Mishel’s popular theory on uncertainty during illness approaches uncertainty as an outcome and is characterized by the patient’s inability to find meaning in illness events. This study used the concepts of liminality and subjunctivity to explore uncertainty throughout the illness trajectory of cancer patients. We interviewed 18 older (age range = 57–92 years) patients with breast cancer or gastro-intestinal cancer 3 to 4 years post diagnosis. Our analysis is based on the QUAGOL guide that draws on elements of grounded theory such as constant comparison. We found that liminality and subjunctivity provide a useful frame for understanding uncertainty with a specific focus on its productive potential and meaning making. Health care professionals should be open to acquiring a complete picture of patients’ diverse and dynamic experiences of uncertainty in the different stages of their illness trajectory.
Few studies have looked at the potential of using diffusion tensor imaging (DTI) in conjunction with machine learning algorithms in order to automate the classification of healthy older subjects and subjects with mild cognitive impairment (MCI). Here we apply DTI to 40 healthy older subjects and 33 MCI subjects in order to derive values for multiple indices of diffusion within the white matter voxels of each subject. DTI measures were then used together with support vector machines (SVMs) to classify control and MCI subjects. Greater than 90% sensitivity and specificity was achieved using this method, demonstrating the potential of a joint DTI and SVM pipeline for fast, objective classification of healthy older and MCI subjects. Such tools may be useful for large scale drug trials in Alzheimer’s disease where the early identification of subjects with MCI is critical.
USP22 controls necroptosis by regulating receptor-interacting protein kinase 3 ubiquitination
(2020)
Dynamic control of ubiquitination by deubiquitinating enzymes is essential for almost all biological processes. Ubiquitin-specific peptidase 22 (USP22) is part of the SAGA complex and catalyzes the removal of mono-ubiquitination from histones H2A and H2B, thereby regulating gene transcription. However, novel roles for USP22 have emerged recently, such as tumor development and cell death. Apart from apoptosis, the relevance of USP22 in other programmed cell death pathways still remains unclear. Here, we describe a novel role for USP22 in controlling necroptotic cell death in human tumor cell lines. Loss of USP22 expression significantly delays TNFα/Smac mimetic/zVAD.fmk (TBZ)-induced necroptosis, without affecting TNFα-mediated NF-κB activation or extrinsic apoptosis. Ubiquitin remnant profiling identified receptor-interacting protein kinase 3 (RIPK3) lysines 42, 351, and 518 as novel, USP22-regulated ubiquitination sites during necroptosis. Importantly, mutation of RIPK3 K518 reduced necroptosis-associated RIPK3 ubiquitination and amplified necrosome formation and necroptotic cell death. In conclusion, we identify a novel role of USP22 in necroptosis and further elucidate the relevance of RIPK3 ubiquitination as crucial regulator of necroptotic cell death.
Oncogenic transformation of lung epithelial cells is a multistep process, frequently starting with the inactivation of tumour suppressors and subsequent development of activating mutations in proto-oncogenes, such as members of the PI3K or MAPK families. Cells undergoing transformation have to adjust to changes, including altered metabolic requirements. This is achieved, in part, by modulating the protein abundance of transcription factors. Here, we report that the ubiquitin carboxyl-terminal hydrolase 28 (USP28) enables oncogenic reprogramming by regulating the protein abundance of proto-oncogenes such as c-JUN, c-MYC, NOTCH and ∆NP63 at early stages of malignant transformation. USP28 levels are increased in cancer compared with in normal cells due to a feed-forward loop, driven by increased amounts of oncogenic transcription factors such as c-MYC and c-JUN. Irrespective of oncogenic driver, interference with USP28 abundance or activity suppresses growth and survival of transformed lung cells. Furthermore, inhibition of USP28 via a small-molecule inhibitor resets the proteome of transformed cells towards a ‘premalignant’ state, and its inhibition synergizes with clinically established compounds used to target EGFRL858R-, BRAFV600E- or PI3KH1047R-driven tumour cells. Targeting USP28 protein abundance at an early stage via inhibition of its activity is therefore a feasible strategy for the treatment of early-stage lung tumours, and the observed synergism with current standard-of-care inhibitors holds the potential for improved targeting of established tumours.
Highlights
• USP32 deubiquitinates the Ragulator complex subunit LAMTOR1 at lysine (K) 20
• LAMTOR1 K20 ubiquitination impairs its binding to the vacuolar H+-ATPase
• USP32 knockout reduces mTORC1 activity and elevates autophagic flux
• Depletion of USP32 in Caenorhabditis elegans inhibits mTOR and induces autophagy
Summary
The endosomal-lysosomal system is a series of organelles in the endocytic pathway that executes trafficking and degradation of proteins and lipids and mediates the internalization of nutrients and growth factors to ensure cell survival, growth, and differentiation. Here, we reveal regulatory, non-proteolytic ubiquitin signals in this complex system that are controlled by the enigmatic deubiquitinase USP32. Knockout (KO) of USP32 in primary hTERT-RPE1 cells results among others in hyperubiquitination of the Ragulator complex subunit LAMTOR1. Accumulation of LAMTOR1 ubiquitination impairs its interaction with the vacuolar H+-ATPase, reduces Ragulator function, and ultimately limits mTORC1 recruitment. Consistently, in USP32 KO cells, less mTOR kinase localizes to lysosomes, mTORC1 activity is decreased, and autophagy is induced. Furthermore, we demonstrate that depletion of USP32 homolog CYK-3 in Caenorhabditis elegans results in mTOR inhibition and autophagy induction. In summary, we identify a control mechanism of the mTORC1 activation cascade at lysosomes via USP32-regulated LAMTOR1 ubiquitination.
The mitotic spindle assembly checkpoint (SAC) maintains genome stability and marks an important target for antineoplastic therapies. However, it has remained unclear how cells execute cell fate decisions under conditions of SAC‐induced mitotic arrest. Here, we identify USP9X as the mitotic deubiquitinase of the X‐linked inhibitor of apoptosis protein (XIAP) and demonstrate that deubiquitylation and stabilization of XIAP by USP9X lead to increased resistance toward mitotic spindle poisons. We find that primary human aggressive B‐cell lymphoma samples exhibit high USP9X expression that correlate with XIAP overexpression. We show that high USP9X/XIAP expression is associated with shorter event‐free survival in patients treated with spindle poison‐containing chemotherapy. Accordingly, aggressive B‐cell lymphoma lines with USP9X and associated XIAP overexpression exhibit increased chemoresistance, reversed by specific inhibition of either USP9X or XIAP. Moreover, knockdown of USP9X or XIAP significantly delays lymphoma development and increases sensitivity to spindle poisons in a murine Eμ‐Myc lymphoma model. Together, we specify the USP9X–XIAP axis as a regulator of the mitotic cell fate decision and propose that USP9X and XIAP are potential prognostic biomarkers and therapeutic targets in aggressive B‐cell lymphoma.
Aim: To study the changes in leiomyoma volume following uterine artery embolization (UAE) and to correlate these changes with the initial leiomyoma volume and location within the uterus and to evaluate the impact of preprocedural prediction of the best tube angle obliquity for visualization of the uterine artery origin using 3D-reconstructed contrast-enhanced MR angiography (CE-MRA) on the radiation dose, fluoroscopy time and contrast medium volume used during UAE. Materials and Methods: The study was performed in two parts. The first part was retrospectively done on 28 patients (age range: 37-57 years, mean: 48 years, SD: 4.81) in whom UAE was performed. All leiomyomas in all patients were evaluated. In total, 84 leiomyomas were evaluated. MRI studies were performed before, 3 months and 1 year after UAE. The volumes and location of each leiomyoma in each patient were evaluated in consensus by two radiologists. The second part included 40 consecutive patients (age range: 37-56 years, mean: 46 years, SD: 4.49) and was done in a controlled prospective/retrospective manner. In 20 sample patients (prospective part) pre-procedural prediction of the best tube angle obliquity was predicted using 3D-reconstructed CE-MRA and provided to the interventionalist. 3D-reconstruction was done using Inspace application. The radiation dose, fluoroscopy time and contrast medium volume for those patients were compared with the data of the last 20 procedures (control) performed by the same interventionalist (retrospective part). Results: For the first part the mean pre-embolization volume was 51.6 cm3 range:0.72-371.1cm3, SD=79.3). At 3-month follow-up 83 (98.8%) leiomyomas showed a mean volume reduction of 52.62% (range: 12.79–96.67%, SD=21.85) and 1 leiomyoma (1.2%) increased in volume. At 1-year follow-up 5 (6%) leiomyomas were not detectable, 72 (85.7%) showed a further mean of 20.5% (range: 2.52–58.72%, SD=11.92) volume reduction compared to the 3-month follow-up volume and 7 (8.3%) leiomyomas increased in volume. A statistically significant (p=0.026 at 3-month, p=0.0046 at 1-year) difference in percentage of volume change was observed based on leiomyoma location; submucous leiomyomas showed the largest volume reduction. The initial leiomyoma volume showed a weak negative correlation (Spearman's correlation-coefficient =-0.35 at 3m and -0.36 at 1y) with the leiomyoma volume change. For the second part the tube angle prediction resulted in a significant reduction of the radiation dose utilized (p<0.001), fluoroscopy time (p=0.002) and contrast medium volume (p<0.001) for the sample patients when compared with the control patients. The overall radiation dose was reduced from a mean of 11044 μGym2 to a mean of 4172.5 μGym2, fluoroscopy time was reduced from a mean of 15.45 minutes to 8.81 minutes and contrast medium volume was reduced from a mean of 135 ml to 75 ml. Conclusion: UAE results in significant leiomyoma volume reduction at 3-month and 1- year follow-up. The leiomyoma location plays an important role in volume changes while the initial leiomyoma volume plays a minor role. Pre-procedural prediction of the best tube angle obliquity for visualization of the origin of the uterine artery using 3D-reconstructed CE-MRA results in a significant reduction of the radiation dose, fluoroscopy time and contrast medium volume used during UAE.
The plaque reduction neutralization test (PRNT) is a preferred method for the detection of functional, SARS-CoV-2 specific neutralizing antibodies from serum samples. Alternatively, surrogate enzyme-linked immunosorbent assays (ELISAs) using ACE2 as the target structure for the detection of neutralization-competent antibodies have been developed. They are capable of high throughput, have a short turnaround time, and can be performed under standard laboratory safety conditions. However, there are very limited data on their clinical performance and how they compare to the PRNT. We evaluated three surrogate immunoassays (GenScript SARS-CoV-2 Surrogate Virus Neutralization Test Kit (GenScript Biotech, Piscataway Township, NJ, USA), the TECO® SARS-CoV-2 Neutralization Antibody Assay (TECOmedical AG, Sissach, Switzerland), and the Leinco COVID-19 ImmunoRank™ Neutralization MICRO-ELISA (Leinco Technologies, Fenton, MO, USA)) and one automated quantitative SARS-CoV-2 Spike protein-based IgG antibody assay (Abbott GmbH, Wiesbaden, Germany) by testing 78 clinical samples, including several follow-up samples of six BNT162b2 (BioNTech/Pfizer, Mainz, Germany/New York, NY, USA) vaccinated individuals. Using the PRNT as a reference method, the overall sensitivity of the examined assays ranged from 93.8 to 100% and specificity ranged from 73.9 to 91.3%. Weighted kappa demonstrated a substantial to almost perfect agreement. The findings of our study allow these assays to be considered when a PRNT is not available. However, the latter still should be the preferred choice. For optimal clinical performance, the cut-off value of the TECO assay should be individually adapted.
Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
(2019)
Background: The COBAS AmpliPrep/COBAS TaqMan assay HCV (CAP/CTM) is widely used in clinical routine for HCV testing. Recently, the new cobas HCV test was established for high throughput testing with minimal operator intervention. As different assays may yield different quantitative/qualitative results that possibly impact treatment decisions, the aim of this study was to externally evaluate the cobas HCV test performance in comparison to CAP/CTM in a clinically relevant setting.
Methods: Serum samples were obtained from 270 patients who received direct acting antiviral therapy with different treatment regimens at two study sites (Hannover and Frankfurt) in 2016. Overall, 1545 samples (baseline, on-treatment and follow-up) were tested in parallel by both assays.
Results: The mean difference between cobas HCV and CAP/CTM for the quantification of HCV RNA was 0.008 log10 IU/ml HCV RNA (95% limits of agreement: -0.02–0.036) showing excellent agreement of both assays. With respect to clinical cut offs (HCV RNA detectable vs. target not detected and HCV RNA above the lower limit of quantification (LLOQ) vs. <LLOQ), discordant results were obtained in 9.5% and 4.6%, respectively; the greatest differences were observed during early stages of antiviral therapy (week 1, week 2 and week 4), but none were statistically significant. Overall percent agreement for SVR between cobas HCV and CAP/CTM at the 15 IU/ml cutoff was 99.2% (95%CI 92.7%-100%).
Conclusion: The performance of the new cobas HCV test was comparable to CAP/CTM in a clinical setting representing a large patient population with HCV GT 1 and 3 treated with DAAs.
Objectives: We aimed to investigate the contemporary usage rate and habits of the WHO Surgical Safety Checklist (SSC) in German urological departments.
Methods: We designed a 26-item questionnaire that was sent to all urological departments in Germany. The primary aim of this study was to evaluate the usage rate of the SSC. Secondary aims were to compare perioperative characteristics of users vs. non-users of the SSC and to assess circumstances of the SSC application.
Results: A total of 213 of 234 (91 %) urological departments were users of the SSC, and 21 (9 %) were non-users. SSC users had more often a standard protocol, took less time and had fewer people involved for checking perioperative patient data compared to non-users. Financial budgeting for the SSC existed in 55 (24 %) departments and for patient safety in 73 (32 %) departments.
Conclusions: The usage rate of the SSC in urological departments in Germany is high despite restricted financial budgeting. Users of the SSC profit by saving time and manpower for checking perioperative patient data.
Human endogenous retrovirus (HERV) genomes are chromosomally integrated in all cells of an individual. They are normally transcriptionally silenced and transmitted only vertically. Enhanced expression of HERV-K accompanied by the emergence of anti-HERV-K-directed immune responses has been observed in tumor patients and HIV-infected individuals. As HERV-K is usually not expressed and immunological tolerance development is unlikely, it is an appropriate target for the development of immunotherapies. We generated a recombinant vaccinia virus (MVA-HKenv) expressing the HERV-K envelope glycoprotein (ENV), based on the modified vaccinia virus Ankara (MVA), and established an animal model to test its vaccination efficacy. Murine renal carcinoma cells (Renca) were genetically altered to express E. coli beta-galactosidase (RLZ cells) or the HERV-K ENV gene (RLZ-HKenv cells). Intravenous injection of RLZ-HKenv cells into syngenic BALB/c mice led to the formation of pulmonary metastases, which were detectable by X-gal staining. A single vaccination of tumor-bearing mice with MVA-HKenv drastically reduced the number of pulmonary RLZ-HKenv tumor nodules compared to vaccination with wild-type MVA. Prophylactic vaccination of mice with MVA-HKenv precluded the formation of RLZ-HKenv tumor nodules, whereas wild-type MVA-vaccinated animals succumbed to metastasis. Protection from tumor formation correlated with enhanced HERV-K ENV-specific killing activity of splenocytes. These data demonstrate for the first time that HERV-K ENV is a useful target for vaccine development and might offer new treatment opportunities for diverse types of cancer.
Nosocomial infectious diseases (e.g. influenza, pertussis) are a threat particularly for immunocompromised and vulnerable patients. Although vaccination of healthcare workers (HCWs) constitutes the most convenient and effective means to prevent nosocomial transmissions, vaccine uptake among HCWs remains unacceptably low. Worldwide, numerous studies have demonstrated that nurses have lower vaccination rates than physicians and that there is a relationship between receipt of vaccination by HCWs and knowledge. Measures to improve vaccination rates need to be profession-sensitive as well as specific in their approach in order to achieve sustained success.
Background: There are no validated standardised clinical procedures for severity measurement of acute bronchitis in children. The "BSS-ped", a short version of the physician-rated assessment scale BSS (Bronchitis Severity Scale), can fill this gap, if it is valid.
Objective: To examine the scale´s validity.
Methods: Investigations were planned according to classical clinical-psychometric validity criteria including a formal competence evaluation of the scale´s authors and statistical analyses of data from 78 patients aged 1-6 and diagnosed with "acute bronchitis". Cross-validation was provided by analysis of data from 70 children with matching age, sex and diagnosis. All children were examined three times (day 0, 3-5 and 7) using the BSS-ped in addition to other clinical and psychometric monitoring procedures.
Results: The evidently high level of expertise of the scale’s authors substantiates pronounced content validity and relevance of the BSS-ped and its items. The validity criterion, i.e. to reflect the unidimensional severity of acute bronchitis and its change using the BSS-ped score, was fulfilled. There were substantial correlations with other scales measuring the current health-related quality of life, as well as satisfaction and success of treatment. Severity change prognoses for acute bronchitis under placebo and an active substance were correct. The BSS-ped was found to be a feasible instrument because it can be repeated at short intervals (minute range) without any special technical aids or extended training.
Conclusion: The BSS-ped is a valid procedure for measuring the severity of acute bronchitis in children.
Biological exploration of early biomarkers for chronic kidney disease (CKD) in (pre)diabetic individuals is crucial for personalized management of diabetes. Here, we evaluated two candidate biomarkers of incident CKD (sphingomyelin (SM) C18:1 and phosphatidylcholine diacyl (PC aa) C38:0) concerning kidney function in hyperglycemic participants of the Cooperative Health Research in the Region of Augsburg (KORA) cohort, and in two biofluids and six organs of leptin receptor-deficient (db/db) mice and wild type controls. Higher serum concentrations of SM C18:1 and PC aa C38:0 in hyperglycemic individuals were found to be associated with lower estimated glomerular filtration rate (eGFR) and higher odds of CKD. In db/db mice, both metabolites had a significantly lower concentration in urine and adipose tissue, but higher in the lungs. Additionally, db/db mice had significantly higher SM C18:1 levels in plasma and liver, and PC aa C38:0 in adrenal glands. This cross-sectional human study confirms that SM C18:1 and PC aa C38:0 associate with kidney dysfunction in pre(diabetic) individuals, and the animal study suggests a potential implication of liver, lungs, adrenal glands, and visceral fat in their systemic regulation. Our results support further validation of the two phospholipids as early biomarkers of renal disease in patients with (pre)diabetes.
Background: Transplantation of human corneal tissue is associated with the potential risk of transmittance of viral infections. In accordance with European directives and federal laws, in Germany each tissue donor has to be tested for infectious diseases such as hepatitis B and C virus (HBV and HCV) and human immunodeficiency virus (HIV) infection. However, most of the currently available CE-marked serologic and nucleic acid screening systems are only validated for antemortem blood. Methods: Twenty related and paired ante- and postmortem blood samples from cornea donors were obtained and subsequently analyzed for hepatitis B surface antigen (HBsAg), hepatitis B antibody (anti-HBc), anti-HCV, HCV RNA, anti-HIV-1/2, and HIV p24 Ag using Abbott test systems. The sera were also spiked with reference materials in concentrations giving low and high positivity for HBV, HCV, and HIV markers. Results: The spiked ante- and postmortem sera from related donors showed similar results for HBsAg, anti-HBc, anti-HCV, HCV RNA, anti-HIV, and HIV p24 Ag, indicating a high stability of viral markers in cadaveric specimens. Three cornea donors had a medical history of HBV infection and revealed anti-HBc at similar levels in the ante- and postmortem sera. In addition, there was a single postmortem sample demonstrating a weak signal of anti-HIV-1 and HIV-1 p24 Ag. False-positive or false-negative results were not detected. The results obtained with the Abbott ARCHITECT analyzer and Abbott RealTime HCV PCR showed no significant differences. Conclusion: The analyzed screening assays are suitable for the detection of infectious markers of HBV, HCV, and HIV at similar levels in spiked ante- and postmortem sera from cornea donors.
Background/Objectives: Agility and cognitive abilities are typically assessed separately by different motor and cognitive tests. While many agility tests lack a reactive decision-making component, cognitive assessments are still mainly based on computer-based or paper-pencil tests with low ecological validity. This study is the first to validate the novel SKILLCOURT technology as an integrated assessment tool for agility and cognitive-motor performance.
Methods: Thirty-two healthy adults performed agility (Star Run), reactive agility (Random Star Run) and cognitive-motor (executive function test, 1-back decision making) performance assessments on the SKILLCOURT. Cognitive-motor tests included lower limb responses in a standing position to increase the ecological validity when compared to computer-based tests. Test results were compared to established motor and agility tests (countermovement jump, 10 m linear sprint, T-agility tests) as well as computer-based cognitive assessments (choice-reaction, Go-NoGo, task switching, memory span). Correlation and multiple regression analyses quantified the relation between SKILLCOURT performance and motor and cognitive outcomes.
Results: Star Run and Random Star Run tests were best predicted by linear sprint (r = 0.68, p < 0.001) and T-agility performance (r = 0.77, p < 0.001), respectively. The executive function test performance was well explained by computer-based assessments on choice reaction speed and cognitive flexibility (r = 0.64, p < 0.001). The 1-back test on the SKILLCOURT revealed moderate but significant correlations with the computer-based assessments (r = 0.47, p = 0.007).
Conclusion: The results support the validity of the SKILLCOURT technology for agility and cognitive assessments in more ecologically valid cognitive-motor tasks. This technology provides a promising alternative to existing performance assessment tools.
Whereas the lack of biomarkers in penile cancer (PeCa) impedes the development of efficacious treatment protocols, preliminary evidence suggests that c-MET and associated signaling elements may be dysregulated in this disorder. In the following study, we investigated whether c-MET and associated key molecular elements may have prognostic and therapeutic utility in PeCa. Formalin-fixed, paraffin-embedded tumor tissue from therapy-naïve patients with invasive PeCa was used for tissue microarray (TMA) analysis. Immunohistochemical staining was performed to determine the expression of the proteins c-MET, PPARg, β-catenin, snail, survivin, and n-MYC. In total, 94 PeCa patients with available tumor tissue were included. The median age was 64.9 years. High-grade tumors were present in 23.4%, and high-risk HPV was detected in 25.5%. The median follow-up was 32.5 months. High expression of snail was associated with HPV-positive tumors. Expression of β-catenin was inversely associated with grading. In both univariate COX regression analysis and the log-rank test, an increased expression of PPARg and c-MET was predictive of inferior disease-specific survival (DSS). Moreover, in multivariate analysis, a higher expression of c-MET was independently associated with worse DSS. Blocking c-MET with cabozantinib and tivantinib induced a significant decrease in viability in the primary PeCa cell line UKF-PeC3 isolated from the tumor tissue as well as in cisplatin- and osimertinib-resistant sublines. Strikingly, a higher sensitivity to tivantinib could be detected in the latter, pointing to the promising option of utilizing this agent in the second-line treatment setting.
Rationale and Objectives: Bone non-union is a serious complication of distal radius fractures (DRF) that can result in functional limitations and persistent pain. However, no accepted method has been established to identify patients at risk of developing bone non-union yet. This study aimed to compare various CT-derived metrics for bone mineral density (BMD) assessment to identify predictive values for the development of bone non-union.
Materials and Methods: CT images of 192 patients with DRFs who underwent unenhanced dual-energy CT (DECT) of the distal radius between 03/2016 and 12/2020 were retrospectively identified. Available follow-up imaging and medical health records were evaluated to determine the occurrence of bone non-union. DECT-based BMD, trabecular Hounsfield unit (HU), cortical HU and cortical thickness ratio were measured in normalized non-fractured segments of the distal radius.
Results: Patients who developed bone non-union were significantly older (median age 72 years vs. 54 years) and had a significantly lower DECT-based BMD (median 68.1 mg/cm3 vs. 94.6 mg/cm3, p < 0.001). Other metrics (cortical thickness ratio, cortical HU, trabecular HU) showed no significant differences. ROC and PR curve analyses confirmed the highest diagnostic accuracy for DECT-based BMD with an area under the curve (AUC) of 0.83 for the ROC curve and an AUC of 0.46 for the PR curve. In logistic regression models, DECT-based BMD was the sole metric significantly associated with bone non-union.
Conclusion: DECT-derived metrics can accurately predict bone non-union in patients who sustained DRF. The diagnostic performance of DECT-based BMD is superior to that of HU-based metrics and cortical thickness ratio.
Background. The aim of this study was to show the importance of the bone marker procollagen type 1 aminoterminal propeptide (P1NP) in detecting bone metastases in women suffering from breast cancer. We furthermore investigated to what degree P1NP is correlated to the degree of bone metastases, and if P1NP is increased in patients with metastases other than bone. Patients and Methods. We analyzed 80 serum samples of women (17 premenopausal/63 postmenopausal) with breast cancer. Therefore we used a specific immunoassay “ELECSYS 2010” by Roche Diagnostics. We divided our group of patients with regard to menopausal status, sites of metastases and number of bone metastases. Results. As a result we found higher concentrations of P1NP in women with radiologically confirmed bone metastases (median: 125.75 ng/mL) in comparison to the collective without bone involvement (median: 73.61 ng/mL). However, both groups showed values above the applied cutoff values of median 27.8 ng/mL for premenopausal women and median: 37.1 ng/mL for the postmenopausal group due to the fact that all patients had cancer. Furthermore higher P1NP concentrations were found in women with more than 5 sites of bone metastases (median: 183.9 ng/mL) than in patients with only one site of bone metastases (median: 37 ng/mL). Also patients with no bone involvement but other sites of metastases showed quite high P1NP concentrations (median: 73.61 ng/mL). Conclusion. The marker of bone turnover procollagen type 1 aminoterminal propeptide can be considered as a useful tool for estimating the extent of bone involvement and for the detection of bone metastases. P1NP cannot replace conventional methods for detecting bone metastases such as radiological methods but it can help clarify unclear radiological results. This study does not take into account the change of P1NP concentration during the course of therapy.
Background: Computed tomography (CT) allows estimation of coronary artery calcium (CAC) progression. We evaluated several progression algorithms in our unselected, population-based cohort for risk prediction of coronary and cardiovascular events.
Methods: In 3281 participants (45–74 years of age), free from cardiovascular disease until the second visit, risk factors, and CTs at baseline (b) and after a mean of 5.1 years (5y) were measured. Hard coronary and cardiovascular events, and total cardiovascular events including revascularization, as well, were recorded during a follow-up time of 7.8±2.2 years after the second CT. The added predictive value of 10 CAC progression algorithms on top of risk factors including baseline CAC was evaluated by using survival analysis, C-statistics, net reclassification improvement, and integrated discrimination index. A subgroup analysis of risk in CAC categories was performed.
Results: We observed 85 (2.6%) hard coronary, 161 (4.9%) hard cardiovascular, and 241 (7.3%) total cardiovascular events. Absolute CAC progression was higher with versus without subsequent coronary events (median, 115 [Q1–Q3, 23–360] versus 8 [0–83], P<0.0001; similar for hard/total cardiovascular events). Some progression algorithms added to the predictive value of baseline CT and risk assessment in terms of C-statistic or integrated discrimination index, especially for total cardiovascular events. However, CAC progression did not improve models including CAC5y and 5-year risk factors. An excellent prognosis was found for 921 participants with double-zero CACb=CAC5y=0 (10-year coronary and hard/total cardiovascular risk: 1.4%, 2.0%, and 2.8%), which was for participants with incident CAC 1.8%, 3.8%, and 6.6%, respectively. When CACb progressed from 1 to 399 to CAC5y≥400, coronary and total cardiovascular risk were nearly 2-fold in comparison with subjects who remained below CAC5y=400. Participants with CACb≥400 had high rates of hard coronary and hard/total cardiovascular events (10-year risk: 12.0%, 13.5%, and 30.9%, respectively).
Conclusions: CAC progression is associated with coronary and cardiovascular event rates, but adds only weakly to risk prediction. What counts is the most recent CAC value and risk factor assessment. Therefore, a repeat scan >5 years after the first scan may be of additional value, except when a double-zero CT scan is present or when the subjects are already at high risk.
Sudden cardiac death (SCD) in adolescents and young adults may be the first manifestation of an inherited arrhythmic syndrome. Thus identification of a genetic origin in sudden death cases deemed inconclusive after a comprehensive autopsy and may help to reduce the risk of lethal episodes in the remaining family. Using next-generation sequencing (NGS), a large number of variants of unknown significance (VUS) are detected. In the majority of cases, there is insufficient evidence of pathogenicity, representing a huge dilemma in current genetic investigations. Misinterpretation of such variants may lead to inaccurate genetic diagnoses and/or the adoption of unnecessary and/or inappropriate therapeutic approaches. In our study, we applied current (ACMG) recommendations for variant classification in post-mortem genetic screening of a cohort of 56 SCD victims. We identified a total 53 rare protein-altering variants (MAF < 0.2%) classified as VUS or worse. Twelve percent of the cases exhibited a clinically actionable variant (pathogenic, likely pathogenic or VUS – potentially pathogenic) that would warrant cascade genetic screening in relatives. Most of the variants detected by means of the post-mortem genetic investigations were VUS. Thus, genetic testing by itself might be fairly meaningless without supporting background data. This data reinforces the need for an experienced multidisciplinary team for obtaining reliable and accountable interpretations of variant significance for elucidating potential causes for SCDs in the young. This enables the early identification of relatives at risk or excludes family members as genetic carriers. Also, development of adequate forensic guidelines to enable appropriate interpretation of rare genetic variants is fundamental.
The genetics responsible for the inter-individually variable G-CSF responsiveness remain elusive. A single nucleotide polymorphism (SNP) in the 3’UTR of CXCL12, rs1801157, was implicated in X4-tropic HiV susceptibility and later, in two small studies, in G-CSR responsiveness in patients and donors. The position of the SNP in the 3’UTR together with in-silico predictions suggested differential binding of micro-RNA941 as an underlying mechanism. In a cohort of 515 healthy stem cell donors we attempted to reproduce the correlation of the CXCL12 3’UTR SNP and mobilization responses and tested the role of miR941 in this context. The SNP was distributed with the expected frequency. Mobilization efficiency for CD34+ cells in WT, heterozygous and homozygous SNP individuals was indistinguishable, even after controlling for gender. miR941 expression in non-hematopoietic bone marrow cells was undetectable and miR941 did not interact with the 3’ UTR of CXCL12. Proposed effects of the SNP rs1801157 on G-CSF responsiveness cannot be confirmed in a larger cohort.
Background: Recently, RBFOX1, a gene encoding an RNA binding protein, has consistently been associated with aggressive and antisocial behavior. Several loci in the gene have been nominally associated with aggression in genome-wide association studies, the risk alleles being more frequent in the general population. We have hence examined the association of four RBFOX1 single nucleotide polymorphisms, previously found related to aggressive traits, with aggressiveness, personality, and alcohol use disorder in birth cohort representative samples.
Methods: We used both birth cohorts of the Estonian Children Personality Behavior and Health Study (ECPBHS; original n = 1,238). Aggressiveness was assessed using the Buss–Perry Aggression Questionnaire and the Lifetime History of Aggressiveness structured interview at age 25 (younger cohort) or 33 (older cohort). Big Five personality at age 25 was measured with self-reports and the lifetime occurrence of alcohol use disorder assessed with the MINI interview. RBFOX1 polymorphisms rs809682, rs8062784, rs12921846, and rs6500744 were genotyped in all participants. Given the restricted size of the sample, correction for multiple comparisons was not applied.
Results: Aggressiveness was not significantly associated with the RBFOX1 genotype. RBFOX1 rs8062784 was associated with neuroticism and rs809682 with extraversion. Two out of four analyzed RBFOX1 variants, rs8062784 and rs12921846, were associated with the occurrence of alcohol use disorder.
Conclusions: In the birth cohort representative sample of the ECPBHS, no association of RBFOX1 with aggressiveness was found, but RBFOX1 variants affected basic personality traits and the prevalence of alcohol use disorder. Future studies on RBFOX1 should consider the moderating role of personality and alcohol use patterns in aggressiveness.
Background: In oldest-old patients (>80), few trials showed efficacy of treating hypertension and they included mostly the healthiest elderly. The resulting lack of knowledge has led to inconsistent guidelines, mainly based on systolic blood pressure (SBP), cardiovascular disease (CVD) but not on frailty despite the high prevalence in oldest-old. This may lead to variation how General Practitioners (GPs) treat hypertension. Our aim was to investigate treatment variation of GPs in oldest-olds across countries and to identify the role of frailty in that decision.
Methods: Using a survey, we compared treatment decisions in cases of oldest-old varying in SBP, CVD, and frailty. GPs were asked if they would start antihypertensive treatment in each case. In 2016, we invited GPs in Europe, Brazil, Israel, and New Zealand. We compared the percentage of cases that would be treated per countries. A logistic mixed-effects model was used to derive odds ratio (OR) for frailty with 95% confidence intervals (CI), adjusted for SBP, CVD, and GP characteristics (sex, location and prevalence of oldest-old per GP office, and years of experience). The mixed-effects model was used to account for the multiple assessments per GP.
Results: The 29 countries yielded 2543 participating GPs: 52% were female, 51% located in a city, 71% reported a high prevalence of oldest-old in their offices, 38% and had >20 years of experience. Across countries, considerable variation was found in the decision to start antihypertensive treatment in the oldest-old ranging from 34 to 88%. In 24/29 (83%) countries, frailty was associated with GPs’ decision not to start treatment even after adjustment for SBP, CVD, and GP characteristics (OR 0.53, 95%CI 0.48–0.59; ORs per country 0.11–1.78).
Conclusions: Across countries, we found considerable variation in starting antihypertensive medication in oldest-old. The frail oldest-old had an odds ratio of 0.53 of receiving antihypertensive treatment. Future hypertension trials should also include frail patients to acquire evidence on the efficacy of antihypertensive treatment in oldest-old patients with frailty, with the aim to get evidence-based data for clinical decision-making.
Background: Standardization in clinical practice may lead to improved outcomes. Unfortunately, little is known about the variability of non-pharmacological anti-infective measures in children with cancer.
Design and Methods: A web-based survey assessed institutional recommendations regarding restrictions of social contacts, pets and food and instructions on wearing face masks in public for children with standard- risk acute lymphoblastic leuk emia and acute myeloid leukemia during intensive chemotherapy.
Results: A total of 336 institutions in 27 countries responded to the survey (range, 1-76 institutions per country; overall response rate 61%). Most institutions recommend that patients with acute myeloid leukemia avoid indoor public places and daycare, kindergarten and school, whereas recommendations for patients with acute lymphoblastic leukemia differ considerably by institution. In terms of restrictions related to pets, there was a wide variability between institutions for both acute lymphoblastic and acute myeloid leukemia patients. Most, but not all institutions do not allow children with either acute lymphoblastic or acute myeloid leukemia to eat raw meat, raw seafood or unpasteurized milk. Whereas most institutions do not routinely recommend that patients with acute lymphoblastic leukemia wear face masks in public, advice on this matter varies for patients with acute myeloid leukemia.
Conclusions: The survey demonstrates that there is a wide variation in recommendations on non-pharmacological anti-infective measures between different institutions, countries and continents. This information may be used to encourage harmonization of supportive care practices and future clinical trials.
Background: Bipolar disorder is associated with circadian disruption and a high risk of suicidal behavior. In a previous exploratory study of patients with bipolar I disorder, we found that a history of suicide attempts was associated with differences between winter and summer levels of solar insolation. The purpose of this study was to confirm this finding using international data from 42% more collection sites and 25% more countries. Methods: Data analyzed were from 71 prior and new collection sites in 40 countries at a wide range of latitudes. The analysis included 4876 patients with bipolar I disorder, 45% more data than previously analyzed. Of the patients, 1496 (30.7%) had a history of suicide attempt. Solar insolation data, the amount of the sun’s electromagnetic energy striking the surface of the earth, was obtained for each onset location (479 locations in 64 countries). Results: This analysis confirmed the results of the exploratory study with the same best model and slightly better statistical significance. There was a significant inverse association between a history of suicide attempts and the ratio of mean winter insolation to mean summer insolation (mean winter insolation/mean summer insolation). This ratio is largest near the equator which has little change in solar insolation over the year, and smallest near the poles where the winter insolation is very small compared to the summer insolation. Other variables in the model associated with an increased risk of suicide attempts were a history of alcohol or substance abuse, female gender, and younger birth cohort. The winter/summer insolation ratio was also replaced with the ratio of minimum mean monthly insolation to the maximum mean monthly insolation to accommodate insolation patterns in the tropics, and nearly identical results were found. All estimated coefficients were significant at p < 0.01. Conclusion: A large change in solar insolation, both between winter and summer and between the minimum and maximum monthly values, may increase the risk of suicide attempts in bipolar I disorder. With frequent circadian rhythm dysfunction and suicidal behavior in bipolar disorder, greater understanding of the optimal roles of daylight and electric lighting in circadian entrainment is needed.
Vascular biotransformation of organic nitrates is independent of cytochrome P450 monooxygenases
(2021)
Background and Purpose: Organic nitrates such as nitroglycerin (NTG) or pentaerythritol tetranitrate (PETN) have been used for over a century in the treatment of angina or ischaemic heart disease. These compounds are prodrugs which release their nitrovasodilators upon enzymic bioactivation by aldehyde dehydrogenase (ALDH2) or cytochromes P450 (CYP). Whereas ALDH2 is known to directly activate organic nitrates in vessels, the contribution of vascular CYPs is unknown and was studied here.
Experimental Approach: As all CYPs depend on cytochrome P450 reductase (POR) as electron donor, we generated a smooth muscle cell-specific, inducible knockout mouse of POR (smcPOR−/−) to investigate the contribution of POR/CYP to vascular biotransformation of organic nitrates.
Key Results: Microsomes containing recombinant CYPs expressed in human vascular tissues released nitrite from NTG and PETN with CYP2C9 and CYP2C8 being most efficient. SFK525, a CYP suicide inhibitor, blocked this effect. smcPOR−/− mice exhibited no obvious cardiovascular phenotype (normal cardiac weight and endothelium-dependent relaxation) and plasma and vascular nitrite production was similar to control (CTL) animals. NTG- and PETN-induced relaxation of isolated endothelium-intact or endothelium-denuded vessels were identical between CTL and smcPOR−/−. Likewise, nitrite release from organic nitrates in aortic rings was not affected by deletion of POR in smooth muscle cells (SMCs). In contrast, inhibition of ALDH2 by benomyl (10 μM) inhibited NTG-induced nitrite production and relaxation. Deletion of POR did not modulate this response.
Conclusions and Implications: Our data suggest that metabolism by vascular CYPs does not contribute to the pharmacological function of organic nitrates.
Characteristically, most solid tumors exhibit an increased tumor interstitial fluid pressure (TIFP) that directly contributes to the lowered uptake of macromolecular therapeutics into the tumor interstitium. Abnormalities in the tumor-associated lymph vessels are a central brick in the development and prolonged sustaining of an increased TIFP. In the current study, vascular endothelial growth factor C (VEGF-C) was used to enhance tumor-associated lymphangiogenesis as a new mechanism to actively reduce the TIFP by increased lymphatic drainage of the tumor tissue. Human A431 epidermoid vulva carcinoma cells were inoculated in NMRI nu/nu mice to generate a xenograft mouse model. Seven days after tumor cell injection, VEGF-C was peritumorally injected to induce lymphangiogenesis. Tumor growth and TIFP was lowered significantly over time in VEGF-C-treated tumors in comparison to control or VEGF-A-treated animals. These data demonstrate for the first time that actively induced lymphangiogenesis can lower the TIFP in a xenograft tumor model and apparently reduce tumor growth. This model represents a novel approach to modulate biomechanical properties of the tumor interstitium enabling a lowering of TIFP in vivo.
Background Vasoplegic syndrome is frequently observed during cardiac surgery and resembles a complication of high mortality and morbidity. There is a clinical need for therapy and prevention of vasoplegic syndrome during complex cardiac surgical procedures. Therefore, we investigated different strategies in a porcine model of vasoplegia.
Methods We evaluated new medical therapies and prophylaxis to avoid vasoplegic syndrome in a porcine model. After induction of anesthesia, cardiopulmonary bypass was established through median sternotomy and central cannulation. Prolonged aortic cross-clamping (120 min) simulated a complex surgical procedure. The influence of sevoflurane-guided anesthesia (sevoflurane group) and the administration of glibenclamide (glibenclamide group) were compared to a control group, which received standard anesthesia using propofol. Online hemodynamic assessment was performed using PiCCO® measurements. In addition, blood and tissue samples were taken to evaluate hemodynamic effects and the degree of inflammatory response.
Results Glibenclamide was able to break through early vasoplegic syndrome by raising the blood pressure and systemic vascular resistance as well as less need of norepinephrine doses. Sevoflurane reduced the occurrence of the vasoplegic syndrome in the mean of stable blood pressure and less need of norepinephrine doses.
Conclusion Glibenclamide could serve as a potent drug to reduce effects of vasoplegic syndrome. Sevoflurane anesthesia during cardiopulmonary bypass shows less occurrence of vasoplegic syndrome and therefore could be used to prevent it in high-risk patients.
Clinical Perspective; what is new?
* to our knowledge, this is the first randomized in vivo study evaluating the hemodynamic effects of glibenclamide after the onset of vasoplegic syndrome
* furthermore according to literature research, there is no study showing the effect of sevoflurane-guided anesthesia on the occurrence of a vasoplegic syndrome
Clinical Perspective; clinical implications?
to achieve better outcomes after complex cardiac surgery there is a need for optimized drug therapy and prevention of the vasoplegic syndrome
In ischemic vascular diseases, leukocyte recruitment and polarization are crucial for revascularization and tissue repair. We investigated the role of vasodilator-stimulated phosphoprotein (VASP) in vascular repair. After hindlimb ischemia induction, blood flow recovery, angiogenesis, arteriogenesis, and leukocyte infiltration into ischemic muscles in VASP−/− mice were accelerated. VASP deficiency also elevated the polarization of the macrophages through increased signal transducer and activator of transcription (STAT) signaling, which augmented the release of chemokines, cytokines, and growth factors to promote leukocyte recruitment and vascular repair. Importantly, VASP deletion in bone marrow–derived cells was sufficient to mimic the increased blood flow recovery of global VASP−/− mice. In chemotaxis experiments, VASP−/− neutrophils/monocytes were significantly more responsive to M1-related chemokines than wild-type controls. Mechanistically, VASP formed complexes with the chemokine receptor CCR2 and β-arrestin-2, and CCR2 receptor internalization was significantly reduced in VASP−/− leukocytes. Our data indicate that VASP is a major regulator of leukocyte recruitment and polarization in postischemic revascularization and support a novel role of VASP in chemokine receptor trafficking.
Protein turnover and quality control by the proteasome is of paramount importance for cell homeostasis. Dysfunction of the proteasome is associated with aging processes and human diseases such as neurodegeneration, cardiomyopathy, and cancer. The regulation, i.e. activation and inhibition of this fundamentally important protein degradation system, is still widely unexplored. We demonstrate here that the evolutionarily highly conserved type II triple-A ATPase VCP and the proteasome inhibitor PSMF1/PI31 interact directly, and antagonistically regulate proteasomal activity. Our data provide novel insights into the regulation of proteasomal activity.
Selective BRAF inhibitors such as vemurafenib have become a treatment option in patients with Langerhans cell Histiocytosis (LCH). To date, only 14 patients receiving vemurafenib for LCH have been reported. Although vemurafenib can stabilize the clinical condition of these patients, it does not seem to cure the patients, and it is unknown, when and how to stop vemurafenib treatment. We present a girl with severe multisystem LCH who responded only to vemurafenib. After 8 months of treatment, vemurafenib was tapered and replaced by prednisone and vinblastine, a strategy which has not been described to date. Despite chemotherapy, early relapse occurred, but remission was achieved by re-institution of vemurafenib. Further investigation needs to address the optimal duration of vemurafenib therapy in LCH and whether and which chemotherapeutic regimen may prevent disease relapse after cessation of vemurafenib.
Venomous secretions from marine snails of the Terebridae family target acetylcholine receptors
(2013)
Venoms from cone snails (Conidae) have been extensively studied during the last decades, but those from other members of the suborder Toxoglossa, such as of Terebridae and Turridae superfamilies attracted less interest so far. Here, we report the effects of venom and gland extracts from three species of the superfamily Terebridae. By 2-electrode voltage-clamp technique the gland extracts were tested on Xenopus oocytes expressing nicotinic acetylcholine receptors (nAChRs) of rat neuronal (α3β2, α3β4, α4β2, α4β4, α7) and muscle subtypes (α1β1γδ), and expressing potassium (Kv1.2 and Kv1.3) and sodium channels (Nav1.2, 1.3, 1.4, 1.6). The extracts were shown to exhibit remarkably high inhibitory activities on almost all nAChRs tested, in particular on the α7 subtype suggesting the presence of peptides of the A-superfamily from the venom of Conus species. In contrast, no effects on the potassium and sodium channels tested were observed. The venoms of terebrid snails may offer an additional source of novel biologically active peptides.
Adolescence has been linked to an enhanced tolerance of uncertainty and risky behavior and is possibly connected to an increased response toward rewards. However, previous research has produced inconsistent findings. To investigate whether these findings are due to different reward probabilities used in the experimental design, we extended a monetary incentive delay (MID) task by including three different reward probabilities. Using functional magnetic resonance imaging, 25 healthy adolescents and 22 adults were studied during anticipation of rewards in the VS. Differently colored cue stimuli indicated either a monetary or verbal trial and symbolized different reward probabilities, to which the participants were blinded. Results demonstrated faster reaction times for lower reward probabilities (33%) in both age groups. Adolescents were slower through all conditions and had less activation on a neural level. Imaging results showed a three-way interaction between age group x condition x reward probability with differences in percent signal change between adolescents and adults for the high reward probabilities (66%, 88%) while adolescents demonstrated differences for the lowest (33%). Therefore, previous inconsistent findings could be due to different reward probabilities, which makes examining these crucial for a better understanding of adolescent and adult behavior.
Ventriculoperitoneal shunts equipped with a reservoir and a valve to manually switch off the shunt function can be used for intraventricular injections of therapeutics in patients suffering from a communicating hydrocephalus caused by leptomeningeal metastases. These shunt devices avoid the risk of injecting therapeutics through the distal leg of the shunt system into the intraperitoneal space, which may cause toxicity. Furthermore, regular intraventricular injections of chemotherapeutics help to maintain sufficient concentrations in the ventricular space. Therefore, ventriculoperitoneal shunts equipped with an on-off valve are a useful tool to reliably inject chemotherapeutics into the ventricles. In order to systematically assess feasibility, safety, and efficacy of this procedure, we performed a retrospective analysis of all patients with leptomeningeal metastases who had received a shunt system at our institution. In total, six adult patients had a ventriculoperitoneal shunt equipped with an on-off valve implanted. Out of these six patients, two patients subsequently received intraventricular injections of chemotherapeutics. The configuration of the valve setting and the intraventricular injections were easily feasible in the setting of a neuro-oncology department. The complication of a shunt leakage occurred in one patient following the first intraventricular injection. No extra-central nervous system (CNS) toxicities were observed. In summary, ventriculoperitoneal shunts with on-off valves are useful tools for reliable intraventricular administration of therapeutics.
Beyond well-established difficulties with working memory in individuals with attention deficit hyperactivity disorder (ADHD), evidence is emerging that other memory processes may also be affected. We investigated, first, which memory processes show differences in adults and adolescents with ADHD in comparison to control participants, focusing on working and short-term memory, initial learning, interference, delayed and recognition memory. Second, we investigated whether ADHD severity, co-occurring depressive symptoms, IQ and physical fitness are associated with the memory performance in the individuals with ADHD.
We assessed 205 participants with ADHD (mean age 25.8 years, SD 7.99) and 50 control participants (mean age 21.1 years, SD 5.07) on cognitive tasks including the digit span forward (DSF) and backward (DSB), the Rey Auditory Verbal Learning Test (RAVLT), and the vocabulary and matrix reasoning subtests of the Wechsler Abbreviated Scale of Intelligence. Participants with ADHD were additionally assessed on ADHD severity, depression symptoms and cardiorespiratory fitness. A series of regressions were run, with sensitivity analyses performed when variables were skewed.
ADHD-control comparisons were significant for DSF, DSB, delayed and recognition memory, with people with ADHD performing less well than the control participants. The result for recognition memory was no longer significant in sensitivity analysis. Memory performance was not associated with greater ADHD or depression symptoms severity. IQ was positively associated with all memory variables except DSF. Cardiorespiratory fitness was negatively associated with the majority of RAVLT variables.
Individuals with ADHD showed difficulties with working memory, short-term memory and delayed memory, as well as a potential difficulty with recognition memory, despite preserved initial learning.
Objective: Vertigo is a common side effect of cochlear implant (CI) treatment. This prospective study examines the incidence of postoperative vertigo over time and aims to analyze influencing factors such as electrode design and insertion angle (IA).
Study Design and Setting: This is a prospective study which has been conducted at a tertiary referral center (academic hospital).
Patients: A total of 29 adults were enrolled and received a unilateral CI using one of six different electrode carriers, which were categorized into “structure-preserving” (I), “potentially structure-preserving” (II), and “not structure-preserving” (III).
Intervention: Subjective vertigo was assessed by questionnaires at five different time-points before up to 6 months after surgery. The participants were divided into four groups depending on the time of the presence of vertigo before and after surgery. Preoperatively and at 6 months postoperatively, a comprehensive vertigo diagnosis consisting of Romberg test, Unterberger test, subjective visual vertical, optokinetic test, video head impulse test, and caloric irrigation test was performed. In addition, the IA was determined, and the patients were divided in two groups (<430°; ≥430°).
Main Outcome Measures: The incidence of vertigo after CI surgery (group 1) was reported, as well as the correlation of subjective vertigo with electrode array categories (I–III) and IA.
Results: Among the participants, 45.8% experienced new vertigo after implantation. Based on the questionnaire data, a vestibular origin was suspected in 72.7%. The results did not show a significant correlation with subjective vertigo for any of the performed tests. In group 1 with postoperative vertigo, 18% of patients showed conspicuous results in a quantitative analysis of caloric irrigation test despite the fact that the category I or II electrodes were implanted, which are suitable for structure preservation. Average IA was 404° for the overall group and 409° for group 1. There was no statistically significant correlation between IA and perceived vertigo.
Conclusions: Though vertigo after CI surgery seems to be a common complication, the test battery used here could not objectify the symptoms. Further studies should clarify whether this is due to the multifactorial cause of vertigo or to the lack of sensitivity of the tests currently in use. The proof of reduced probability for vertigo when using atraumatic electrode carrier was not successful, nor was the proof of a negative influence of the insertion depth.
Introduction and Objectives: Surgical techniques such as preservation of the full functional-length of the urethral sphincter (FFLU) have a positive impact on postoperative continence rates. Thereby, data on very early continence rates after radical prostatectomy (RP) are scarce. The aim of the present study was to analyze very early continence rates in patients undergoing FFLU during RP.
Materials and Methods: Very early-continence was assessed by using the PAD-test within 24 h after removal of the transurethral catheter. The PAD-test is a validated test that measures the amount of involuntary urine loss while performing predefined physical activities within 1 h (e.g., coughing, walking, climbing stairs). Full continence was defined as a urine loss below 1 g. Mild, moderate, and severe incontinence was defined as urine loss of 1–10 g, 11–50 g, and >50 g, respectively.
Results: 90 patients were prospectively analyzed. Removal of the catheter was performed on the 6th postoperative day. Proportions for no, mild, moderate and severe incontinence were 18.9, 45.5, 20.0, and 15.6%, respectively. In logistic regression younger age was associated with significant better continence (HR 2.52, p = 0.04), while bilateral nerve-sparing (HR 2.56, p = 0.057) and organ-confined tumor (HR 2.22, p = 0.078) showed lower urine loss, although the effect was statistically not significant. In MVA, similar results were recorded.
Conclusion: Overall, 64.4% of patients were continent or suffered only from mild incontinence at 24 h after catheter removal. In general, reduced urine loss was recorded in younger patients, patients with organ-confined tumor and in patients with bilateral nerve sparing. Severe incontinence rates were remarkably low with 15.6%.